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Zusammenfassung 
 
Die Methylierung von Cytosin zu 5-methyl-Cytosin in DNA spielt eine wichtige Rolle 
in zahlreichen epigenetischen Regulationsprozessen. In Eukaryoten wird die 
Methylierungsreaktion von der Familie der DNA-Methyltransferasen (Dnmts) 
katalysiert. Das Dnmt2-Protein ist das am höchsten konservierte und das am 
weitesten verbreitete Mitglied dieser Enzymfamilie; jedoch blieb seine katalytische 
Funktion lange rätselhaft. Aufgrund von Strukturanalysen wurde die Vorhersage 
getroffen, dass Dnmt2 eine bona fide DNA-Methyltransferase sein sollte; jedoch 
konnte nur eine sehr geringe katalytische Aktivität von Dnmt2 in einem in vitro 
Methylierungsexperiment nachgewiesen werden. Kürzlich wurde allerdings entdeckt, 
dass Dnmt2 eine tRNA-Methyltransferase ist, welche die Position C38 in dem 
Anticodon-Loop von tRNAAsp methyliert.  
Die vorliegende Arbeit trug zu der weiteren Charakterisierung des Enzyms in dem 
Modellorganismus Drosophila melanogaster bei. Eine Dnmt2-Nullmutante wurde 
charakterisiert und in DNA-Methylierungsanalysen mit Wildtyp-Fliegen verglichen. 
Dnmt2-abhängige DNA-Methylierung wurde an einer definierten Stelle im 
Fliegengenom gefunden: in der 3´-Region des mini-white-Markergens eines mobilen 
Elements, welches in das Retrotransposon Invader 4 gesprungen war.  
In weiteren Experimenten konnte gezeigt werden, dass in vitro transkribierte, nicht 
modifizierte tRNAs als Substrate von Dnmt2 aus Mensch und Fliege akzeptiert 
werden, und dass demnach andere Modifikationen keine Voraussetzung für die 
Substraterkennung durch Dnmt2 darstellen. Neben tRNAAsp wurde tRNAVal als neues 
in vivo und in vitro Substrat von Drosophila Dnmt2 identifiziert. Die Optimierung und 
die vielseitige Anwendung der DNAzym-Methode ermöglichte die Quantifizierung des 
Methylierungssignals. Darüber hinaus konnten mehrere nicht-C38-enthaltende 
tRNAs aus verschiedenen Organismen von Dnmt2 in vitro methyliert werden. Als 
neue Methylierungsstellen wurden C40 in tRNAPhe aus Saccharomyces cerevisiae 
und C40 und C42 in tRNALys aus Drosophila melanogaster identifiziert. Die Analyse 
mehrerer katalytischer Mutanten von humanem Dnmt2 unter Verwendung 
verschiedener tRNA-Substrate zeigte zwei unterschiedliche katalytische 
Mechanismen auf. 
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Summary 
 
The modification of cytosine to 5-methyl-cytosine within DNA plays an important role 
in epigenetic processes. In eukaryotes, the methylation reaction is catalyzed by the 
family of DNA methyltransferases (Dnmts). The Dnmt2 protein is the most conserved 
and most widely distributed member of the Dnmt family, however, its catalytic 
function has been an enigma. Structural analysis predicts the enzyme to be a bona 
fide DNA methyltransferase, though it exhibits only marginal DNA methylating activity 
in vitro. Recently, however, Dnmt2 was discovered to be a tRNA methyltransferase, 
catalyzing the formation of 5-methyl-cytosine at position 38 of tRNAAsp within the 
anticodon stem-loop.  
This work contributed to the further characterization of the enzyme in the model 
organism Drosophila melanogaster. A null mutant was characterized and used for 
further DNA methylation analysis in comparison to Dnmt2-containing wildtype flies. 
Dnmt2-dependent DNA methylation was discovered at one defined locus in the fly 
genome: within the 3´-region of the mini-white marker gene of a mobile element 
which had inserted into the retrotransposon invader 4.  
Further experiments could show that unmodified, in vitro transcribed tRNAs are 
targets of the Dnmt2 enzyme derived from fly and human, and that other 
modifications are not a prerequisite for Dnmt2 target recognition. Besides tRNAAsp, 
tRNAVal was identified as a new target of Dnmt2 in vitro and in vivo. The optimization 
and versatile application of the DNAzyme technique allowed the quantification of the 
methylation signal. Furthermore, non-C38 containing tRNAs from various organisms 
were also found to be methylated by Dnmt2 in vitro. The new methylation site could 
be mapped to C40 in tRNAPhe from Saccharomyces cerevisiae, and to C40 and C42 
in tRNALys from Drosophila melanogaster. The analysis of several catalytic Dnmt2 
mutants of human Dnmt2 in combination with various tRNA substrates revealed two 
different catalytic mechanisms.  
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1  Introduction 
 
1.1 DNA and RNA Modifications 
 
The presence of non-canonical nucleotides in DNA was reported 60 years ago by 
Hotchkiss (Hotchkiss, 1948). Two years later, they were identified as 5-methyl-
cytidine (Wyatt, 1950). Not long after, pseudouridine was detected as the “fifth 
ribonucleoside” in RNA (Cohn & Volkin, 1951; Davis & Allen, 1957; Cohn, 1960). In 
the following decades, the discovery rate of new modified nucleotides increased 
rapidly, culminating in presently more than 100 different modified nucleotides 
reported in RNA and four in DNA (Grosjean & Benne, 1998). By far the most 
nucleotide modifications have been identified in tRNA.  
 
1.2 DNA Methylation 
 
Methylation of DNA can occur at C5 and N4 of cytosine and N6 of adenine. N4-
methylcytosine is restricted to bacteria, and N6-methyladenine can be found in 
bacteria, fungi, and simple eukaryotes such as green algae and ciliates. Only 5-
methylcytosine (m5C; see Fig. 1.1) is present in all three domains of life (reviewed in 
Cheng, 1995 and Wion & Casadesus, 2006). The functions of the methylation signal 
in DNA are diverse. In bacteria, for example, DNA adenine and cytosine methylation 
play an important role in the genome defense against bacteriophages. Hereby, 
methylation of the bacterial DNA is the crucial signal for genome identity or “self” 
(Murray, 2002). Unmethylated DNA will be recognized as an intruder and destroyed 
by endonucleolytic digestion. This interplay of a DNA methyltransferase conferring 
“self” and a restriction endonuclease recognizing and eliminating the unmethylated 
“non-self” DNA has been described as restriction-methylation system(s) (Murray, 
2002). Other functions of bacterial methylation include for example methylation-
guided mismatch-repair, chromosome replication and segregation (reviewed in Wion 
& Casadesus, 2006).  
The role of m5C DNA methylation in higher eukaryotes is much more complex and 
will be described in the following. 
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1.3 Definition of Epigenetics 
 
In higher eukaryotes, the presence of 5-methyl-cytidine in DNA is closely linked to 
epigenetic processes. The term epigenetics describes the phenomenon and the 
analysis of heritable changes in gene function that occur without a change in the 
DNA sequence. “Epi” is a prefix of greek origin meaning “upon” or “above”. 
Epigenetic research encompasses for example the state of modification of DNA and 
its degree of packaging in the context of chromatin. DNA is the information coding 
molecule of the cell, but besides the information itself, it is the accessibility of this 
information which is inherited and contributes to the regulation of gene expression. 
DNA methylation at the position 5 of cytosine in a CpG context and modification of 
histone tail residues by e.g. methylation, acetylation, and ubiquitinylation are the two 
key players which take part in the generation of epigenetic signals. The interplay 
between m5C methylation of genomic DNA and a combination of histone tail 
modifications leads to loose or tight packaging of the nucleosomes, thereby creating 
transcription competent (euchromatin) or transcription incompetent chromatin 
(heterochromatin).  
Fig. 1.1: Chemical structure of 5-methyl-cytosine (m5C) 
5-methyl-cytosine differs from canonical cytosine by the addition of a 
methyl group to the C5 atom of the pyrimidine ring (red circle). R stands 
for the hydrogen atom in 5-methyl-cytosine, and for the (deoxy)ribosyl-
moiety in 5-methyl-cytidine. 
1 
2 
3 
4 
5 
6 
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1.4 The Role of m5C Methylation in Epigenetic Regulatory   
Processes in Higher Eukaryotes 
 
m5C methylation plays an important role throughout the development of an organism. 
Main functions of DNA methylation in higher eukaryotes are the silencing of 
retrotransposons and genes (reviewed in Bird, 2002; Yoder et al., 1997). The 
methylation of satellite sequences in pericentric regions contributes to 
heterochromatin formation and structural stabilization of the chromosomes. 
Furthermore, DNA methylation is involved in imprinting and X-chromosome 
inactivation in the process of dosage compensation in female mammals (Panning & 
Jaenisch, 1998; Feil & Khosla, 1999).  
In animals, methylation occurs usually in the context of CpG dinucleotides. The term 
CpG islands was first mentioned in 1987 (Gardiner-Garden & Frommer, 1987) and 
was later refined to describe regions larger than 500 bp with a GC content equal to or 
greater than 55 % (Takai & Jones, 2002). CpG islands can be found in the promoter 
and exonic regions of about 40 % of all genes (Larsen et al., 1992) where they are 
usually unmethylated. However, in numerous cancers, the methylation of CpG 
islands in the promoters of tumor suppressor genes has been observed (Esteller & 
Herman, 2002). Therefore, aberrant DNA methylation has an important impact on 
cancer development.  
 
 
 
1.5 RNA Modification 
 
The number of observed RNA modifications is much higher compared to DNA. The 
most abundantly modified RNA species is transfer RNA (tRNA). RNA modifications 
have also been detected in ribosomal RNA (rRNA), messenger RNA (mRNA), and 
small RNAs like piwi-interacting RNAs (piRNAs), microRNAs (miRNAs), and small 
nucleolar RNAs (snoRNAs). The cellular function of RNA modifications still remains 
to be determined in many cases. So far, it is largely unclear why many modifications 
are so conserved yet lead to no obvious phenotype when absent.  
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1.5.1 Modifications in rRNA, mRNA and Small RNAs 
 
In ribosomal RNA of higher eukaryotes, three different types of modification at over 
200 sites have been reported: largely 2-O-methylation of the ribose ring, 
pseudouridine, and a few methyl groups at heterocyclic bases (reviewed in Maden et 
al., 1995). Especially the 2-O-methyl groups reside in regions conserved between 
several species and are – like pseudouridine – introduced by snoRNA-dependent 
mechanisms (Maden & Hughes, 1997; Decatur et al., 2007).  
Besides the m7G cap, modified nucleotides found within mRNA are the product of the 
RNA-editing process. In mammals, this is mainly limited to the exchange of adenine 
for inosine. The so-called A-to-I-editing was for example identified in the mRNA of 
mammalian glutamate receptor subunits (Simpson & Emeson, 1996). The exchange 
of adenine for inosine is mediated by an adenosine deaminase. Failure of A-to-I 
editing has been linked to neurological diseases such as amyotrophic lateral 
sclerosis, epilepsy, depression and schizophrenia (reviewed in Maas et al., 2006). In 
addition to inosine, the presence of 6-methyladenine (m6A) in eukaryotic mRNA has 
also been reported (Tuck, 1992; Rottman et al., 1994). 30 – 50 % of all incorporated 
methyl groups into RNA have been attributed to m6A. The majority of analyzed 
mRNAs carries at least one m6A residue, with the exception of histone and globin 
transcripts (Tuck, 1992). 
Even in small RNAs such as snoRNAs and piRNAs, modifications have been 
detected. snoRNAs and piRNAs harbour 2-O-methylated nucleotides, and small 
nuclear RNAs carry pseudouridine (Patton, 1994; Rozenski et al., 1999; Kirino & 
Mourelatos, 2007). piRNAs are modified specifically at their 3´ends (Horwich et al., 
2007). Micro-RNA precursors (pri-miRNAs) are subject to A-to-I editing by adenosine 
deaminases acting on RNA (Luciano et al., 2004; Yang et al., 2006). 
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1.5.2 tRNA Modification  
 
Transfer RNAs are adaptor molecules which are crucial for translation of messenger 
RNA into protein. tRNAs bind with their anticodon to defined codon triplets and carry 
the codon-specific amino acid, which is attached to the emerging peptide chain in the 
ribosome. Of all RNA species, tRNA is by far the most heavily and most diversely 
modified. Presently, around 100 different tRNA modifications have been reported in 
all three domains of life (Fig. 1.2). Some modifications are common to bacteria, 
archaea and eukaryotes – such as inosine, pseudouridine, m1G, m1A, m5U – while 
others are unique and can only be found in bacteria, such as m3Ψ, m4Cm, and m2A 
(Grosjean & Benne, 1998).  
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Fig. 1.2: tRNA modifications of all three kingdoms 
Green circle: eukaryotic tRNA modifications; red circle: tRNA modifications 
found in bacteria; blue circle: tRNA modifications present in archaea. Overlap: 
common tRNA modifications found in two or all three kingdoms. m5C is marked 
in yellow. Adapted from Grosjean & Benne, 1998. 
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tRNA molecules adapt a cloverleaf structure in the secondary structure, with D-loop, 
anticodon-loop and T-loop forming its leaves, with short stems that allow Watson-
Crick pairing for stabilization. The tertiary structure of a tRNA-molecule is L-shaped. 
Modifications are found in all parts of a tRNA molecule, both within the stems and 
loops. An example of modifications that were identified within total tRNA of one 
species is given in Fig 1.3, using S. cerevisiae as a model organism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ψ 
m5C 
I; Gm; Cm; m5C; Ψ; 
ncm5U; ncm5Um; 
mcm5U; mcm5s2U 
m1I; t6A; i6A; 
m1G; yW 
Cm; Am 
D 
Gm 
m1G
m2G
ac4C
m22G; Ψ; m2G 
Cm; Ψ; m3C 
m1A 
m5U 
Um 
m7G 
Ar(p) 
D-Loop T-Loop 
Anticodon-Loop 
variable Loop 
Fig. 1.3: Possible sites of tRNA modification in S. cerevisiae  
A) Two-dimensional structure of a tRNA molecule (scheme). B) Reported tRNA 
modification sites in S. cerevisiae (adapted from Grosjean, 2005). 
A 
B 
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It is important to note that sites of a certain modification can differ between species. 
Fig 1.4 shows a comparison of the m5C modification sites in S. cerevisiae and higher 
eukaryotes. While m5C occurs in S. cerevisiae at positions 34, 40, 48, and 49, it has 
been reported at positions 38, 48, 49, 50, and 72 in animals (tRNA sequence 
database; Sprinzl & Vassilenko, 2005).  
 
 
 
 
 
 
 
1.5.3 Function of tRNA Modifications 
 
tRNA modifications can be classified in several ways, including the chemical 
complexity of modifications, their degree of conservation, as well as their localization 
within the tRNA molecule. The latter allows drawing conclusions about its function. 
Modifications within the anticodon loop are by far the most frequent and are crucial to 
ensure proper translation and correct codon recognition; they are involved in reading 
frame maintenance and show a positive influence on the processivity of translation 
(reviewed in Bjork et al., 1987). Especially positions 34 and 37 within the anticodon 
m5C modification sites 
in S. cerevisiae tRNA 
m5C modification sites in tRNA of 
higher eukaryotes 
Fig. 1.4: m5C tRNA modification sites in S. cerevisiae and higher eukaryotes 
Left: tRNA molecule with m5C modification sites found in S. cerevisiae marked in 
red. Right: m5C modification sites in higher eukaryotes (red circles). Common is 
m5C modification at C48 and C49. m5C methylation at positions 34 and 40 has 
not been reported in animals. There, however, m5C modification can also be 
found at C38, C50, and C72, which is not the case for tRNA of S. cerevisiae. 
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loop are usually hypermodified and contribute to the fine-tuning of codon reading. 
The position 37 is located 3´ to the anticodon and contains very often bulky 
modifications in eukaryotes and eubacteria, especially in the context UNN and ANN, 
where N can be any nucleotide (Bjork et al., 1987). In E.coli, 2-methyl-thio-N6-
isopentenyl-adenosine at position 37 has been found to exert a stabilizing effect on 
the anticodon-anticodon interaction of tRNAPro and tRNATrp (Vacher et al., 1984). The 
lack of this modification in S. typhimurium results in 20 – 50 % reduction in growth 
rate as well as in a reduction of translational chain elongation rate from 16 amino 
acids per second (aa/ s) to 11 aa/ s (Ericson & Bjork, 1986). The direct influence of a 
bulky modification present at position 37 on ribosome binding could be demonstrated 
with yW37 of yeast tRNAPhe. Its absence led to reduced binding to ribosomes and 
inefficient in vitro translation performance (Thiebe & Zachau, 1968; Bjork et al., 
1987). Of all the smaller modifications present at position 37, the presence of m1G 
after an anticodon starting with C is very frequent.  
To ensure the decoding of 61 amino acid codons by the ~ 40 tRNAs, some tRNAs 
must recognize more than one codon. This can be explained by the wobble 
hypothesis. The nucleotide at position 34 in the anticodon of a tRNA binds to the third 
base of the mRNA codon triplet with relaxed affinity and enables non-canonical (non-
Watson-Crick) base pairing, which increases the number of recognizable codons for 
one tRNA (reviewed in Agris et al., 2007).  
Therefore, the important role of these modifications lies primarily in the expansion 
and regulation of codon reading and improvement of translation fidelity. Several 
examples exist in bacteria and eukaryotes where the presence of a modification at 
position 34 leads to the preferred and more efficient binding of one codon over the 
other, which differ only in the third letter of the to-be-read codon sequence (Lustig et 
al., 1981; Hagervall & Bjork, 1984). The modification of position 34 with queuosine 
(Q) can be found in tRNATyr, tRNAHis, tRNAArg, and tRNAAsp. In Drosophila 
melanogaster, the presence of Q in tRNAHis also has an influence on codon choice: 
when tRNAHis carrying either GUG or QUG in the anticodon was analyzed for the 
acceptance of the codons CAC and CAU, unmodified tRNAHis displayed a clear 
preference for CAC over CAU, whereas the queuosine-carrying tRNAHis accepted 
both codons equally well (Meier et al., 1985). This finding points to a role of 
queuosine modification in translational regulation, with a possible impact on gene 
expression depending on codon usage and frequency. 
Introduction 
  19  
Other modifications within the anticodon loop have been reported at positions 32, 35, 
38, 39 and 40, and consist mainly of Ψ and m5C (Bjork et al., 1987; Grosjean, 2005). 
Especially for m5C and pseudouridine, the stabilization of nucleic acid structure by 
increased base stacking has been described (Agris et al., 1995; Helm, 2006).  
The structural stabilization of the tRNA and facilitated Mg2+ binding is also the main 
function of modifications outside the anticodon loop. Studies using tRNA of 
hyperthermophile organisms such as Thermus thermophilus identified modifications 
at position 54 (2-thioribothymidine) and 58 (m1A) in the T-Loop, which are important 
for tRNA stability at high temperatures (up to 80 °C). The absence of these 
modifications is associated with a thermosensitive phenotype (Kowalak et al., 1994; 
Shigi et al., 2002; Droogmans et al., 2003). Melting curve analyses revealed that the 
absence of 2-thioribothymidine at position 54 lowers the melting point of tRNAIle by 
three degrees compared to wildtype, 2-thioribothymidine containing tRNAIle (Horie et 
al., 1985).  
 
1.6 Nucleotide Modification Associated Diseases 
 
1.6.1 DNA Methyltransferases and Cancer 
 
The role of dysregulated DNA methylation and other epigenetic mechanisms in 
cancer development becomes evident in the large number of studies and reviews 
published on this topic. Concerning DNA methylation within tumors, two general 
features are observed which differ from healthy cells: First, the hypomethylation of 
pericentromeric satellites and other repeat sequences such as retrotransposons, and 
second, the hypermethylation and silencing of normally unmethylated and active 
tumor suppressor genes. The occurrence of hypomethylation in tumors was first 
observed 25 years ago (Feinberg & Vogelstein, 1983). The reduction in methylation 
levels can vary greatly between tumor types and is most evident in colon and breast 
cancers (reviewed in Wilson et al., 2007). Possible causes for the decrease in m5C 
content are altered activities of methyltransferases and histone modification 
enzymes, but also dietary factors, infection and environmental influences. 
Detrimental carcinogenic consequences for the affected cell are loss of imprinting, 
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microsatellite instability, activation of retrotransposons, and chromosomal instabilities 
(Wilson et al., 2007).  
The inactivation of tumor suppressor genes on both alleles by mutation or loss of 
heterozygosity is a crucial step in carcinogenesis. Similarly, the silencing of one allele 
by promoter CpG island methylation is a possibility to eliminate tumor suppressor 
gene function (Jones & Laird, 1999). Epigenetically silenced tumor suppressor genes 
include p16ink4A, p53, MLH1, BRCA1, VHL, TIMP3, ATM, and APC (reviewed in 
Baylin & Herman, 2000; Jones & Baylin, 2002). Many studies have reported an 
upregulation of one or more DNA methyltransferases in tumor tissues. In a study 
including ten matched sets of tumor and healthy tissue derived from bladder, colon, 
kidney and pancreas, overexpression of the Dnmt1, 3a and 3b was seen in at least 
50% of all cases. In some tumor samples, a simultaneous upregulation of all three 
Dnmts could be observed (Robertson et al., 1999).  
 
1.6.2 Imprinting disorders 
 
Imprinted genes are expressed in a parent-of-origin-specific manner. Only the allele 
coming either from the mother or the father is expressed while the other is 
epigenetically silenced. Many of the imprinted genes play an important role in 
embryonic growth regulation. Usually the paternally expressed genes support fetal 
growth, while the maternally expressed genes exert a growth-limiting effect. The 
disturbance of the carefully regulated expression pattern of these imprinted genes 
leads to their bi-allelic expression and manifests in imprinting disorders such as 
Angelman syndrome, Prader-Willi syndrome, Silver-Russell syndrome (SRS), and 
Beckwith-Wiedemann syndrome (BWS). Hypo- and hypermethylation of imprinting 
control regions (ICR) can also play a substantial role (reviewed in Eggermann et al., 
2008). While SRS is characterized by severe growth retardation, BWS is associated 
with overgrowth. This contrasting phenotype is mirrored in the epigenetic status of 
two imprinting control regions. While ICR1 on 11p15 is hypermethylated in BWS, it is 
hypomethylated in SRS. ICR2, on the other hand, is hypomethylated in BWS and 
hypermethylated in SRS (Eggermann et al., 2008).  
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1.6.3 tRNA point mutations and mitochondrial diseases 
 
High concentrations of reactive oxygen species within mitochondria render the 
mitochondrial genome especially sensitive to DNA damage. Point mutations within 
the mitochondrially encoded tRNA genes have been shown to contribute to a number 
of mitochondrial diseases with complex symptoms. The mutation A3243G within the 
tRNALeu(UUR) gene, for example, contributes to the MELAS (mitochondrial 
encephalomyopathy, lactic acidosis and stroke-like episodes) and MIDD (maternally 
inherited diabetes and deafness) syndromes (Goto et al., 1990; van den Ouweland et 
al., 1992). Several mutations within mitochondrial tRNALys and tRNALeu(UUR) are 
implicated in MERRF (myoclonic epilepsy associated with ragged red fibers) 
(Shoffner et al., 1990 ; Zeviani et al., 1993). In these mutant tRNAs, the modification 
taurine (2-aminoethanesulphonic acid) is missing at the wobble position 34 (Suzuki et 
al., 2002). The phenotypes and onset of the multisystem disorders MELAS and 
MERRF are very diverse. Myopathies, seizures and deafness are among the most 
frequently observed features, which correlates with a very high number of 
mitochondria in muscle and brain tissue (Finsterer, 2007).  
 
1.6.4 tRNA modifications and cancer 
 
Fluctuations in tRNA modification status occur between different organs, and can be 
induced by hormones or drug treatment. Variation in modification content is also 
observed during ageing and differentiation (reviewed in Dirheimer et al., 1995). Over 
the last fifty years, many laboratories have searched for a possible link between 
hypo- or hypermodified tRNAs and cancer development. The comparison of Morris 
hepatoma cells to hepatocytes revealed less m5U, m3C, m5C in cancer versus 
healthy tissue, as well as a hypermodification of m1G (Randerath et al., 1974). Using 
mainly mouse and rat as experimental systems, changes of multiple modifications 
were detected in several tRNAs in various tumor types (summarized in Dirheimer et 
al., 1995). However, tRNA modification differences were also found in human 
cancers. Emmerich and colleagues analyzed the queuosine content (usually found at 
position 34 in tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr) in human lymphomas and 
leukemias and found that queuosine is underrepresented in these cancer cells. 
Moreover, the degree of underrepresentation correlated with the malignancy of the 
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disease (Emmerich et al., 1985). Similar results were achieved with solid lung 
tumors, where a high correlation between lack of Q (and replacement by G) and the 
histopathological classification was demonstrated (Huang et al., 1992). These data 
are further supported by a study of ovarian cancers, which shows a link between 
queuosine deficiency and differentiation state of the tumor (Baranowski et al., 1994).  
 
1.7 Structural Motifs of DNA and RNA Methyltransferases – Similar 
yet Different 
 
 
Common to DNA m5C methyltransferases are ten conserved motifs, numbered I to X, 
which can usually be found arranged in strict order and form two domains (see Fig. 
1.5). The large domain consists of the motifs I to VIII and X, while the small domain 
comprises motif IX and a variable region with very low sequence conservation and 
great variation in length. Motif I is the cofactor binding site; additionally, motifs II-V 
and X also play an important role in the formation of a binding pocket for the cofactor 
and methyl-group donor S-adenosyl-methionine (SAM). The catalytic site (consisting 
of an invariant Pro-Cys dipeptide) resides in motif IV (Kumar et al., 1994). The target 
recognition domain is situated in a loop region between motif VIII and IX in the small 
domain. These ten important signature motifs are also present in RNA m5C 
methyltransferases. However, the sequence context as well as the degree of 
conservation can vary, and sometimes the motifs can only be identified by structural 
homology. Usually, the order of the ten motifs is X-I-II-III-IV-V-VI-VII-VIII-IX, while in 
DNA m5C methyltransferases, motif X is C-terminal. In some cases, the order of the 
motifs has been found rearranged. Nevertheless, the presence of the structural 
motifs in DNA and RNA m5C methyltransferases predicts their function: the transfer 
of methyl groups onto nucleic acids (Reid et al., 1999; Bujnicki et al., 2004).  
Despite the similar structural outline that is necessary for substrate recognition, SAM-
binding and catalysis, striking differences regarding the catalytic residue have been 
reported. Both DNA and RNA m5C methyltransferases use a highly conserved 
cysteine as the catalytic residue. The catalytic cysteine of DNA m5C 
methyltransferases lies in motif IV, whereas RNA m5C methyltransferases use two 
conserved cysteines in motifs IV and VI. After mutational studies of the two 
conserved cysteines, the cysteine in motif VI was proposed to be responsible for the 
actual formation of the enzyme-RNA intermediate (see below), and the cysteine in 
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motif IV to be involved in the reversal of the covalent intermediate (King & Redman, 
2002; Walbott et al., 2007b). Sequence analysis of RNA and DNA m5C 
methyltransferases revealed that while both possess the highly conserved cysteine in 
the proline-cysteine-context in motif IV, only RNA m5C methyltransferases harbour 
the second conserved cysteine in motif VI (Bujnicki et al., 2004).  
 
 
 
 
 
N
IX
TRD 
C
VIII VI IV X I II III
Fig. 1.5: Conserved motifs within the catalytic domain of DNA 
methyltransferases 
The catalytic domain consists of two subdomains. The large subdomain contains 
motifs I, II, III, IV, V, VI, VIII and X. The small domain encompasses motif IX and 
the target recognition domain (TRD). Motif I, II-V and X participate in cofactor 
binding. Motif IV carries the catalytic site, an invariant PC dipeptide. (Adapted from 
Dong et al., 2001) 
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1.8 Common Mechanism of DNA and RNA Methyltransferases 
 
1.8.1 Base Flipping and SAM binding 
 
Surprisingly, the core structure encompassing the SAM-dependent MTase fold is 
similar for all methyltransferases, regardless of their targets ranging from small 
molecules such as glycine to macromolecules such as DNA or tRNA. The question 
arises how an enzyme that methylates deoxycytosine in a DNA template can access 
its target base if it is hidden within the double helix (Cheng & Roberts, 2001). In 
1994, Klimasauskas and colleagues analyzed the crystal structure of the bacterial 
methyltransferase MHhaI from Haemophilus haemolyticus together with S-adenosyl-
L-homocysteine and a duplex 13mer DNA oligonucleotide (Klimasauskas et al., 
1994). In the resolved structure, the authors were able to show that the target base is 
flipped out of the helix by a rotation on its flanking sugar-phosphate bonds by an 
angle of 180°. This enables the easy projection of the target base into the concave 
catalytic pocket of the methyltransferase without the cleavage of covalent bonds 
(Cheng & Roberts, 2001; Klimasauskas et al., 1994).  
S-adenosyl-L-methionine (SAM) is the cofactor common to all methyltransferases. Its 
chemical properties make this molecule a good methyl group donor. The attachment 
of the methyl group to the sulphur atom adds a positive charge to the sulfur and 
leads to thermodynamic destabilization and increased reactivity of the usually inert 
methylthiol towards nucleophiles such as N, O, S and carbanions (Cheng & Roberts, 
2001; Hermann et al., 2004; Fontecave et al., 2004).  
 
1.8.2 Catalytic mechanism 
 
The catalytic mechanism of methyl group transfer to position 5 of cytosine was first 
proposed for the bacterial DNA methyltransferase MHhaI by (Wu & Santi, 1987). 
Detailed kinetic analysis revealed a sequential order of DNA binding to the enzyme, 
followed by the binding of the cofactor S-adenosyl-methionine. After methyl group 
transfer and conversion of S-adenosyl-methionine to S-adenosyl-homocysteine 
(SAH), the cofactor is released from the enzyme-DNA-cofactor complex prior to the 
dissociation of the DNA from the enzyme. SAH is then further hydrolyzed to 
adenosine and homocysteine by AdoHcy hydrolase (Chiang et al., 1996). 
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The actual methylation step comprises the attack of an invariant cysteine residue of 
the enzyme as a nucleophile to the C6 atom of the target cytosine ring, thereby 
creating a covalent intermediate: a dihydropyrimidine with carbanion character at C5. 
This renders the C5 atom sufficiently nucleophilic to accept the methyl group from its 
donor, S-adenosyl-methionine (Wu & Santi, 1987 and Fig. 1.6). The catalytic center 
in motif IV, which comprises the proline-cysteine (PC) dipeptide, is found in all DNA 
methyltransferases. Due to the high conservation of the structured catalytic motifs, 
the above described catalytic mechanism is not limited to prokaryotic 
methyltransferases but also holds true for the DNA methyltransferases of higher 
eukaryotes. Additionally, a conserved glutamic acid residue within the amino acid 
sequence ENV in motif VI plays an important role in the stabilization of the DNA-
enzyme complex through contact of N3 in the pyrimidine ring (Jeltsch et al., 2006). 
As mentioned above, for RNA m5C methyltransferases, another conserved cysteine 
residing in motif VI has been suggested to be the site of catalysis. Its inactivation 
abolished all enzymatic activity, whereas the mutation of the cysteine in motif IV 
showed no effect (Walbott et al., 2007b; Liu & Santi, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.6: The catalytic mechanism of DNA and RNA methyltransferases 
The nucleophilic attack of the invariant cysteine at position 6 of the pyrimidine ring is 
facilitated by a glutamatic residue interacting with N3. After the formation of  the 
dihydropyrimidine covalent intermediate, the nucleophilic C5 accepts the methyl 
group from its donor, SAM. Figure modified after Jeltsch et al., 2006. 
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1.9 Eukaryotic DNA Methyltransferases  
 
The methylation mark at position 5 of cytosine is catalyzed by DNA 
methyltransferases. In the eukaryotic kingdom, these enzymes can be divided into 
three classes according to sequence and structure, namely the Dnmt1, Dnmt2, and 
Dnmt3 families (Fig. 1.7). Not all organisms possess DNA methyltransferases of 
every family, and there are even organisms without any DNA methyltransferase, such 
as Caenorhabditis elegans and Saccharomyces cerevisiae.  
 
1.9.1 The Dnmt1 Family of DNA Methyltransferases 
 
The first mammalian DNA methyltransferase was cloned in 1988 (Bestor, 1988) and 
was later named Dnmt1. Murine Dnmt1 comprises 1620 amino acids, with a long N-
terminal region containing regulatory domains of partly unknown function. Among 
them are a nuclear localisation signal domain (NLS-domain), a domain which targets 
replication foci via PCNA (proliferating cell nuclear antigen) interaction (PCNA 
binding domain, PBD domain), a zinc binding domain (Zn-domain), a cysteine-rich 
region and a polybromo homology domain (PBHD) (Fatemi et al., 2001; Margot et al., 
2003). Only the C-terminal part displays high homology to bacterial 
methyltransferases, which led to the conclusion that mammalian and prokaryotic 
DNA methyltransferases share a common evolutionary origin (Bestor, 1988). A 
schematic overview of the domains of DNA methyltransferases is given in Fig. 1.7. 
In vitro methylation assays using various substrates showed a clear preference of 
human Dnmt1 for hemimethylated DNA (Gruenbaum et al., 1983; Pradhan et al., 
1999; Fatemi et al., 2001), which led to the conclusion that Dnmt1 is a maintenance 
methyltransferase. During replication, methylation of the unmethylated daughter 
strand is re-established using the parental DNA strand as a template. Support for this 
theory comes from the observation that Dnmt1 is recruited to DNA repair sites 
(Mortusewicz et al., 2005) and interacts with PCNA via its PBD domain also at 
replication foci. The PCNA interaction leads to a two-fold increase in methylation 
efficiency (Schermelleh et al., 2007). The targeted mutation of both Dnmt1 alleles in 
murine embryonic stem cells resulted in a decrease of m5C content in the DNA by 
two thirds, with no effect on the growth rate and morphology. However, homozygous 
mutant mouse embryos display a recessive lethal phenotype and die around mid-
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gestation. Earlier stages appear stunted and delayed in development (Li et al., 1992). 
A similar effect was observed upon the injection of Dnmt1-overexpressing embryonic 
stem cells into early blastocysts: these embryos die as well (Biniszkiewicz et al., 
2002). One major cause for the embryonic lethality is the loss of imprinting due to 
disruption of allele-specific methylation signals. Loss of methylation signal due to 
absence of Dnmt1 or hypermethylation due to Dnmt1 overexpression leads to 
biallelic gene expression e.g. of the important growth factor Igf2 (Li et al., 1992; 
Biniszkiewicz et al., 2002).  
 
1.9.2 The Dnmt3 Family of DNA Methyltransferases 
 
The presence of a de novo DNA methyltransferase activity in mammalian cells 
became evident in 1996. Looking closely at Dnmt1 null mutant mouse embryonic 
stem cells, Lei and coworkers observed stable levels of m5C and low de novo 
methyltransferase activity independent of Dnmt1 (Lei et al., 1996). Three years later, 
two members of this new family of de novo methyltransferases – called Dnmt3 – 
were cloned and characterized in detail. The human Dnmt3a and 3b proteins were 
shown to be highly homologous to the murine Dnmt3 enzymes, especially in the 
C-terminal catalytic domain and in a cysteine-rich region (Xie et al., 1999). 
Expression studies revealed Dnmt3a mRNA transcripts throughout most tissues. 
Dnmt3b is expressed at much lower levels. Both enzymes are of essential 
importance for proper de novo methylation and mammalian development (Okano et 
al., 1998a). The generation of homozygous mouse mutants lead to the observation 
that Dnmt3a-/- mice die 4 weeks after birth, whereas Dnmt3b-/- mice do not develop 
further than E9.5 (embryonic day 9.5). Homozygous Dnmt3a-/- Dnmt3b-/- double 
mutants are smaller and display abnormal morphology as early as E 8.5 and die 
before E11.5 (Okano et al., 1998a). A conditional, germ-line-specific knockout of 
Dnmt3a and 3b allowed the study of their impact on imprinting. Embryos derived from 
their conditional knockout mothers died early and showed absence of methylation at 
maternally imprinted loci (Kaneda et al., 2004). The conditional knockout males had 
defective spermatogenesis. However, Dnmt3b conditional knockouts had apparently 
healthy offspring and showed no observable phenotype.  
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1.9.3 The Dnmt2 Family of DNA Methyltransferases 
 
Dnmt2 is the most highly conserved and most widely distributed DNA 
methyltransferase (Dong et al., 2001). With the notable exception of Caenorhabditis 
elegans and Saccharomyces cerevisiae, this protein has been reported in many 
model organisms such as Drosophila melanogaster, Bombyx mori, Arabidopsis 
thaliana, Xenopus laevis, Danio rerio, Mus musculus, and Homo sapiens. It is also 
present in simple eukaryotes such as Dictyostelium discoideum and Entamoeba 
histolytica. Compared to the Dnmt1 and Dnmt3 enzymes, Dnmt2 is rather small and 
consists only of the catalytic domain. Additional N-terminal regulatory domains are 
absent. The structure of the catalytic domain of human Dnmt2 is nearly 
superimposable on the structure of the bacterial DNA methyltransferase MHhaI 
(Dong et al., 2001), and carries the ten catalytic motifs in the correct order. The target 
recognition domain is surrounded by a 41 amino acid stretch of highly conserved 
residues (Dong et al., 2001). Structural analysis clearly allows the prediction that 
Dnmt2 is a bona fide DNA methyltransferase. Surprisingly, this enzyme failed to 
show DNA methylating activity in the classical in vitro methylation assays (Okano et 
al., 1998b). Nevertheless, denaturing-resistant binding of Dnmt2 to DNA was 
reported in vitro (Dong et al., 2001). Others were able to detect residual methylating 
activity, however at a much lower level than Dnmt1 and Dnmt3a and b. An m5C spot 
resulting from Dnmt2 enzymatic activity on λ-DNA or PCR-amplified plasmid DNA in 
an in vitro methylation assay could be detected by two-dimensional thin-layer 
chromatography (Hermann et al., 2003). In mouse and human, Dnmt2 is expressed 
in various presumable splice forms in all tissues at low levels; with highest 
transcription rates in testis, ovary and thymus (Yoder & Bestor, 1998). Dnmt2 
knockout mice show no obvious phenotype and are viable and fertile. Despite the 
high degree of conservation, this enzyme is therefore not essential for development 
(Goll et al., 2006). The targeted deletion of the catalytic motif crucial for Dnmt2 
function in murine embryonic stem (ES) cells had no effect on global methylation 
levels or de novo methylation of newly integrated retroviruses (Okano et al., 1998b). 
In vivo data supporting a DNA methylating function of the enzyme Dnmt2 has been 
reported in three model organisms: the slime mold Dictyostelium discoideum, the 
amoeba Entamoeba histolytica and the fruit fly Drosophila melanogaster (see below). 
Ribosomal DNA circles from Entamoeba histolytica were enriched via m5C-binding 
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antibodies, and their methylation status was confirmed by bisulfite sequencing 
(Fisher et al., 2004). In addition, the m5C methyltransferase Ehmeth was described, 
which bears high homology to human Dnmt2 and was shown to (weakly) methylate 
genomic DNA of Entamoeba (Banerjee et al., 2005). Further analysis revealed that 
Ehmeth is a nuclear matrix binding protein which binds to a DNA region that includes 
a scaffold/matrix attachment region. The overexpression of Ehmeth leads to a 
complex phenoptype, with resistance to oxidative stress, upregulation of the heat 
shock protein HSP70, and the accumulation of multinucleated cells (Fisher et al., 
2006). In Dictyostelium discoideum, only one DNA methyltransferase has been 
identified: DnmA, which belongs to the Dnmt2 family. Despite the very low genome-
wide methylation content of 0.2 % of all cytosines (Kuhlmann et al., 2005), two 
methylated regions could be identified. The retrotransposons DIRS-1 and Skipper 
carry mostly asymmetric m5C methylation (in a non-CpG context), which is lost upon 
disruption of DnmA. A developmental role of DnmA has been suggested, but is 
discussed controversially. While Kuhlmann et al. reported a downregulation of DnmA 
throughout the developmental cycle, Katoh et al. observed an increase of methylation 
during development and described morphological defects of DnmA mutants in late 
developmental stages (Katoh et al., 2006).  
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1.9.4 A Methylation System in Drosophila Mediated by Dnmt2 
 
The first finding of a potential DNA methylation system in Drosophila melanogaster, 
consisting of the m5C methyltransferase Dnmt2 and a methyl-CpG-binding-domain 
protein (MBD2/3), was reported by Tweedie and colleagues (Tweedie et al., 1999). 
Sequence comparison with yeast (S. pombe) and mouse DNA methyltransferases 
led to the classification of Dnmt2 as a member of the Dnmt2 family of m5C 
methyltransferases, with a reported sequence homology to both mammalian Dnmt2 
Fig. 1.7: Structural comparison of DNA methyltransferase families of the 
animal kingdom 
Dnmt1 has the largest N-terminal regulatory domain consisting of a nuclear 
localization signal (NLS), the replication foci-localization domain, a cysteine-rich 
region, and a large polybromo homology domain (PBHD). Dnmt2 is the smallest 
enzyme and consists only of the catalytic region and has no N-terminal regulatory 
domain. The de novo methyltransferases Dnmt3a and 3b carry a PWWP domain 
and a cysteine-rich region. Dnmt3L misses the complete catalytic region and 
shows homology to the Dnmt3a and 3b proteins via its conserved cysteine-rich 
region. Adapted from (Goll & Bestor, 2005). 
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and pmt1 of 50 % (Hung et al., 1999). Dnmt2 transcript was found throughout all 
developmental stages. Further studies of expression revealed predominant 
expression of Dnmt2 transcript in ovarian nurse cells and through early embryonic 
development (Lyko et al., 2000b). The occurrence of endogenous m5C DNA 
methylation in young embryos of D. melanogaster was reported using sensitive 
methods such as HPLC and nearest neighbour analysis (Lyko et al., 2000a). 
Interestingly, m5C methylation appeared mainly in a CpT context, as opposed to the 
CpG context reported for mammals. Later, additional expression studies 
demonstrated the expression of Dnmt2 throughout embryonic and larval 
development, although slightly reduced in second and third instar larvae. Gowher 
and colleagues demonstrated the presence of m5C in genomic DNA of all 
developmental stages using a combinatorial approach of nucleoside purification by 
HPLC, radioactive labelling, and one- or two-dimensional thin-layer-chromatography 
(Gowher et al., 2000). Dnmt2 protein was detected in all developmental stages of 
Drosophila, albeit to a lower extent in somatic tissue of adult flies (Schaefer et al., 
2008). Biochemical analysis of cellular Dnmt2 localization revealed that Dnmt2 is 
mainly cytoplasmic (as has also been reported by Goll et al., 2006), but in addition, a 
significant nuclear fraction could be detected. Throughout the cell cycle, Dnmt2 
accumulated in mitotic cells and localized to mitotic nuclei in a dynamic fashion 
(Schaefer et al., 2008).  
 
1.10 RNA m5C Methyltransferases  
 
1.10.1 Trm4 
 
A well characterized m5C methyltransferase acting on tRNA is the Trm4 enzyme of S. 
cerevisiae. Originally identified by homology search using the bacterial ribosomal 
m5C methyltransferase SUN for comparison, this multisite-specific enzyme was found 
to methylate cytosines at positions 34, 40, 48 and 49 (Motorin & Grosjean, 1999). 
The actual site of methylation was mapped by nearest neighbour analysis. The 
occurrence of m5C at positions 48 or 49 is quite frequent and does not require any 
pre-modifications, as in vitro transcribed tRNA and total tRNA of E.coli are accepted 
as substrates for Trm4. However, the methylation at positions 34 and 40 was 
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identified in only two tRNA species, tRNALeu(CUA) and tRNAPhe(GAA), and the presence 
of an intron is absolutely mandatory for correct target recognition of these two pre-
tRNAs. The methylating activity was measured by 3H incorporation into tRNA, using 
radioactive S-adenosyl-methionine as the methyl-group donor. Comparison of 
several tRNA targets revealed differing turnover rates. Apparently, the methylation at 
C48 or 49 is slightly faster than the methylation of the intron-containing pre-tRNAs. 
Deletion of the Trm4 gene abolished all detectable m5C methylation within yeast 
tRNA. Therefore, in S. cerevisiae, Trm4 can be considered the only m5C tRNA 
methyltransferase. The human orthologue of yeast Trm4 was identified in 2006, albeit 
with limited substrate recognition ability. Only the intron-dependent methylation of 
C34 could be demonstrated for hTrm4; whereas no methylation of positions 48 and 
49 was detected in both human and yeast tRNA precursors. hTrm4 is encoded as a 
single-copy gene on chromosome 5 and the protein was found to be localized in the 
nucleoplasm and nucleolus (Brzezicha et al., 2006).  
 
1.10.2 Dnmt2 as a tRNA m5C Methyltransferase 
 
The enzymatic activity of Dnmt2 was further characterized in 2006, when Goll et al. 
reported that recombinant, his-tagged hDnmt2 enzyme was able to methylate 
tRNAAsp derived from homozygous Dnmt2 mutants of Mus musculus, Arabidopsis 
thaliana and Drosophila melanogaster. RNA samples from the respective wildtype 
organisms could not be modified, arguing for the presence of an endogenous 
methylation signal which blocks additional methylation by the recombinant enzyme 
(Goll et al., 2006). Mass spectrometry analysis led to the identification of tRNAAsp as 
the target molecule, and the site of methylation was narrowed down to C38 in the 
anticodon loop. The authors did not observe methylation of in vitro transcribed, 
unmodified tRNAAsp, which led to their hypothesis that methylation by Dnmt2 
depends on other tRNA modifications. One year later, the first severe phenotype in a 
Dnmt2 null mutant was reported in the zebrafish Danio rerio (Rai et al., 2007). 
Previous mutants in mouse and fruitfly had not shown any deviation from wildtype 
behaviour and development. 
In Danio rerio, the morpholino knockdown of the Dnmt2 enzyme led to severe 
differentiation defects in retina, liver and brain, which became evident at 80 hours 
post fertilization. Rescue experiments using Dnmt2 targeted either exclusively to the 
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nucleus or the cytoplasm revealed that the phenotype can only be reversed if Dnmt2 
localizes to the cytoplasm. Furthermore, immunopurified Dnmt2 of zebrafish was 
incubated with morphant-derived or wt-derived RNA and radioactive SAM, which 
resulted in 7.5 fold increase in tritium-incorporation in the 80 base species of 
morphant-RNA (where endogenous Dnmt2 had been knocked down) compared to 
the wildtype situation. In summary, the data obtained in zebrafish support the 
hypothesis that the Dnmt2 enzyme is a cytosolic tRNA methyltransferase. 
 
1.11  Aim of this work 
 
Dnmt2 is an enigmatic enzyme which was assigned to the family of DNA m5C 
methyltransferases based on sequence homology to the other family members 
Dnmt1, Dnmt3a/b, and its nearly superimposable structure onto the bacterial 
methyltransferase MHhaI (Dong et al., 2001). However, the extremely weak catalytic 
activity on DNA raises questions about its target preference. Two years ago, Goll and 
co-workers found that Dnmt2 is able to exclusively methylate position C38 in 
tRNAAsp, which was derived from Dnmt2 mutant mice and flies (Goll et al., 2006). The 
authors made a strong effort to state that Dnmt2 activity is limited to tRNAAsp.  
The aim of this work was to characterize the enzymatic function of Dnmt2 with 
special focus on the identification of further target molecules, their characterization 
with respect to the degree of m5C modification, and the detailed investigation of the 
catalytic mechanism of the Dnmt2 m5C methyltransferase.  
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2  Results 
 
 
In vivo studies of Dnmt2 function and its substrates have proven to be very 
challenging. Especially the analysis of its DNA methylating activity requires a careful 
choice of model organism, as it is crucial to distinguish obtained 5-methyl-cytosine 
measurements from the activities of other DNA methyltransferases present in the 
animal model. Since the fruitfly Drosophila melanogaster carries the Dnmt2 gene as 
the only member of the DNA methyltransferase family, it is ideally suited for the 
investigation of Dnmt2 function. Therefore, this work started with the characterization 
of an important tool for many experiments: a Dnmt2 null mutant.  
 
 
2.1 The Genomic Locus of the Putative Null Mutant Dnmt2149 
 
The putative Dnmt2-null mutant Dnmt2149 was obtained and created by our 
collaborators Sameer Phalke and Günther Reuter (University of Halle) through an 
imprecise excision screen out of the founder line GE15695 (also called “EP”), which 
contains a P-element situated upstream of the Dnmt2 gene. Upon mobilization of the 
P-element, it inserted into the Dnmt2 gene and was cut out again incompletely, 
leaving 55 bp of transposon sequence (plus 13 bp duplicated endogenous sequence) 
within the Dnmt2 gene behind (Fig. 2.1 A and B). The inserted bases cause a 
frameshift during codon-reading in the translation process. In silico translation of the 
Dnmt2149 gene shows a complete change in amino acid sequence after the first 
18 amino acids (Fig 2.1 C).  
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   GE15695 Line: 
Dnmt2149: Dnmt2 
imprecise P-element 
excision 
Dnmt2 
 
Sequencing of the genomic Dnmt2149 locus 
 
  Dnmt2 (Flybase): 
 
ATGGTATTTCGGGTCTTAGAACTATTTAGTGGCATTGGCGGCATGCATTATGCCTTTAATTGTG
AGTTCGTCGATCATGATACATGCGAAACTAATATATACTTTTGAAGATGCCCAATTGGATGGAC
AAATAGTTGCCGCCTTGGATGTCAACACCGTGGCCAATGCGGTTTATGCGCACAATTACGGC
AGTAATTTGG 
 
   Dnmt2149: 
 
ATGGTATTTCGGGTCTTAGAACTATTTAGTGGCATTGGCGGCATGCATTATGCCATGATGAAA
TAACATATGTTATGTTATGTATATGTATATATATATGTTATTTCATCATGCATTATGCCTTTAATT
GTGAGTTCGTCGATCATGGTACATGCGAAACTAATATATACTTTTGAAGATGCCCAATTGGAT
GGACAAATAGTTGCCGCCTTGGATGTCAACACCGTGGCCAATGCGGTTTATGCGCACAATTA
CGGCAGTAATTTGG 
 
A 
B 
 
In silico translation 
 
       Dnmt2 protein sequence (wt): 
 
MVFRVLELFSGIGGMHYAFNYAQLDGQIVAALDVNTVANAVYAHNYGSNLVKTRNIQSL
SVKEVTKLQANMLLMSPPCQPHTRQGLQRDTEDKRSDALTHLCGLIPECQELEYILMEN
VKGFESSQARNQFIESLERSGFHWREFILTPTQFNVPNTRYRYYCIARKGSDFPFAGGKI
WEEMPGAIAQNQALSQIAEIVEENVSPDFLVPDDVLTKRVLVMDIIHPAQSRSMCFTKGY
THYTEGTGSAYTPLSEDESHRIFELVKEIDTSNQDASKSEKILQQRLDLLHQVRLRYFTP
REVARLMSFPENFEFPPETTNRQKYRLLGNSINVKVVGELIKLLTKK 
 
      Dnmt2149 protein containing the 55 + 13 bp insertion:  
 
  MVFRVLELFSGIGGMHYAMMKZHMYVMYMYIY… 
 
C 
(See Figure legend on the following page.) 
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2.2 Characterization of Dnmt2149  
 
The first goal was to characterize the mutant on a molecular level. The 68 base pair 
insertion is apparent in the mRNA, as is shown by a non-quantitative RT-PCR 
(Fig. 2.2): The cDNA of Dnmt2 originating from Dnmt2149 mutants runs higher than 
the wt cDNA (Fig. 2.2). Even though a transcript is made, there is no translation into 
protein. The Western Blot in Fig 2.3 shows Dnmt2 protein in the wildtype background 
at the correct size of 40 kDa, whereas no Dnmt2 protein is observable in the mutant. 
The antibody used had been raised against a peptide near the catalytic region 
(Schaefer et al., 2008), and the specificity of the signal was demonstrated by 
including a peptide block. Equal loading was confirmed by immuno-detection of 
α-tubulin in the same blot. The complete absence of Dnmt2-protein confirms that 
Dnmt2149 is indeed a null mutant. 
 
 
 
 
 
 
 
 
 
 
Dnmt2 
OrR 149 
-RT 
EF1α48D 
Fig. 2.2: RT-PCR of Dnmt2 cDNA.  
Upper panel: The PCR-band of mutant-derived cDNA (149) runs higher than 
wildtype (OrR) due to the 68 bp insertion; middle panel: -RT control;  
lower panel: RT-PCR of EF1α48D was used as a loading control.   
 
Fig 2.1:  Characterization of the Dnmt2149 mutation 
A) Establishment of Dnmt2149. The founder line GE15695 contains a P-element 
right upstream of the Dnmt2 gene. Mobilization of this P-element, followed by 
re-insertion into the ORF of Dnmt2 and subsequent, imprecise re-excision 
resulted in 55 bp of transposon sequence insertion within the 5´region of the 
Dnmt2 gene. 
B) The insertion site in Dnmt2149. Sequencing of genomic DNA of Dnmt2149 and 
comparison to the genomic Dnmt2 sequence available on Flybase reveals a 
55 bp insertion of transposon sequence (marked in red), followed by 13 bp 
dupliation (grey) of endogenous sequence (italics). The site of insertion is 
marked in red letters. 
C) in silico translation of Dnmt2149. After the first 18 residues, the frameshift 
leads to a change in amino acid sequence (depicted in red) compared to the 
wildtype protein sequence.  
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Dnmt149 flies are viable, fertile, and exhibit no obvious phenotype. Egg laying 
behaviour, hatch and growth rates are comparable to wildtype flies. Cuticle stainings 
of embryos display normal patterning. Similarly, DAPI-staining of nuclei of young 
embryos shows no disturbance of the developmental programme. This is consistent 
with the Dnmt2 knockout mouse, of which also no aberrant phenotype has been 
reported (Goll et al., 2006).  
 
2.3 Identification of the Dnmt2215 Revertant Fly Line 
 
There are several fly strains that are used to generate mutants. However, their 
genetic backgrounds can differ, and it is of great importance to either include a 
wildtype control of the same genetic founder background as the mutant, or to ensure 
that the wildtype control is comparable to the strain of which the mutant was derived. 
Since the original fly strain out of which the “EP”-line was generated could not be 
obtained, several fly lines of the P-element excision screen (a kind gift of S. Phalke) 
OrR 149 
+ + - - Peptide block 
Dnmt2 
α-Tubulin 
45 kDa 
35 kDa 
149 OrR 
Fig. 2.3: Dnmt2-Western Blot 
Upper panel: Western blot using a peptide antibody against Dnmt2. 
Wildtype protein runs at 40 kDa. No Dnmt2 protein is observed in mutant 
protein extracts. Addition of the peptide against which the antibody was 
designed abolishes the Dnmt2 signal, thereby underlining the specificity of 
the antibody reaction. Lower panel: α-Tubulin staining was used as a 
loading control. 
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were screened for a precise excision of the P-element. Non-viable strains were 
excluded, and the precise excision was monitored by PCR (Fig. 2.4 A). Complete 
removal of the P-element from the Dnmt2 locus should restore Dnmt2 expression. 
PCR of the Dnmt2 locus and subsequent sequencing led to the identification of the 
fly line Dnmt2215, which will thereafter also be referred to as “the revertant”, and 
which carries a wildtype Dnmt2 locus (Fig. 2.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Northern Blotting of wildtype, revertant, mutant, and founder fly line (EP) revealed an 
abundance of Dnmt2-transcript in the Dnmt2149 mutant fly embryos compared to 
equal levels of Dnmt2-transcript in wildtype and revertant. Interestingly, Dnmt2-
mRNA is not expressed in the EP-line, where the P-element insertion upstream of the 
Dnmt2 gene probably blocks the initiation of transcription (Fig. 2.5).  
The corresponding Western blot shows comparable levels of Dnmt2 protein 
expression in the OrR (wildtype) and 215 (“revertant”) strains, whereas no Dnmt2 
protein is expressed in Dnmt2149 fly embryos (Fig. 2.5). Therefore, the P-element has 
indeed been excised completely in the revertant Dnmt2215, permitting Dnmt2 re-
Fly lines 207 211 212 215 217 
Viable without balancer no yes yes yes yes 
Precise excision yes no no yes no 
OrR 149 211 207 212 215 217 H2O 
Fig. 2.4: Screening for a „revertant“ of identical genetic background to 
Dnmt2149 
A) The table lists the viability of several putative revertant fly lines without a 
balancer and the PCR experiment concerning a precise excision. B) PCR 
experiment using primers HD39 and HD57. Comparison with the wildtype 
amplicon reveals that only the fly line 215 has the correct amplicon size. 
A 
B 
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expression. Similar mRNA and protein levels of OrR and Dnmt2215 fly embryos allow 
both fly strains to be used as suitabe wildtype control for the analysis of Dnmt2149 
embryos.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OrR 215 149 
Dnmt2 
Adh 
Fig. 2.5: Comparison of Dnmt2 mRNA and protein levels in wildtype, 
revertant and mutant 
A) Northern Blot of wildtype (OrR), revertant Dnmt2215 (215), Dnmt2 null 
mutant Dnmt2149 (149) and founder fly strain (EP). Upper panel: probed 
against Dnmt2; lower panel: loading control probed with Adh mRNA. 
B) Corresponding Western Blot. Wildtype (OrR) and revertant (215) 
express equal levels of Dnmt2 protein. Dnmt2 is absent in Dnmt2149 and the 
EP-line. α-Tubulin was used as a loading control (lower panel).  
A 
B 
OrR 215 149 
Dnmt2 
α-Tubulin 
EP 
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OrR 149
EF1α 
inv4 
-RT 
OrR 149 
mic 
-RT 
EF1α 
OrR 149 
-RT 
EF1α
inv2 
2.4 Dnmt2 and its Role in Transposon Regulation 
 
The silencing of repeats and retrotransposons by m5C methylation is among the most 
important functions of the DNA methyltransferase Dnmt1 (Bird, 2002; Gaudet et al., 
2004). To a lesser extent, Dnmt3b also contributes to the silencing of LINE-1 
elements specifically on the to-be-inactivated X chromosome in humans (Hansen, 
2003) and during male germ cell development in mice (Kato et al., 2007). Since 
Drosophila melanogaster lacks any other DNA methyltransferase besides Dnmt2, it is 
reasonable to investigate whether Dnmt2 also plays a role in this mechanism. Semi-
quantitative RT-PCR was used to investigate transposon expression in wildtype and 
mutant fly embryos. A moderate effect of increased transposon expression could be 
observed in the Dnmt2149 mutant flies. In all three examined cases – the 
retrotransposons invader 4, micropia, and invader 2 – the amplified cDNA band is 
stronger in the mutant background compared to the wildtype (Fig 2.6, upper panel). 
A PCR on non-reversely-transcribed RNA (-RT, middle panel) was included as a 
negative control. The absence of bands in the negative control confirms that the RNA 
preparation was free of genomic DNA contamination. EF1α48D (short: EF1α) served 
as the control housekeeping gene which was used as a loading control (Fig. 2.6, 
lower panel).  
 
 
 
 
 
 
 
 
 
Fig. 2.6: Transposon expression differences in wt and Dnmt2 mutant 
embryos 
RT-PCR of mRNA prepared from 0 – 3 h old embryos was performed. Expression 
of the transposons invader 4 (inv4), micropia (mic) and invader 2 (inv2) is 
increased in the mutant Dnmt2149. –RT: negative control, without reverse 
transcription; EF1α (EF1α48D): loading control. 
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Since the small increase in transposon expression might be due to methylation 
changes based on the loss of Dnmt2 protein in the mutant Dnmt2149, different regions 
of two retrotransposons were analyzed for DNA methylation. The random bisulfite 
sequencing approach showed dense methylation in one region of invader 2, but none 
in invader 4 (Fig. 2.7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transposon/ 
primer pairs 
Fly 
strain 
meth. 
Clones CpT CpA CpG CpC strand % m5C 
Inv4_76/77 OrR 4 (10) 2 2 0 0 c 0.60% 
Inv4_88/89 OrR 0 (10) 0 0 0 0 n.c. 0 
Inv4_60/61 OrR 0 (5) 0 0 0 0 c 0 
Inv4_ 51/52 OrR 0 (5) 0 0 0 0 c 0 
Inv4_51/52 149 0 (2) 0 0 0 0 c 0 
Inv4_51/52 OrR 0 (2) 0 0 0 0 c 0 
Inv4_55/56 149 0 (2) 0 0 0 0 c 0 
Inv4_55/56 OrR 1 (2) 1 0 0 0 c 1.70% 
Inv4_60/61 149 0 (2) 0 0 0 0 c 0 
Inv4_60/61 OrR 0 (2) 0 0 0 0 c 0 
Inv2_37/38 149 0 (2) 0 0 0 0 c 0 
Inv2_37/38 OrR 2 (4) 12 34 18 6 c 33% 
C U 
deamination
m5C m5C 
PCR 
amplification 
T 
C 
Bisulfite sequencing:  
A 
B 
Fig. 2.7: Random bisulfite sequencing approach of two retrotransposons 
A) Overview of the bisulfite sequencing method. B) Scheme of the sequenced 
regions in invader 4 and invader 2 C) Summary of bisulfite sequencing analysis of 
different regions of invader 4 and one region of invader 2. Numbers in the first 
column refer to primer pairs. C: coding strand; n.c.: non-coding strand. OrR: 
wildtype strain; 149: Dnmt2149 strain. 
 invader 4 
55/56 60/61 51/5276/77 
88/89 
 invader 2 
37/38
C 
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2.5 A Defined Genomic Locus to Search for DNA Methylation 
 
An approach to enrich for methylated sequences via immunoprecipitation of 
methylated sequences was unsuccessful due to the general low level of DNA 
methylation. The strategy was changed and the search for genomic DNA methylation 
was focused on a defined genomic locus. Our collaborator S. Phalke (University of 
Halle, Germany) had generated a fly strain (5Ha1925) which carried a mobile 
element insertion within a transposon sequence. The RS5 element, carrying the 
white gene (coding for red eye colour) as a marker, had inserted into an invader 4 
element in the Y chromosome (Fig. 2.8). As the parental fly line is deficient for white 
gene expression, the expression of red eye colour is due to expression of the 
transposon sequence and is – due to the location on the Y chromosome - restricted 
to male flies.  
It was reported by S. Phalke that crossing Dnmt2149 into 5Ha1925 led to an increase 
in red eye colour compared to 5Ha1925 only. This could be confirmed (Fig. 2.9). 
Furthermore, when Dnmt215 – the wildtype control with identical genetic background 
as the mutant Dnmt149 – was crossed into a 5Ha1925 background, the eye 
pigmentation was comparable to “wildtype” 5Ha1925 flies (Fig. 2.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Y chromosome: 
RS5 element 
Invader4 retrotransposon 
white
Fig. 2.8 :  
The fly line 5Ha1925 carries the insertion of an RS5 element into the 5´ LTR of 
the retrotransposon invader 4 on the Y chromosome. Due to the marker gene 
“white” in the RS5 element, male adult flies show red eye colour whereas 
female flies which do not carry a Y chromosome have white eyes. 
5´- - 3´ 
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Several primer pairs were designed to cover the 5´ and 3´ region of the mini-white 
marker gene as well as the transposon boundaries, where the RS5 element has 
inserted into the LTR of invader 4 (an overview is given in Fig 2.10).  
 
 
5Ha 1925 
5Ha 149 
5Ha 215 
Fig 2.9: Increased eye pigment variation in the Dnmt2149 background 
Eye pigment comparison of freshly hatched adult male flies carrying the 
mini-white gene in the RS5 element on the Y chromosome. In wt and 
revertant background (upper and lower panel), the eye colour is a light 
orange. In the Dnmt2149 background (middle panel), the eyes are darker, 
which can be attributed to increased expression of the mini-white gene. 
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In order to investigate the methylation status of the RS5 element, bisulfite sequencing 
was performed on deaminated DNA isolated from 0 - 3 h old embryos. Out of the five 
regions examined, only one region (No. 1), in the 3´ end of the mini-white marker 
gene, reproducibly showed dense methylation in a fraction of examined clones 
whereas no methylation could be observed in the Dnmt2149 background (see 
Fig. 2.11b). Of note, the methylation was not distributed evenly among sequenced 
clones. Rather, a few clones appeared almost fully methylated in a non-CpG context, 
while other clones completely lacked methylation in the wildtype background. An 
example of a typical electropherogram of the bisulfite treated and subsequently 
sequenced clones is displayed in Fig. 2.11. All cytosines in the sequencing reaction 
can be attributed to m5C in the original sequence before bisulfite treatment and PCR 
reaction. Since the wildtype and mutant DNA samples were purified and deaminated 
in parallel under the same conditions, and there was never dense methylation found 
in the mutant background, deamination artefacts appear highly unlikely. 
Unexpectedly, no methylation could be found in other regions examined. 
These data provide preliminary evidence for Dnmt2-mediated DNA methylation in a 
Y-chromosomal invader 4 element. Future experiments and large scale methylation 
analysis are needed to further investigate its function.  
 
 
 
 
white
123 4 5
Inv4 Inv4 RS5 element 
Fig. 2.10: Overview of regions within the RS5 element analyzed 
for m5C methylation by bisulfite sequencing 
The numbers one to five describe the five amplicons that were 
subjected to bisulfite sequencing. 1, 2, and 4 are located within the 
mini-white gene in the RS5 element, and 3 and 5 mark the 
boundaries of the two mobile elements.  
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 Region 1 Region 2 Region 3 Region 4 Region 5 
Methylation found yes no no no no 
# of sequenced clones 37/32 15/15 15/15 13/19 26/21 
# of methylated clones 6/(1) 0/0 0/0 0/0 0/0 
# m5C 666/1 0/0 0/0 17/13 12/21 
% m5C 16/0 0/0 0/0 0.9/0.5 0.5/0.6 
A 
Fig. 2.11: The 3´ region of the white gene is methylated within the RS5 
element in wildtype, but not in Dnmt2149 embryos 
A) Example of two electropherograms of the 3´-region of the white gene, showing 
m5C methylation in the wildtype background (upper panel). m5C is completely 
absent in the Dnmt2149 background, where all cytidines have been converted into 
thymines (lower panel).  B) Summary of the bisulfite sequencing data. Only in 
region 1 could substantial amounts of m5C methylation be identified. Numbers in 
black correspond to m5C in wt embryos, numbers in red correspond to 
5Ha/Dnmt2149 embryos. 
wt (5Ha1925) 
5Ha1925/Dnmt2149 
B 
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2.6 The tRNA methyltransferase Dnmt2 
 
After the publication that Dnmt2 is a tRNA methyltransferase in 2006, the focus of 
this work was shifted towards the analysis of tRNA molecules as possible targets of 
this enzyme. Several findings of the publication (Goll et al., 2006) warranted further 
analysis, including the suggestion that in vitro transcribed tRNAs are not a target of 
Dnmt2, and that tRNAAsp is the sole target of this enzyme. The first experimental tool 
to address these issues was an in vitro methylation assay, where the target tRNA 
was incubated with Dnmt2 enzyme in the presence of the tritiated cofactor 
S-adenosyl-methionine. Upon catalysis, the radioactive methyl group is transferred 
onto the tRNA, which is then precipitated and subjected to liquid scintillation 
counting.  
As a central component of the in vitro methylation assays, Flag-tagged Drosophila-
Dnmt2 (a kind gift of Dr. Matthias Schaefer) was isolated out of stably overexpressing 
S2R+ cells. Additionally, recombinantly expressed, His-tagged human Dnmt2 (a kind 
gift of Tomek Jurkowski, University of Bremen) was used. Recombinant hDnmt2 has 
the advantage that it can be produced in large amounts. On the other hand, typical 
post-translational modifications of this enzyme might be lacking. Immunoprecipitation 
of dDnmt2 out of Drosophila cells leads to a much lower yield, however, the 
environment under which the enzyme is produced is comparable to endogenous 
Dnmt2. Fig. 2.12 shows the quantification of a Flag-Dnmt2-immunoprecipitation with 
BSA as a standard. Western blotting of input, supernatant, and eluate of the IP 
protocol reveals a quantitative isolation of cytosolic, soluble Flag-Dnmt2 out of the 
cell extract.  
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2.7 Optimization of the tRNA In Vitro Methylation Assay 
 
The enzymatic activity of human and Drosophila Dnmt2 was tested with an in vitro 
assay, in which the respective enzyme was incubated with its putative targets in the 
presence of [3H]-S-adenosyl-methionine as methyl-group-donor. Dnmt2 catalyzes the 
transfer of the tritiated methyl-group to its target tRNA, which is precipitated on filter 
paper. The amount of radioactivity is measured by liquid scintillation counting. Prior to 
the testing of several different in vitro transcribed tRNAs, the reaction conditions were 
optimized regarding Mg2+ and DTT concentration. Total tRNA of E. coli was used as 
a target substrate, as bacterial tRNA does not contain m5C and therefore harbours 
several potential acceptor sites. 
As shown in Fig. 2.13, the enzymatic activity of hDnmt2 clearly increases with the 
addition of 10 mM Mg2+, whereas the addition of 30 mM Mg2+ leads to a reduction in 
activity, which is even lower than without Mg2+. Therefore, 10 mM Mg2+ was added to 
all further experiments. The presence of Mg2+ ions has a stabilizing effect on the 
tertiary structure of tRNA molecules. The activity increase of hDnmt2 with the 
0.5 1 3 5 3 5 
μg BSA μl Flag-Dnmt2
In
pu
t I
P
 
S
up
er
na
ta
nt
  
E
lu
at
e 
10 µl 10 µl 3 µl 
Fig. 2.12: Purification of Flag-Dnmt2 out of Drosophila S2R+ cells 
A) Coomassie-stained gel for the quantification of Flag-Dnmt2, using 
BSA as a standard. B) Western blot against the Dnmt2 protein. No 
protein is detected in the supernatant fraction. 
A B 
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addition of 10 mM Mg2+ suggests that this stabilized three-dimensional structure of 
tRNA is necessary in order to be recognized as a target for the Dnmt2 enzyme.  
Drosophila Dnmt2, which was isolated out of overexpressing S2R+ cells, was stored 
in a glycerol-containing buffer at -20 or -80 °C. However, a dramatic decrease in 
enzymatic activity could be observed after a few weeks of storage (first bar of 
Fig. 2.14). The addition of fresh DTT could reverse this effect and recover the 
enzymes´ original activity. As represented in Fig 2.14., a titration of several DTT 
concentrations ranging from 1 mM to 25 mM DTT shows that the addition of 10 mM 
DTT directly to the methylation reaction supports the highest raise in activity of 
dDnmt2. Accordingly, further in vitro methylation experiments were carried out in the 
presence of 10 mM DTT.  
 
 
 
 
 
 
 
Fig. 2.13:  Influence of Mg2+ ions on Dnmt2 activity 
In vitro methylation assay with total tRNA of E.coli and hDnmt2 
enzyme under varying Mg2+ concentrations.  
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2.8  Dnmt2 Methylates In Vitro Transcribed, Unmodified tRNAAsp 
 
Goll et al. published the observation that in vitro transcribed, unmodified tRNAAsp is 
not a substrate for Dnmt2 (Goll et al., 2006), however, it is possible that the observed 
lack of modification was a result of the chosen assay or of the in vitro transcription 
conditions. To further analyze the possibility that in vitro transcribed, unmodified 
tRNAs are a substrate for the Dnmt2 enzyme after all, mouse tRNAAsp was 
transcribed using the hammerhead ribozyme method which facilitates transcription of 
tRNAs that do not start with a guanine (Fechter et al., 1998). Drosophila tRNAAsp was 
transcribed without the hammerhead ribozyme. Both tRNAs differ in only four bases 
unrelated to the anticodon loop. After isolation, both in vitro transcribed tRNAAsp 
preparations were subjected to the methylation assay using Drosophila or human 
Dnmt2 (Fig. 2.15 A - C). Although the methylation efficiency differs between dDnmt2 
(Fig. 2.15 A) and hDnmt2 (Fig. 2.15 B), a modification signal clearly above 
background signals can be observed. Quantification of several experiments resulted 
in a modification efficiency of 0.15 - 0.2 mol m5C/ mol tRNA for Drosophila Dnmt2, 
and 0.8 - 1 mol m5C/ mol tRNA for human Dnmt2 (Fig. 2.15 C). Additionally, mouse 
Fig. 2.14: Influence of DTT on the reactivation of dDnmt2 
An in vitro methylation assay was performed with dDnmt2, total tRNA 
of E. coli and increasing concentrations of freshly added DTT. 
dDnmt2 activity peaks at 10 mM DTT added.  
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tRNAAsp was radioactively transcribed using [α-P32]-CTP. After isolation, tRNAAsp was 
incubated with (cold) SAM, Mg2+-containing buffer and Dnmt2, precipitated and 
digested with ribonuclease P1. The single nucleotides were then separated by 2-
dimensional thin layer chromatography. An m5C spot could clearly be detected (Fig. 
2.15 D). The in vitro methyltransferase assay as well as the TLC approach clearly 
shows that in vitro transcribed, unmodified tRNAAsp is recognized and methylated by 
Dnmt2. Therefore, pre-modification of tRNAAsp at other sites is not a necessary 
requirement for the catalytic action of the Dnmt2 enzyme.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.15 : In vitro transcribed, unmodified tRNAAsp is a target of Dnmt2  
A) Methylation assay using hDnmt2 and in vitro transcribed tRNAAsp of 
Drosophila melanogaster and Mus musculus. B) Methylation assay using 
hDnmt2 and in vitro transcribed tRNAAsp of Drosophila melanogaster and Mus 
musculus. C) Quantification of the modification efficiency of Dnmt2-mediated 
methylation of tRNAAsp (D.m.). D) Two-dimensional thin layer chromatography of 
radioactively transcribed ([α-P32]-CTP), Dnmt2-methylated tRNAAsp (M.m.). Red 
arrow: m5C spot; black arrow: cytosine spot. 
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2.9 Structural Requirements for Target Recognition by Dnmt2 
 
 
Previously, it was assumed that pre-modifications of tRNA are necessary for Dnmt2 
activity. This is not the case, as could be shown in the previous chapter. So far, it has 
been unclear which elements of the target tRNAAsp are absolutely required for it to be 
recognized as a substrate by the Dnmt2 enzyme. Among the possibilities are the 
recognition of sequence elements independent of structure, short structured units (for 
example single loops) or the whole tRNA molecule. To analyze the structural 
requirements, three in vitro transcripts of mouse tRNAAsp were designed: One 
consisting only of the anticodon stem loop, one where the anticodon loop size was 
decreased by the exchange of C32 to a G32, thereby allowing Watson-Crick-base 
pairing, and the third construct harboured a similar change in anticodon architecture 
as in construct two, but this time the C38 was exchanged for a U38. This should 
serve as a negative control, as C38 is the site of Dnmt2 action. The constructs are 
depicted in Fig. 2.16 A. These constructs (including a wild type tRNAAsp construct) 
were in vitro transcribed, purified and precipitated, and then subjected to the in vitro 
methylation assay together with purified Drosophila Dnmt2.  
Clearly, only the complete tRNA molecule forming a clover-leaf structure and 
therefore the typical L-shape in the third dimension is suited to be recognized as a 
target by the Dnmt2 enzyme. The anticodon stem loop alone is not sufficient. 
Similarly, the additional base-pairing of G32 and C38 or C32 and U38 is 
disadvantageous and abolishes the methylation signal almost completely. This 
finding contrasts with the yeast m5C methyltransferase Trm4, which does not depend 
on the whole tRNA molecule for efficient methylation of position 34 in the anticodon 
loop. For this site, a minisubstrate encompassing the anticodon stem loop as well as 
an intron, is sufficient (Walbott et al., 2007a).  
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Fig. 2.16: Structural requirements for target recognition by Dnmt2 
A) Overview of designed and tested constructs; 1) wildtype construct 
(lacking the last 4 bases for technical reasons), 2) anticodon stem loop 
only, 3) C32 exchanged for G32 to tighten the anticodon loop, 4) C38 
exchanged for U38. B) Methylation assay of the in vitro transcribed 
constructs. Only the wildtype construct is methylated efficiently by 
dDnmt2. Triplicate measurements of one experiment are shown. 
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2.10 The Application of DNAzymes Facilitates the Analysis of tRNA 
Modification Sites 
 
The use of 10 - 23 DNAzymes – short single-stranded DNA oligonucleotides with the 
ability to cleave RNA at purine-pyrimidine junctions – is a very elegant technique to 
analyze defined modification sites within tRNA. The DNAzyme consists of two arms 
which are complementary to the RNA sequence and a defined sequence forming a 
loop, which is necessary for the catalytic function. Due to the hybridization properties 
of the DNAzyme arms, the site of cutting can be directed exactly to the nucleotide of 
interest e.g. within tRNA, as long as a purine is followed by a pyrimidine, for example 
A-C, A-U, G-C, G-U (Cairns et al., 2003). This technique thereby conserves 
sequence context and is preferred over the detection of nucleotides via HPLC or 
capillary electrophoresis by which the existence of modification can be proven but not 
its location within the tRNA. Mass-spectrometry would also be suited to analyse tRNA 
fragments for their modification content, but the DNAzyme method is much more 
cost-efficient. However, not all purine-pyrimidine pairs are cleaved equally well, e.g. 
A-U is cleaved with much higher efficiency than A-C. It was reported that the 
cleavage efficiency of problematic combinations can be greatly improved by the 
introduction of inosine opposite the target pyrimidine (Cairns et al., 2003). 
To determine the level of methylation of tRNAAsp by Dnmt2 at C38 in wildtype flies, 
the DNAzyme technique was chosen to cleave at the site of interest – C38 in the 
anticodon loop - and to quantify the methylated fraction after radioactive labelling and 
subsequent 2-dimensional TLC (see chapter 2.14). Prior to the analysis of material 
derived from Drosophila embryos, however, experiments were carried out with 
unmodified, in vitro transcribed tRNAAsp to optimize the method. Temperature cycling 
enables re-annealing of the DNAzyme to tRNA and increases the yield of cleaved 
tRNA. The improvement of tRNAAsp cleavage both by the introduction of inosine and 
repeated temperature cycling is shown in Fig. 2.17.  
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When the DNAzyme approach is applied to quantify modifications present at the 
cleavage site, it is important to consider whether the presence of the modification 
impairs cleavage efficiency. Additionally, not only the cleavage but also the labeling 
efficiency of the subsequent PNK reaction can be impaired by the presence of m5C. 
To investigate this, a titration experiment was carried out. Known concentrations of 
oligonucleotides containing either a C or m5C at the 5´-end were mixed and 
radioactively labelled using [γ-32P]-ATP and PNK. After gel-purification the fragments 
were digested and separated by two-dimensional TLC and the C and m5C signals 
were quantified. Indeed, the PNK enzyme had a slight preference for C versus m5C. 
tRNAAsp 
cleavage 
product 
*
As
p 
0 10 20 30 0 10 20 30 
without 
Inosine 
with 
Inosine 
0 30 number of cycles 
Fig. 2.17: Optimization of the DNAzyme approach 
Two DNAzymes cleaving tRNAAsp at C38 were compared in their 
activity under temperature cycling conditions. Left: DNAzyme without 
inosine; right: DNAzyme with inosine. Clearly, the introduction of 
inosine greatly improves the cleavage efficiency of the DNAzyme. 
Asterisk: unspecific cleavage band 
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While C was labeled with 100 % efficiency, m5C was labeled only with about 80 – 
90 % efficiency (Fig. 2.18). This has to be taken into account when quantifying the 
m5C content directly via DNAzyme cutting at the modification site.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To analyse the DNAzyme cutting efficiency in the presence of m5C at the site of 
cleavage, tRNAAsp molecules were ligated from three RNA fragments, which carry 
either a C or m5C at position C38. After radioactive labeling of the 5´-end, equal 
amounts of tRNAAsp were subjected to DNAzyme cycling, run over a polyacrylamide 
gel, and the cleaved fraction was compared to the uncleaved by quantification of the 
bands using ImageQuant software. As it turned out, the DNAzyme is indeed impaired 
by the presence of m5C and cuts 4.75 times less efficiently than unmodified tRNA 
(see Fig. 2.19). This has to be taken into account when the DNAzyme approach is 
used to quantify modifications within tRNA.  
 
 25% m5C 50% m5C 75% m5C 
10 mM ATP 23.4 % 37.1 % 63 % 
100 mM ATP 26.9 % 45.3 % 63 % 
average 25 % 41.2 % 63 % 
Fig. 2.18: Titration of 5´-Labeling of m5C- or C-containing RNA 
oligos using PNK 
A) Two-dimensional TLC of different mixtures of 5´OH-C- or 5´OH-m5C- 
containing RNA oligos after PNK-labeling and P1 digest.  
B) Quantification of TLC signals using ImageQuant-software. 
50 % m5C 75 % m5C 25 % m5C 
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2.11 A Tandem DNAzyme 
 
Previously, only DNAzymes with one catalytic loop have been described in the 
literature. To cut a small oligonucleotide out of a tRNA molecule, the subsequent 
application of several DNAzymes is necessary. If the target regions of the DNAzymes 
lie too close together, there can be mutual inhibition and a decrease in cleavage 
efficiency. In this case a consecutive approach becomes necessary, where the 
cleaved fragments have to be gel-purified before being incubated with the next 
DNAzyme. The purification steps lead to a considerable amount of material loss. To 
overcome this problem, and to test whether a multiple-loop-DNAzyme is functional, 
a tandem DNAzyme comprising two catalytic loops was designed. 
25 cycles50 cycles
m5C
C
+ ++++ + 
+++++ + 
-
--
-
-
-
-
-
- 
- 
- 
- 
- DNAzyme + DNAzyme
full length 
cleaved fragments 
Fig 2.19: Influence of m5C on the cutting efficiency of the DNAzyme 
Radioactively labeled, ligated tRNAAsp containing either m5C or C at 
position 38 was incubated with 10 or 100x molar excess of DNAzyme and  
subjected to 25 or 50 temperature cycles. The presence of m5C at C38 
severly impaired the cleavage efficiency of the DNAzyme.  
Results 
  57  
Fig. 2.20 compares the action of two DNAzymes with a single-molecule tandem 
DNAzyme recognizing the same cutting sites. As depicted in the two lanes on the 
right, the tandem DNAzyme “34” cleaves with similar efficiency as the combination of 
the two DNAzymes “3” and “4” (Fig. 2.20 C). This is a new method to isolate the 
anticodon loop of a desired target tRNA. Due to the enrichment of the desired region 
– e.g. the anticodon loop in this case – the analysis of the unknown modification 
content is facilitated and the signal-to-noise ratio can be increased. Identification of 
the modifications e.g. by mass spec should yield cleaner signals when analyzing only 
the loop region and not the entire tRNA.  
 
2.12 Comparison of Two tRNA Methyltransferases Both Acting on 
tRNAAsp 
 
The DNAzyme technique allows the analysis and comparison of modification 
enzymes acting on the same target tRNA at different target sites. This approach can 
be used to identify and separate different modification types or to compare the same 
modification introduced at different positions by two modification enzymes. To 
demonstrate this possibility, tRNAAsp was methylated by the m5C tRNA 
methyltransferase Trm4 from Saccharomyces cerevisiae on position 48 plus 49, and 
by Drosophila Dnmt2 on C38 in two separate reactions. After purification, the 
methylated tRNAAsp was subjected to DNAzyme cycling with the tandem DNAzyme 
34 and the DNAzyme III which cuts after the position 58 (Fig. 2.21 A). The fragments 
carrying the introduced modification were gel-purified, precipitated and digested to 
single nucleotides (Fig. 2.21 B). Two-dimensional thin layer chromatography 
permitted the detection and quantification of 5-methyl-cytosine on a cellulose plate 
(Fig. 2.21 C). Modification by Trm4 could only be detected in the 18-mer that includes 
the predicted target sites 48 and 49. No Trm4-mediated methylation could be 
observed in the 9-mer derived from the anticodon loop (Fig. 2.21 C, upper and lower 
panel on the left). Dnmt2, on the other hand, was found to methylate in the 9-mer 
only, but not in the 18-mer (Fig. 2.21 C, upper and lower panel on the right). The 
methylation signal for Trm4 is higher than for Dnmt2, and was quantified to 0.8 mol 
m5C per mol tRNA (the methylation signal of Dnmt2 was quantified to 0.05 mol m5C 
per mol tRNA). The low Dnmt2-mediated methylation signal can be either attributed 
to poor performance of the enzyme prep out of Drosophila cells (in this experiment no 
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fresh DTT was added), or to the quantification procedure, since the intensity of the 
cytosine spot is out of the linear range, which could impede the exact determination 
of the low m5C signal. With human recombinant Dnmt2, the modification yield is 
similar to the one obtained by Trm4 (compare with Fig. 2.15 A and C).  
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Fig. 2.20:  Design and Performance 
of a tandem DNAzyme 
A) Design of the tandem DNAzyme 
34 with two catalytic loops. Arrows 
point to the cleavage site in the target 
sequence. B) Scheme of in vitro 
transcribed tRNAAsp. Arrows depict 
the cleavage site of DNAzymes 3, 4, 
and 34 respectively, within the 
anticodon loop. C) Denaturing PAGE 
of the DNAzyme cycling reaction, 
comparing the cleavage efficiency of 
the single DNAzymes 3 and 4 with 
the tandem DNAzyme 34.  
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Fig. 2.21 The DNAzyme 
technique allows 
simultaneous analysis 
of several modification 
sites 
A) Scheme of in vitro 
transcribed tRNAAsp, the 
sites of modification by 
dDnmt2 and Trm4, and 
the cleavage sites by the 
DNAzymes.  
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B) Polyacrylamide gel electrophoresis of pre-modified, DNAzyme-cleaved 
tRNAAsp. Asterisks mark bands which contain the modified cytidines. C) Two-
dimensional TLC of the 18-mer (containing the Trm4 modification site) and of 
the 9-mer (containing the Dnmt2 modification site). Trm4-mediated m5C 
formation is limited to the 18-mer, and Dnmt2-mediated m5C formation is 
limited to the 9-mer. Purified recombinant Trm4 from S. cerevisiae shows a 
higher activity than the Flag-tagged Drosophila Dnmt2 which was purified out 
of cells.  
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2.13 In Vivo Substrates of Dnmt2 
 
 
Native, fully modified tRNAs can also be a substrate for Dnmt2, as long as existing 
modifications do not block the methylation target site. Total tRNA preparations of 
E. coli, S. cerevisiae, and D. melanogaster were tested with Drosophila Dnmt2 in the 
in vitro methylation assay. Since m5C is not present in the tRNA of bacteria, it is not 
surprising that the E. coli tRNA is a good substrate for Dnmt2 (Fig. 2.22). 
S. cerevisiae is besides C. elegans the only eukaryotic model organism which does 
not possess a Dnmt2 enzyme. Despite the absence of an endogenous competitor, 
however, the total tRNA preparations of brewers´ yeast are not a substrate for Dnmt2 
in the in vitro assay. Possible explanations for this finding are that the Dnmt2 target 
sites are modified otherwise, that modifications located nearby interfere with the 
substrate recognition by Dnmt2, or that a different m5C tRNA methyltransferase has 
adopted the function of Dnmt2 in yeast. Native tRNA isolated from OrR or Dnmt2215 
wildtype flies cannot be modified by Dnmt2 any further in the in vitro assay, indicating 
that all possible target sites are either fully methylated or inaccessible for further 
methylation, for example due to modifications in the vicinity of the target region. Total 
tRNA derived from a Dnmt2 null background, such as Dnmt2149 or the founder line 
EP, however, can be methylated by Dnmt2 (Fig. 2.22). 
 
 
 
 
 
 
Fig. 2.22: Dnmt2 methylates total tRNA of E. coli, Dnmt2149, and the 
founder line EP 
In vitro methylation assay using Drosophila Dnmt2 enzyme and total tRNA of 
E. coli, S. cerevisiae, and D. melanogaster (OrR, Dnmt2215, Dnmt2149, EP). 
Wildtype-derived tRNA is already modified and leaves no site for additional 
methylation by Dnmt2. tRNA of E. coli contains no m5C and is therefore readily 
accepted as a substrate. Even though S. cerevisiae contains no endogenous 
Dnmt2 enzyme, its tRNA is not a substrate for dDnmt2. Triplicate 
measurements of one experiment are shown. 
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2.14 Quantification of In Vivo tRNAAsp Methylation at C38 
 
After the establishment of the DNAzyme technique, the approach was applied to 
tRNA molecules which were isolated out of Drosophila melanogaster wildtype and 
mutant embryos. tRNAAsp was specifically isolated out of a pool of total RNA from 
Drosophila embryos (over night collections) using a biotinylated oligo complementary 
to 37 bases of the tRNAAsp sequence. The enrichment of tRNAAsp was confirmed via 
a T1-ladder after end-labelling (Nuclease T1 cuts after every G and therefore leads to 
a sequence-specific pattern, or ladder). After gel purification, the tRNA was subjected 
to DNAzyme cycling. The DNAzyme cleavage leaves the C38 (the site of interest) 
with a free 5´OH-group, which allows radioactive labeling with T4 PNK. After another 
gel-purification step, the labeled fragments were digested to single nucleotides and 
separated by two-dimensional TLC. As expected, there was an m5C spot in the TLC 
depicting tRNA from Dnmt2-expressing wildtype flies (either OrR or Dnmt2215; Fig. 
2.23 A, left and middle panel). No m5C spot could be detected in tRNA isolated from 
Dnmt2149 embryos (right panel). In summary, the published observations – the 
methylation of tRNAAsp of Drosophila melanogaster at position C38 – could be 
confirmed. The application of the DNAzyme technique to verify the published data 
was advantageous over the mass spectrometry used previously (Goll et al., 2006), as 
the TLC signal was clean and a smaller amount of tRNA material was needed.  
The TLC signals were quantified using Imagequant software. In wildtype Drosophila 
embryos, C38 is methylated between 31 % (OrR) and 37 % (Dnmt2215) of all tRNAAsp 
molecules, whereas no m5C can be detected at C38 in the Dnmt2149 background 
(Fig. 2.23 B). Compared to the data in Figure 2.22, a higher degree of methylation 
would have been expected. The question remains, why total tRNA isolated from 
wildtype is not methylated further by Dnmt2 in an in vitro methylation assay (Fig. 
2.22), if not all C38 are converted to m5C. However, it could be possible that a 
subgroup of tRNAAsp contains modifications in close proximity to C38 which hinder 
the methylation at C38. 
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2.15 In Vitro Transcribed tRNAVal Is Also a Target of Dnmt2 
 
After the thorough investigation of in vitro transcribed and ex vivo isolated tRNAAsp of 
Drosophila melanogaster, the analysis was extended to the search for further targets. 
Among obvious candidates are those tRNAs which also contain a C38. This includes 
tRNAAsp molecules from other species (Fig. 2.24 A), for example from 
Saccharomyces cerevisiae and Pyrococcus abyssi. In Drosophila melanogaster, 
tRNAGlu, tRNAGly, tRNAHis, and tRNAVal also possess a C38. tRNAVal of Drosophila 
melanogaster was chosen as the most promising candidate, since it had been 
reported to carry a m5C at position 38 (Addison et al., 1982). 
dDnmt2 methylates in vitro transcribed, unmodified tRNAVal with similar efficiency as 
in vitro transcribed tRNAAsp from Drosophila melanogaster (see Fig. 2.24 A). 
However, not all tRNAs carrying a C38 are automatically targets of Dnmt2. 
Fig. 2.23 tRNAAsp is methylated in vivo by Dnmt2 
A) Two-dimensional TLC of position 38 of isolated and DNAzyme-cut tRNAAsp 
from Drosophila melanogaster. In the wildtype (OrR and Dnmt2215, left and 
middle panel), a m5C spot (pm5C) is clearly visible. In the Dnmt2149 mutants, no 
m5C spot is observed (right panel). Asterisk: unrelated labelling of residual 
DNAzyme.  
B) Quantification of the TLC signal in (A) after background correction. Black: C at 
position 38, white: m5C at position 38. 
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Mitochondrial tRNALeu(CUN) has a stable cloverleaf structure and could therefore be 
considered a target for the structure-sensitive Dnmt2 enzyme. Still, it is not 
recognized as a substrate (Fig. 2.24 A). This could be explained by the absence of 
conserved nucleotides within the substrate tRNA, which are necessary for recognition 
and methylation by Dnmt2, and remain to be identified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.24: In vitro transcribed tRNAVal 
is a target of Dnmt2 
A) In vitro methylation assay of C38-
containing tRNAs using Drosophila 
Dnmt2 enzyme: tRNAAsp of Drosophila 
melanogaster (D.m.), tRNAAsp of 
Pyrococcus abyssi (P.a.); tRNAVal of 
D. m., and mitochondrial tRNALeu of 
Homo sapiens (H.s.). The mean +/- 
standard deviation of three 
independent experiments is shown. 
B) Scheme of in vitro transcribed, 
unmodified tRNAVal of D. m. which had 
been found to be methylated at C40. 
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2.16 tRNAVal Is Methylated by Dnmt2 In Vivo 
 
C38 methylation in tRNAVal had been reported in Drosophila melanogaster (Addison 
et al., 1982), but it remained to be determined whether the Dnmt2 enzyme was 
responsible for this modification. If tRNAVal is methylated in a Dnmt2-dependent 
manner, then the m5C signal should be absent in tRNAVal from Dnmt2149 mutant flies.  
Similar to tRNAAsp, tRNAVal was isolated out of a preparation of total embryonic RNA 
of wildtype and mutant using an oligo complementary to tRNAVal. Again, the specific 
isolation of tRNAVal was monitored via a T1-ladder which provides a sequence 
specific banding pattern. A mix of several tRNA species would result in a smear or an 
aberrant banding pattern. Since there was a clear banding pattern, and therefore 
clean enrichment of tRNAVal, the tRNA was subjected to DNAzyme cycling, gel 
purification and P1 digestion similar to tRNAAsp (see chapter 2.14). The two-
dimensional TLC showed an m5C spot in wildtype (the revertant Dnmt2215) embryos 
but not in Dnmt2149 mutant embryos (Fig. 2.25). Therefore, the C38 methylation of 
tRNAVal is mediated by Dnmt2. The TLC spots corresponding to m5C and C were 
quantified using the ImageQuant 5.2 software. However, it is crucial to take the 
correction factors into account since otherwise the m5C signal will not be quantified 
adequately. This has two reasons: First, the DNAzyme cleaves m5C containing RNA 
about 4.75 times less efficient than the same RNA containing an unmodified cytosine 
instead. Second, the enzyme Polynucleotide kinase (PNK) which is used for 
5´-radioactive labeling also has a slight preference for C as opposed to m5C (factor 
1:0.8 – 0.9), as described in chapter 2.10. With the introduction of the correction 
factors, the quantification experiments show an average methylation level of C38 in 
tRNAVal of 89 % in OrR and 97 % in Dnmt2215 wildtype embryos, whereas in 
Dnmt2149 mutants, the large majority of C38 (96 %) is unmethylated. The remaining 
4 % can be attributed either to background signals (m5C signal coming from a 
different position, due to degradation in the DNAzyme cycling process, which was cut 
out with the correct-sized band) or to methylation of this site by an additional 
hypothetical enzyme. The methylation level of Drosophila-isolated tRNAVal is higher 
than Dnmt2-mediated methylation of tRNAAsp, indicating that Dnmt2-mediated tRNA 
methylation can be regulated.  
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2.17 Dnmt2 Activity Is Not Limited to C38 
 
Originally, a transcript of tRNAPhe from S. cerevisiae was intended to be included as a 
negative control in the in vitro methylation assays, as this tRNA has no C38, but an 
adenine at this position instead (see Fig. 2.26). Surprisingly, when incubated with 
Dnmt2, tRNAPhe appeared to be a substrate for the enzyme, since methylation of the 
 tRNAVal OrR tRNAVal 215 tRNAVal 149 
% m5C at Position 38 89 % 97 % 4 % 
% C at Position 38 11 % 3 % 96 % 
OrR Dnmt2215 Dnmt2149 
pC pC pC 
pm5C pm5C 
** *
Fig 2.25: tRNAVal is methylated at C38 by Dnmt2 in vivo 
A) Two-dimensional TLC of the C38 locus of tRNAVal (isolated from 
Drosophila embryos). Left panel and middle panel: tRNA isolated from 
wildtype embryos (OrR and Dnmt2215). An m5C spot is detectable. Right 
panel: tRNA isolated from mutant embryos (Dnmt2149). No m5C signal can be 
detected, and the cytosine (pC) spot is stronger, arguing for complete 
absence of m5C methylation at C38 in the Dnmt2 null background. The 
asterisk marks a DNAzyme derived spot which is unrelated to the C38 signal. 
B) and C) Quantification of the TLC signals using ImageQuant 5.2 software. 
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in vitro transcribed tRNAPhe could be distinctly detected. Native (fully modified) 
tRNAPhe (purified out of yeast) showed no further methylation by Dnmt2 in the assay 
(see Fig. 2.26 B). This implied that the methylation of tRNAPhe by Dnmt2 could take 
place at a site which is usually modified (and thereby inaccessible for further 
methylation by Dnmt2). The strongest candidate was C40. Firstly, this site is 
methylated by an intron-dependent mechanism by Trm4. Secondly, the site of 
modification lies very close to the C38 site which is recognized by Dnmt2 in tRNAAsp 
and tRNAVal.  
A template for in vitro transcription was designed, where C40 was exchanged for 
G40, and the corresponding, Watson-crick-pairing G30 to a C30, to keep the overall 
stem-loop architecture intact. This construct, where the putative modification site has 
been abolished, was tested together with wildtype, in vitro transcribed tRNAPhe in the 
methylation assay using hDnmt2. The lack of C40 led to a complete absence of 
Dnmt2 activity on tRNAPhe (Fig. 2.26 C), which confirms the hypothesis that tRNAPhe 
is methylated at C40 by Dnmt2. 
 
 
 
 
 
 
 
 
 
A 
 
Fig. 2.26:  
A) tRNAPhe of S. cerevisiae  
Schematic representation of in vitro 
transcribed tRNAPhe from S. cerevisiae. 
The arrow points to position 38 which 
is occupied by adenine, not cytosine.  
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Fig. 2.26 continued 
B) Dnmt2 activity is not limited to C38 
Methylation assay of in vitro transcribed tRNAPhe (blue bar), native tRNAPhe isolated 
out of yeast (purple bar) and the negative controls (yellow and green bars). hDnmt2 
can only methylate unmodified, in vitro transcribed tRNAPhe. The mean +/- standard 
deviation of at least three independent experiments is shown.  
C) hDnmt2 methylates tRNAPhe from S. cerevisiae at C40 
The exchange of C40 to G40 and of the Watson-Crick pairing G30 to C30 abolishes 
the catalytic activity of hDnmt2 (violet bar) compared to wildtype (blue bar). Therefore, 
hDnmt2 methylates C40 in tRNAPhe. Yellow and green bar: negative controls 
measuring background signals. The mean +/- the standard deviation of at least three 
independent experiments is shown. 
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2.18 Additional In Vitro Targets of Dnmt2 
 
It is plausible that in vitro transcribed tRNAPhe from S. cerevisiae is not the only target 
which is lacking C38 and is still being recognized and methylated by the Dnmt2 
enzyme. Since the characterization of tRNAPhe-methylation led to the identification of 
C40 as second possible modification site, a panel of several non-C38 containing 
tRNAs was screened for their target qualities regarding Dnmt2 (Fig. 2.27). tRNALys 
from H. sapiens and from D. melanogaster was found to be an even better substrate 
than tRNAPhe from S. cerevisiae. Modification levels were calculated to 65 % for 
Drosophila tRNALys, and 90 % for human tRNALys. Mitochondrial human tRNAThr was 
not a substrate for hDnmt2. Since the substrate recognition of Dnmt2 depends on the 
correct structure (chapter 2.9; Fig. 2.16), and the structure of mitochondrial tRNAs 
can deviate from the canonical cloverleaf structure, this structural divergence most 
likely prevents the methylation by Dnmt2.  
 
 
 
 
 
 
Fig 2.27: Dnmt2 methylation is not limited to C38 
In vitro methylation assay of a panel of tRNAs which do not contain C38. 
tRNALys(AAG) from D. melanogaster and tRNALys(AAA) from H. sapiens, as well as 
tRNAPhe from S. cerevisiae were methylated by human Dnmt2 with varying 
efficiencies. Mitochondrial tRNAThr of H. sapiens was included as a non-C38-
containing tRNA that is not a target of hDnmt2. Negative controls were conducted 
either without enzyme or without RNA substrate. The mean +/- the standard 
deviation of at least three independent experiments is shown. 
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2.19 tRNALys Is Modified at C40 and C42 by hDnmt2 In Vitro 
 
The characterization of the modification site of in vitro methylated tRNALys of 
D. melanogaster started with the rough determination of the target region. For this 
purpose, two DNAzymes were designed to divide the tRNALys into three parts 
(Fig. 2.28 A). The efficient cutting is demonstrated in Fig. 2.28 B. Then, in vitro 
transcribed tRNALys was subjected to in vitro methylation by hDnmt2 using tritiated 
SAM. After purification and precipitation, the tRNA carrying the radioactive methyl 
group was cleaved using both DNAzymes, and then resolved by denaturing 
polyacrylamide gel electrophoresis. [α-32P]-CTP transcribed, DNAzyme-incubated 
tRNALys was used as a marker to cut out the resulting bands. After elution from the 
gel, the remaining radioactivity was measured using liquid scintillation counting. 
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Fig. 2.28: DNAzyme design of tRNALys of D. melanogaster 
A) Schematic overview of in vitro transcribed, unmodified tRNALys and the 
cutting sites of DNAzyme 1 and DNAzyme 2. B) Denaturing PAGE of the 
DNAzyme cycling reaction. Lane 1: tRNALys only; lane 2: cycling with 
DNAzyme 1 and 2, lane 3: cycling with DNAzyme 2, lane 4: cycling with 
DNAzyme 1.  
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Since the tRNALys was not cut completely, there are four possible fragments which 
can carry the methylation signal: The cutting of DNAzyme 1 will only give rise to the 
fragments 46 and 30; the action of DNAzyme 2 yields two 38-mers, and the cleavage 
of both enzymes leads to the generation of an 8-mer. Methylation was readily 
detectable in the uncut fragment, the 46-mer and the 8-mer, but not in the 38-mer 
and the 30-mer (Fig. 2.29). Methylation in the T-Loop can therefore be completely 
excluded. Residual methylation signal in the 38-mer was observed in one out of two 
experiments and resulted from the incomplete cutting of DNAzyme1. This suggests 
that the methylation signal lies in the second half of the tRNA. Since this second half 
is comprised of the 8-mer and 30-mer, the methylation can be narrowed down to the 
8-mer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2.29: Methylation of tRNALys by hDnmt2 can be narrowed down to C40 
and C42  
Methylated tRNALys was subjected to DNAzyme cycling reactions. The fragments 
were resolved by denaturing PAGE, and subjected to scintillation counting. The 
38-mer (blue bar) and 30-mer (yellow bar) did not show any methylation signal. A 
clear methylation signal is seen in the 8-mer (purple bar), which harbours only two 
cytosines, C40 and C42. The 46-mer (green bar) – arising from incomplete cutting 
– as well as the full length tRNALys (dark purple) also shows a methylation signal, 
since they both contain the 8-mer fragment. Therefore, the site of Dnmt2-
dependent methylation of tRNALys can be limited to the anticodon stem. Summary 
of two independent experiments. 
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There are only two cytosines in the 8-mer (C40 and C42) which can carry a tritiated 
methyl group. To confirm the exact target site of Dnmt2-mediated tRNALys 
methylation in vitro, several constructs were designed for in vitro transcription, where 
one or more bases were exchanged (Fig. 2.30 B). After in vitro transcription and 
purification, the mutated tRNALys constructs were tested in the standard in vitro 
methylation assay using 3H-SAM as a methyl group donor (Fig. 2.30 C). Surprisingly, 
only two of the six constructs showed a severe reduction (up to complete inactivation) 
in enzymatic activity: Construct “e” harbours two Gs lying opposite to each other, 
which interrupts the anticodon stem loop structure. Previous experiments showed 
that the correct three-dimensional architecture of tRNA is important for target 
recognition (Fig. 2.16). The destruction of the anticodon stem could therefore be the 
reason for the enzymatic inactivity. In construct “d”, all cytosines were completely 
eliminated from the anticodon stem and replaced by U. Due to lack of cytosine as a 
substrate for methyl-group transfer, the enzymatic activity is reduced. However, the 
elimination of only one of the two cytosines at positions 40 and 42 and their 
replacement by G did not have any impact on methyl group transfer by Dnmt2. In 
other words, in vitro transcribed tRNALys can be methylated at C40 and/ or C42. It is 
unclear, however, whether the enzyme preferentially methylates one of the two 
cytosines. In summary, Dnmt2 is able to methylate C40 and 42 in vitro, pointing to an 
unexpected flexibility in the target recognition process.  
Due to the unfavourable sequence context of tRNALys – the absence of a purine-
pyrimidine junction at position 39-40 and 41-42 – it was not possible to analyze 
purified tRNALys from Drosophila melanogaster by the DNAzyme approach. The 
experiment to methylate tRNALys isolated from Dnmt2149 and wildtype embryos in the 
in vitro methylation assay was not successful. Neither wildtype- nor mutant-derived 
tRNALys was a target of hDnmt2. A database search comparing modified tRNALys 
from several animals ranging from insects to mammals revealed no methylation at 
the positions 40 or 42. Therefore, the methylation status of tRNALys of Drosophila 
melanogaster remains to be determined. 
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investigation of the target 
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A) Drosophila tRNALys. 
B) Scheme of the exchanged 
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loop. C) In vitro methylation 
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tRNALys with the constructs 
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three independent experiments 
is shown. 
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2.20 Two Distinct Catalytic Mechanisms of Dnmt2 
 
Dnmt2 was shown to be a tRNA methyltransferase but does not contain the cysteine 
in motif VI which has been postulated to be the catalytic cysteine in the tRNA 
methyltransferase Trm4 (Walbott et al., 2007b). Until recently, it was unclear which 
mechanism is used for the methylation of tRNAAsp by Dnmt2. In collaboration with 
T. Jurkowski and others, it could be shown that Dnmt2 methylates tRNAAsp via a DNA 
methyltransferase-like mechanism (Jurkowski et al., 2008). To identify the catalytic 
residues of importance, all cysteines and two arginine residues (previously identified 
to play an important role in the DNA methyltransferase MHhaI; O'Gara et al., 1998) of 
human Dnmt2 enzyme were exchanged for alanine. These Dnmt2 mutants were 
tested in their ability to methylate tRNAAsp. It could be shown that the abrogation of 
the catalytic cysteine 79 abolished all enzymatic activity. Similarly, the glutamic acid 
residue E119 of the ENV motif, and the two arginines R160 and R162 were essential 
for Dnmt2-mediated methylation of tRNAAsp (Jurkowski et al., 2008). The ENV motif is 
said to be involved in the catalysis due to interaction of the glutamic acid residue with 
N3 of the cytidine base. A schematic overview of the C79 and E119 residues in 
catalysis is given in Fig. 2.31. This mechanism is reminiscent of the bacterial DNA 
methyltransferases.  
Mutant 2: E119A 
Glu exchanged 
for Ala 
Mutant 1: C79A 
Cys exchanged 
for Ala 
Fig. 2.31: Schematic representation of two catalytic mutants of hDnmt2 
In mutant 2, also called E119A (left), the glutamic acid E119 is changed to 
alanine. E119 facilitates the formation of the enzyme-substrate intermediate by 
interaction with N3. In mutant 1 (C79A, on the right), the catalytic cysteine was 
exchanged for alanine, thereby abolishing all catalytic activity (adapted from 
Jeltsch et al., 2006). 
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The cysteine 292 mutant within the target recognition domain led to a reduction in 
methylation. In the present work, three of the generated Dnmt2 mutants – C79A, 
E119A, and C292A – were obtained and tested in the in vitro methylation assay. The 
results for tRNAAsp could be confirmed, as no methylation of tRNAAsp could be 
observed in the C79A and E119A mutants (Fig. 2.32). However, the question 
remained, whether the targets which are methylated at C40 or C42 use the same 
catalytic mechanism. When in vitro transcribed tRNAPhe of S. cerevisiae and tRNALys 
of D. melanogaster were tested with wildtype Dnmt2 and the three mutants C79A, 
E119A, and C292A, a surprising difference in catalytic activity of the E119A mutant 
was observed. This mutant was either equally or more active than wildtype hDnmt2 
enzyme when incubated with non-C38 containing tRNAs (Fig. 2.32). Furthermore, the 
absence of C79 did not abolish the catalytic activity completely, when tRNAPhe and 
tRNALys were used as substrates for Dnmt2. Since 20 to 50 % of the methylation 
capacity of wildtype Dnmt2 remained in the C79A mutant, C79 cannot be the sole 
catalytic cysteine in the methylation of tRNAPhe and tRNALys.The mutant C292A also 
showed a reduction in catalytic activity in all three tRNAs tested. Since the mutation 
is located in the target recognition domain, this effect can probably be attributed to a 
constraint in substrate recognition and binding, and is not directly linked to the methyl 
group transfer itself. These results describe an unexpected difference in the catalytic 
mechanism of Dnmt2 between the methylation of position 38 and 40/42. Apparently, 
for non-C38 targets, E119 is dispensable for Dnmt2-mediated methylation, and its 
absence is even advantageous for the methylation of tRNAPhe and tRNALys. Future 
experiments will be necessary to determine the residues which are important for 
catalysis of non-C38 tRNA targets.  
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Fig. 2.32: Dnmt2 utilizes distinct enzymatic mechanisms for the methylation of 
different substrates.  
Green bars: In vitro methylation assay of in vitro transcribed, C38 containing tRNAAsp 
of D. melanogaster using wildtype Dnmt2 and three catalytic mutants (see below the 
diagram). Mean values of three independent experiments with standard deviations 
are given. Blue bars: In vitro methylation assay of tRNAPhe (S. cerevisiae) as a 
substrate. Mean values of three independent experiments and the standard 
deviations are given. Yellow bars: In vitro methylation assay with non-C38 containing 
tRNALys of D. melanogaster. Mean values of two representative experiments are 
given. 
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3  Discussion 
 
3.1 Dnmt2 and a Possible Role in Transposon Silencing 
 
DNA methyltransferases play a crucial role in the transcriptional silencing of repeats 
and retrotransposons (reviewed in Goll & Bestor, 2005) which prevents mutagenesis 
due to transposon insertion. Absence of DNA methylation leads to increased 
transposon transcription, transposon transposition, and disturbed transcription of 
neighbouring genes. This has been shown for IAP elements in Dnmt1-deficient 
mouse embryos (Walsh et al., 1998). As Dnmt2 is the most conserved and most 
ancient member of the family of DNA methyltransferases (Goll & Bestor, 2005), it is 
tempting to speculate that Dnmt2 also contributes to the protection of genetic 
information due to the silencing of repeats and retrotransposons. In species where 
Dnmt2 is the only member of the DNA methyltransferase family, its function in 
genome defence may be of even greater importance. Previously, it had been shown 
that Dnmt2 does not play an essential role in the de novo silencing of retroviral DNA 
in murine embryonic stem cells (Okano et al., 1998b). However, the presence of the 
other Dnmt family members in murine cells may have a compensatory effect on the 
absence of Dnmt2. Therefore it is important to study Dnmt2 in the absence of Dnmt1 
and Dnmt3a/b. Drosophila melanogaster is the best studied eukaryotic model 
organism which does not contain other members of the Dnmt family, and was 
therefore the model organism of choice. Semi-quantitative RT-PCR of 0 – 3 h old 
embryo-derived mRNA revealed a slight up-regulation of three transposons tested 
(Fig. 2.6). The up-regulation of other retrotransposons in the Dnmt2149 mutant 
compared to wildtype fly embryos has also been confirmed by our collaborator 
Sameer Phalke (personal communication). In summary, the observed effect of 
increased transposon expression in the absence of the Dnmt2 enzyme in Drosophila 
embryos is not as strong as the up-regulation of transposon transcription caused by 
the absence of Dnmt1 in mouse (Yoder et al., 1997; Walsh et al., 1998; Gaudet et al., 
2004). Clearly, the global silencing of retrotransposons is not entirely mediated by 
Dnmt2, but a regulatory contribution of this enzyme appears likely.  
Bisulfite sequencing of several regions of the transposons invader 4 and invader 2 in 
wildtype embryos yielded no reproducible methylation signal within the regions 
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examined (Fig. 2.7). However, due to the abundance of these transposons – with 
several full length and multiple fragment copies – the methylation of only a subgroup 
might remain undetected. Therefore, the insertion of a mobile element (the RS5 
element carrying the mini-white gene as a marker) at a defined region was 
investigated. In the locus of interest, the mobile element RS5 had inserted into the 
long terminal repeat of the invader 4 retroelement on the Y-chromosome. As this 
work could show, methylation was absent from the Dnmt2149 mutant embryos. In the 
wildtype strain, however, the 3´-region of the mini-white gene was specifically found 
to contain dense methylation (Fig. 2.11). The methylation was not limited to CpG, but 
occurred in every context in the wildtype strain. It is important to note that only a 
fraction of the examined clones of the mini-white-region contained m5C, but always in 
a very dense manner. If the presence of DNA methylation is indeed playing a role in 
the silencing of this locus, it becomes evident that this silencing is not pronounced, 
since heavy transcriptional silencing of this locus would result in white eyes. The fact 
that the eyes of freshly hatched male wildtype flies are orange – and therefore not 
fully, but rather mildly suppressed – corresponds well with the finding that not all 
examined clones show dense methylation.  
In summary, the data of this work point to a weak role of Dnmt2-mediated DNA 
methylation in transposon regulation. m5C within a DNA context was found within the 
white locus of a RS5-element which had been inserted into a transposon. In the 
Dnmt2149 mutant, no methylation was detected. The DNA samples of wildtype and 
mutant flies were always processed in parallel, and biological replicates were used 
for bisulfite treatment and cloning. It is unlikely that the methylation detected in 
wildtype flies is a bisulfite sequencing artefact, since these artefacts would also have 
been expected in the unmethylated DNA from Dnmt2149 – which is not the case. The 
finding of DNA methylation within the fly genome is in line with previous reports (Lyko 
et al., 2000a; Gowher et al., 2000). Still, the role of Dnmt2-mediated DNA methylation 
within an organism remains to be determined. Dnmt2 enzyme function seems not to 
be essential under laboratory conditions; however, a highly specialized function 
under environmental stress might not have been detected.  
 
 
 
Discussion 
  78  
3.2 In Vitro tRNA Targets of Dnmt2 
 
The publication which describes Dnmt2 being a tRNA methyltransferase claims that 
the enzyme does not recognize in vitro transcribed, unmodified tRNA and concludes 
that certain pre-modifications are necessary for Dnmt2 to be active (Goll et al., 2006). 
This is in conflict with the data of this work. Unmodified, in vitro transcribed tRNAs 
were reproducibly modified by Dnmt2 enzymes of Drosophila and human origin. The 
reason for these differing results probably lies in the design and performance of the in 
vitro methylation assay. In this work, the assay conditions were optimized carefully. 
Among the most important factors that need to be considered is the pH, as well as 
the Mg2+ and DTT concentrations. The pH varied only slightly (7.4 in Goll et al. and 8 
in this work), but Goll et al did not add magnesium to the buffer. Mg2+ ions are crucial 
for tRNA structure, especially for unmodified, in vitro transcribed tRNA molecules 
(Hall et al., 1989; Maglott et al., 1998; Nobles et al., 2002). Since it had been 
postulated that unmodified, in vitro transcribed tRNAs would not be a substrate of 
Dnmt2, the assay optimization was conducted with total tRNA of E. coli. These tRNA 
molecules are fully modified and therefore more stable than unmodified tRNAs, but 
do not contain m5C. When the influence of different magnesium concentrations on 
the methylation efficiency was tested, the best results could be achieved with 10 mM 
Mg2+. There was activity measurable without Mg2+ due to the stability of the native 
tRNAs, but clearly reduced compared to 10 mM Mg2+.  
According to Goll et al., 2006, only the position C38 in the anticodon stem of tRNAAsp 
is methylated by Dnmt2. However, tRNAVal was also identified as a target. 
Furthermore, C40 of tRNAPhe (S. cerevisiae) and C40/C42 of tRNALys (from D. 
melanogaster) can be methylated by Dnmt2 in vitro (Fig. 2.26 and 2.27). This 
revealed an unexpected flexibility of Dnmt2 with respect to its substrate acceptance, 
since not only another C38-containing tRNA besides tRNAAsp can be methylated by 
Dnmt2, but also C40 and C42-containing substrates are recognized. Different modes 
of substrate recognition exist for tRNA modification enzymes, and examples have 
been described in the literature where a single tRNA modification enzyme targets 
several positions within tRNA, in a sequence-independent, but structural-dependent 
manner (Simos et al., 1996; Motorin et al., 1998; Motorin & Grosjean, 1999; Hur & 
Stroud, 2007). These will be compared to Dnmt2 in chapter 3.5. 
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3.3. In Vivo Targets of Dnmt2 
 
Using alternative methods, this work could corroborate that tRNAAsp of Drosophila 
melanogaster is methylated at C38 by Dnmt2 (Goll et al., 2006). Furthermore, it could 
be clearly demonstrated that tRNAAsp is not the only in vivo target, but that tRNAVal is 
also methylated in vivo by Dnmt2. The use of the DNAzyme technique (see below) 
allowed not only the detection, but also the quantification of the m5C signal at 
position 38. The mehylation status of native tRNALys derived from Drosophila 
melanogaster could not be investigated by the DNAzyme method due to the lack of 
purine-pyrimidine junctions at C40 and C42. However, further in vivo targets besides 
tRNAAsp and tRNAVal seem to be likely. For example, possible substrates could be the 
C38-containing tRNAs encoding for Glu, Gly, and His from Drosophila melanogaster 
(tRNA sequence database; Sprinzl & Vassilenko, 2005). All three of them contain a 
purine-pyrimidine junction at the locus 37-38, and can therefore be potentially 
analyzed by the DNAzyme method. Besides tRNAAsp and tRNAVal, no other 
Drosophila tRNAs have been reported to contain m5C at C38. However, the 
modification analysis of all Drosophila tRNAs is not complete. tRNAGly has been 
reported to contain an m5C at position 38 in the silkworm Bombyx mori (Garel & 
Keith, 1977), and thus represents an additional candidate target for Dnmt2-mediated 
methylation. 
It is intriguing to speculate that Dnmt2 can methylate also other RNA species besides 
tRNA. It is possible that apart from tRNAs, other RNAs with loop structures – such as 
ribosomal RNAs, pre-microRNAs, or other small RNAs – might be targets of the 
Dnmt2 enzyme. The methylation of small RNAs could have an impact on the 
translational regulation and fine-tuning of numerous processes. A tRNA modification 
enzyme acting also on small nuclear RNA of the spliceosome has been reported 
previously. Pus1p, a pseudouridine synthase from Saccharomyces cerevisiae, was 
identified to modify uridine 44 to pseudouridine within spliceosomal U small nuclear 
RNAs (Massenet et al., 1999; see also chapter 3.5). So far, however, there is no 
evidence that Dnmt2 is able to methylate ribosomal RNA or small RNA components. 
A preliminary experiment analyzing ribosomal RNA as well as preparations of total 
small RNAs below 40 nucleotides in parallel with tRNA (all derived from wildtype as 
well as from Dnmt2149 mutants) revealed tRNAs as the only RNA species to be 
methylated by Dnmt2. However, due to low sequence abundance of the small RNAs 
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compared to tRNAs, it cannot be excluded that there are rare RNAs which are also 
modified by Dnmt2. In this case, the in vitro methylation assay would not be the 
method of choice and should be replaced by a method which enriches for the 
putative targets first. This could be achieved by crosslinking the Dnmt2 targets to the 
enzyme via formaldehyde or 5-azacytidine treatment and subsequent 
immunoprecipitation of the Dnmt2-substrate complex using Dnmt2-specific 
antibodies. The availability of cell lines and fly strains expressing tagged Dnmt2 will 
further facilitate the search under in vivo conditions. 
 
3.4 Advantages of the DNAzyme Method 
 
The identification of tRNA modifications within their sequence context is challenging. 
The modifications per se can easily be detected via a two-dimensional TLC 
approach; however, the precise location of the modification within the tRNA 
sequence is not easily identified. Mass spectrometry is certainly the method of choice 
if large amounts of the target tRNA and the expertise to analyze the data are 
available. However, only a few laboratories have the requisite knowledge and 
experience, and therefore the mass spectrometry approach cannot be seen as a “fast 
core facility service” available to everybody. In addition, one to several micrograms of 
the tRNA of interest is needed, which is not easily obtained, especially if only one 
tRNA species and not total tRNA is to be analyzed. A second approach is based on 
the use of 2´-O-methyl- (2´-O-Me) modified oligos combined with RNase H cleavage 
at the site of interest. After post-cleavage radioactive labelling, the signal is resolved 
by 2-dimensional TLC (Yu et al., 1997; Zhao & Yu, 2004; Hou et al., 2006). The 
major disadvantage of this method lies in the very high cost of the 2´-O-Me 
oligonucleotides, and the sometimes imprecise cutting of RNase H, which requires 
laborious optimization of the assay conditions. 
The extensive use and further development of the DNAzyme technique proved to be 
a highly effective and very cost-efficient method to identify m5C in tRNA. The 
combination of inosine integration within the DNAzyme sequence (Cairns et al., 
2003) and repeated temperature cycling (Hengesbach et al., 2008) greatly improved 
the cleavage yield and the detection of m5C at position C38 in tRNAAsp and tRNAVal in 
wildtype fly embryos. The absence of m5C in tRNAAsp and tRNAVal derived from 
Dnmt2149 fly embryos demonstrated that Dnmt2 function is responsible for the 
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methylation of tRNAVal at C38 and that Dnmt2 is therefore not limited to tRNAAsp as 
its only target. Besides the direct proof of a suspected m5C signal at a certain 
position, the DNAzyme technique has also been successfully used to narrow down 
the unknown modification site of tRNALys of D. melanogaster in vitro.  
The use of DNAzymes to cleave a tRNA in defined pieces might also prove very 
helpful, when several modifications within one tRNA molecule are to be analyzed. In 
combination with mass spectrometry, for example, the analysis of smaller tRNA 
fragments should yield cleaner results due to less background signal. In this regard, 
the development of a tandem DNAzyme has been a useful tool to separate the 
anticodon loop from the rest of the tRNA molecule. In summary, the improved 
DNAzyme method is a very versatile technique which has permitted the analysis of 
tRNA methylation in a qualitative as well as a quantitative manner.  
 
3.5  Comparison of Multisite-Specific tRNA-Modifying Enzymes 
 
The multi-substrate specificity of Dnmt2 and its ability to methylate at different 
positions within the anticodon stem-loop is comparable to several tRNA modifying 
enzymes; of which three well characterized examples will be described in the 
following (Fig. 3.1).  
TruA is a bacterial pseudouridine synthetase which modifies uridine to pseudouridine 
at the positions 38, 39, and 40 (Hur & Stroud, 2007). Pseudouridines within the 
anticodon loop contribute to the efficiency and accuracy of translation, also due to an 
increase in the thermal stability of the modified tRNA. Similar to m5C 
methyltransferases, base flipping is used to access the substrate uridine. The 
anticodon stem-loop alone is not recognized as a substrate, which is another 
common feature between Dnmt2 and TruA. The second pseudouridine synthase 
which modifies several uridines in the anticodon stem-loop is Pus1p. This enzyme 
from yeast has been shown to catalyze pseudouridine formation in vitro at the 
positions 27, 28, 34, 35, and 36 in various cytoplasmic tRNAs (Simos et al., 1996; 
Motorin et al., 1998). Modifications of the anticodon appear in an intron-dependent 
manner (positions 34 and 36 of tRNAIle, and position 35 of tRNATyr), while 
pseudouridine formation at positions 27 and 28 is intron-independent. The 
modification of positions 34, 35, and 36 does not require the full tRNA molecule, 
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since a mini-substrate consisting of the anticodon stem-loop plus the intron is 
modified by Pus1p (Motorin et al., 1998). Recently, position 1 has also been identified 
as an additional target of yeast and mouse Pus1p (Behm-Ansmant et al., 2006). 
Furthermore – as mentioned previously – Pus1p also modifies U2 snRNA of the 
spliceosome (Massenet et al., 1999; Behm-Ansmant et al., 2006). 
Another multi-substrate specific enzyme from S. cerevisiae is the aforementioned 
m5C tRNA methyltransferase Trm4 (Motorin & Grosjean, 1999), which modifies 
cytosines at the positions 34 and 40 in the anticodon loop, as well at positions 48 and 
49 in the variable loop. Similar to Pus1p, the Trm4-mediated modifications located 
within the anticodon stem-loop (positions 34 and 40) are intron-dependent, while 
methylation within the variable loop does not require an intron.  
The human Dnmt2 enzyme was found to methylate various in vitro transcribed tRNAs 
at the positions 38, 40, and 42. None of the tested tRNAs contained an intron, but it 
cannot be excluded that additional intron-containing tRNAs might be an in vitro target 
of Dnmt2. Out of the three cytosolic intron-containing tRNAs (tRNALeu, tRNAIle, and 
tRNATyr), tRNALeu and tRNAIle could be possible targets, since tRNALeu(UUG) and 
tRNAIle carry a C40, and tRNALeu(CUG) C39 and C41. For tRNATyr, modifications have 
been described (Sprintzl database; Sprinzl & Vassilenko, 2005), but m5C is not 
among the reported modifications.  
The positions which are modified by the above mentioned TruA enzyme depend on 
the correct tRNA structure for proper target recognition, rather than a sequence 
context surrounding the modification site. The anticodon stem-loop plays an 
important role, but also the other tRNA parts are needed (Hur & Stroud, 2007). This 
is also the case for Dnmt2, as was shown in this work. The disruption of the 
anticodon stem loop of tRNAAsp and tRNALys abolished all activity of Dnmt2 (Fig. 2.16 
and 2.30). Similarly, the tightening of the anticodon loop by Watson-Crick base 
pairing of positions 32 and 38 decreases the modification efficiency in Dnmt2 (Fig. 
2.16) and TruA (Hur & Stroud, 2007). For the intron-dependent modification by Pus1p 
and Trm4, not the whole tRNA is needed, as minisubstrates are also accepted. 
However, it is crucial that these minisubstrates contain the intron. This also points to 
structural determination factors needed for Trm4 and Pus1p activity (Motorin et al., 
1998; Motorin & Grosjean, 1999). Still, it cannot be excluded that for example the 
base composition within the anticodon loop can play a favourable role. 
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According to Hur & Stroud, 2007, the key to the regional specificity of TruA lies in the 
plasticity of the anticodon stem loop. Further experiments will be needed to confirm 
or exclude the existence of sequence elements within the substrate tRNAs of Dnmt2 
that contribute to target recognition and efficient catalysis. 
 
 
 
 
 
 
Fig. 3.1: Multisite-specific tRNA Modification Enzymes 
Schematic representation of tRNA modification enzymes and their 
target sites. TruA ans Pus1 are pseudouridine synthases which modify 
different tRNAs within the anticodon stem-loop (positions marked in 
yellow). Trm4 and Dnmt2 are m5C tRNA methyltransferases. The 
target positions are marked in orange (see text for details).  
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3.6 The Catalytic Mechanism of Dnmt2-Mediated tRNA 
Methylation 
 
Dnmt2 is a tRNA methyltransferase but does not possess a catalytic cysteine in motif 
VI, which is the main catalytic residue in other tRNA m5C methyltransferases (King & 
Redman, 2002; Walbott et al., 2007b). Dnmt2 was shown to methylate tRNA with a 
DNA methyltransferase-like mechanism (Jurkowski et al., 2008). This was achieved 
by exchanging all cysteines of human Dnmt2 as well as other potentially important 
sites for catalysis, such as E119, R160, and R162. The arginine residues have been 
proposed to also play an important role during catalysis (O'Gara et al., 1998; Gowher 
et al., 2006). Dnmt2 uses the cysteine of motif IV for catalysis, and is assisted by the 
glutamic acid of the ENV motif (Fig. 1.6). This is in accordance with DNA m5C 
methyltransferases. The ability to methylate tRNAAsp was lost when the cysteine 79 
and the glutamic acid 119 were exchanged for alanine, and it was reduced in the 
cysteine 292 mutant (Jurkowski et al., 2008). These data could be confirmed in this 
work using the in vitro methylation assay. Surprisingly, residual activity of the C79A 
mutant of 20 – 50 % wildtype activity was still measurable when the non-C38 
containing tRNAs (Phe and Lys) were analyzed (Fig. 2.32). The E119A mutant 
showed even higher activity, yielding methylation levels comparable either to wildtype 
levels (tRNALys) or even above (tRNAPhe). This suggests that the non-C38 containing 
tRNAs are methylated by a catalytic mechanism which differs from the “canonical” 
DNA-methyltransferase-like mechanism. So far, it is unclear, which residues perform 
the methylation reaction in the catalytic mutants, as the exchange of the other 
cysteines did not show an effect (Jurkowski et al., 2008). It is possible that the “main” 
catalytic cysteine and the glutamic acid can be partially replaced by other residues. In 
this respect, it would be interesting to generate and analyze double mutants, where 
two cysteines have been simultaneously exchanged for alanines.  
An in vitro evolution experiment of the DNA m5C methyltransferase SinI which 
methylates the internal cytosine of GGACC or GGTCC sequences led towards a 
relaxation of its substrate specificity to GGGCC and GGCCC (Timar et al., 2004). 
The substitution of only two amino acids between the motifs VI and VII led to a 20 
fold increase of enzymatic activity towards the new substrates, whereas the original 
activity was lowered only 5 fold (Timar et al., 2004). Similarly, directed evolution of 
the DNA m5C methyltransfease MHaeIII led also to the acceptance of alternative 
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substrates, and increased even the methylation efficiency of the canonical sequence 
GGCC (Cohen et al., 2004). In this mutant, only four amino acids in the target 
recognition domain were exchanged. These protein engineering experiments using 
the two DNA m5C methyltransferases SinI and MHaeIII have shown that changes of 
only a few residues are sufficient to enlarge the substrate specificity of an enzyme, 
with only a minor negative impact on the methylation of the original target sequence. 
The methylation of cytosine at different positions requires a flexible enzyme and 
therefore conformational changes. Especially loop regions of proteins have been 
described to have the ability to adapt different conformations, also depending on the 
bound substrate. In other words, the protein structure can differ depending on the 
substrate which was present at the time of crystallization. Structural data of Dnmt2 
have been generated so far only with a deletion mutant of human Dnmt2 (lacking 
residues 191-237) in the presence of S-adenosyl-homocysteine (Dong et al., 2001). 
A substantial information gain could probably be achieved by structural analysis of 
Dnmt2 crystals, which were generated in the presence of tRNAAsp (as a C38 target) 
or tRNALys (as a C40 target), as well as the co-factor S-adenosyl-methionine. 
Differences in conformation might then identify the residues that are involved in non-
C38 target methylation.  
 
3.7 Dnmt2 – a Promiscuous Enzyme?  
 
Broad substrate specificity and the ability to perform several catalytic reactions was a 
feature of ancestral enzymes and a prerequisite for the evolution of multiple, highly 
specialized enzyme families. Over time, randomly occurring mutations led to 
increased metabolic efficiency of one catalytic activity compared to the others. 
Selective pressure such as environmental stress signals together with duplication 
events caused the specialization of enzymes for one catalytic activity, often 
accompanied by loss of broad substrate acceptance and loss of alternative catalytic 
reactions (Aharoni et al., 2005; Khersonsky et al., 2006). Despite the high 
specialization of many enzymes throughout evolution, there still exist many cases of 
enzyme promiscuity. Usually, these enzymes exert one main catalytic reaction, and 
are also able to perform others, albeit with lower efficiency. Alternatively, there are 
many cases where there is a single catalytic reaction type, but several substrates. 
The main substrate is usually turned over at a much higher rate than the secondary 
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substrates (reviewed in Khersonsky et al., 2006). Could Dnmt2 be a promiscuous 
enzyme?  
The Dnmt2 enzyme was found to be the oldest and most widely distributed member 
of the Dnmt family among eukaryotes. It has been characterized to be a tRNA 
methyltransferase methylating C38 of tRNAAsp (Goll et al., 2006). The work at hand 
has identified a new in vivo substrate – tRNAVal – and several new in vitro targets 
which are methylated by Dnmt2 in a flexible manner at different target sites. Although 
the in vivo relevance of these alternative methylation sites still remains to be 
determined, it has become clear that the Dnmt2 enzyme is not as specialized as it 
was previously thought (namely, the methylation of exclusively one premodified tRNA 
– tRNAAsp – at one position: C38). When the structure of human Dnmt2 was solved, it 
was shown to be nearly super-imposable onto the structure of the bacterial DNA 
methyltransferase MHhaI (Dong et al., 2001). Structure and sequence analysis of 
bacterial and eukaryotic DNA m5C methyltransferases has revealed a high degree of 
conservation (Goll & Bestor, 2005). This can lead to the general assumption that 
eukaryotic m5C methyltransferases evolved from bacterial methyltransferases via 
horizontal transfer (Bestor, 1988). However, the molecular phylogenetic analysis of 
88 DNA m5C methyltransferases supports a different view: that the m5C 
methyltransferases were already present in the last common ancestor of bacteria, 
archaea, and eukaryotes (Bujnicki & Radlinska, 1999). The investigation of 
sequence-structure-function relationship of the yeast Trm4 m5C tRNA 
methyltransferase in comparison to m5U tRNA methyltransferases and m5C DNA 
methyltransferases revealed that tRNA m5C methyltransferases evolved from m5U 
tRNA methyltransferases, and that the DNA m5C methyltransferases then evolved 
from tRNA m5C methyltransferases (Bujnicki et al., 2004). This makes sense in the 
light of the fact that the “RNA world” is older than the “DNA world”, and that tRNA 
modification molecules must have occurred at a rather early stage of evolution, since 
they can be found in every organism in all three kingdoms. A tRNA modification 
enzyme – the tRNA (m(1)G37) methyltransferase – was even found in the smallest 
genome of an organism sequenced to date: Mycoplasma genitalium. This parasite is 
a unicellular bacterium which has reduced its genome to a size of 480 kb (Bjork et al., 
2001; de Crecy-Lagard et al., 2007). The fact that this organism has retained a gene 
for tRNA modification despite its limited coding capacity underlines the importance of 
tRNA modification and its role in translation fidelity regulation. It is very probable that 
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already before the separation of the three kingdoms into bacteria, archaea, and 
eukaryotes, a common ancestor possessed tRNA modifying enzymes. Since bacteria 
do not harbour m5C as a tRNA modification, it was most likely lost during or shortly 
after the separation from archaea and eukaryotes.  
The data of this thesis and other works (Goll et al., 2006) point towards the new 
hypothesis that the eukaryotic DNA methyltransferases did not evolve out of bacterial 
DNA methyltransferases, but out of an ancestor of Dnmt2. This new model is 
supported by several findings: tRNA m5C methyltransferases are older than m5C 
DNA methyltransferases, and m5C is not found among the tRNA modifications of 
bacteria, but is common to eukaryotes and archaea. The Dnmt2 enzyme represents 
a conserved eukaryotic m5C tRNA methyltransferase, which already possesses the 
catalytic motifs and the structural requirements needed for DNA methylating activity. 
Dnmt2 might therefore be seen as a conserved promiscuous enzyme, which 
represents the transit state from m5C tRNA to m5C DNA methylation. According to 
the model (see Fig. 3.2), the common ancestor of archaea and eukaryotes would 
have carried a bona fide tRNA m5C methyltransferase. This ancestral tRNA 
methyltransferase probably contained a cysteine in motif VI for catalysis, similar to 
most tRNA m5C methyltransferases (Bujnicki et al., 2004; Walbott et al., 2007b). The 
ENV motif, which is conserved in DNA methyltransferases, was not yet present (this 
is in line with its absence for example in Trm4, Motorin & Grosjean, 1999). Several 
mutations would then have led to the loss of the cysteine in motif VI, and acquirement 
of the ENV motif in Dnmt2. The presence of the cysteine and the glutamic acid in the 
catalytic pocket enabled the Dnmt2 enzyme then to retain its activity as a tRNA m5C 
methyltransferase. As a promiscuous enzyme, Dnmt2 not only had broader substrate 
specificity on tRNA, but would also have had the ability to recognize and methylate 
DNA to a small extent. During evolution, further mutations, duplication events, and 
gene fusion led then to the development of the DNA methyltransferases of the Dnmt1 
and 3 families. The N-terminal domain, which is missing in Dnmt2, but is present in 
Dnmt1 and 3a and b, probably facilitates their nuclear localization and the tethering 
of the Dnmts to DNA. Dnmt2, on the other hand, is mainly cytoplasmic (Goll et al., 
2006; Schaefer et al., 2008). Additional mutations which still remain to be determined 
led to the abolishment of tRNA methylating activity and an increase in DNA 
methylating activity in the Dnmt1 and Dnmt3a and b enzymes.  
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In this respect, it would be interesting to investigate, whether the catalytic domains of 
the eukaryotic DNA m5C methyltransferases 1 and 3a/b display residual tRNA 
methylating activity. Full length Dnmt1 and 3b were tested in preliminary experiments 
and did not show any activity on tRNA as a substrate. Even if the catalytic domain of 
Dnmt1 and 3a/b is not accepting tRNA as a substrate, it is possible that the exchange 
of one or more bases can introduce the tRNA methylating activity of Dnmt1 and 
Ancestor:
PC dipeptide  
(motif IV) 
Catalytic cysteine in motif VI 
Dnmt2:
Catalytic cysteine in 
PC dipeptide 
(motif IV) Loss of cysteine in motif VI 
Acquirement of ENV motif 
Dnmt1/3:
E
N
V
 N-terminal domain 
N-terminal fusion Additional mutations 
P
C
 
tRNA m5C methyltransferase 
DNA m5C methyltransferase 
tRNA m5C methyltransferase 
DNA m5C methyltransferase 
Figure 3.2: Dnmt2 as the evolutionary link between tRNA m5C and eukaryotic 
DNA m5C methyltransferases 
This model describes the emergence of eukaryotic m5C DNA methyltransferases 
out of tRNA m5C methyltransferases. The Dnmt2 enzyme probably evolved out of 
an ancestral tRNA m5C methyltransferase. The original catalytic cysteine in motif VI 
was lost, and the cysteine in motif IV became the catalytic residue. A glutamic acid 
was acquired within the ENV motif which is also needed for C38 methylation. The 
Dnmt2 enzyme displays good tRNA methyltransferase activity and a minor DNA 
methyltransferase activity. Mutation of further, currently still uncharacterized 
residues and the fusion with other proteins – generating the N-terminal domain – 
led then to the evolution of the bona fide eukaryotic DNA m5C methyltransferases. 
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Dnmt3a/b. This should be tested via protein engineering experiments. Complimentary 
to this approach, engineering experiments using Dnmt2 enzyme in combination with 
fusions of the N-terminal domain of Dnmt1 and/ or Dnmt3a/b may increase its ability 
to methylate DNA. 
In summary, this work has contributed to the identification of novel in vitro and in vivo 
substrates of Dnmt2 using an optimized DNAzyme technique. The investigation of 
catalytic mutants revealed an alternative catalytic mechanism for non-canonical (non-
C38) targets. This surprising promiscuity of the Dnmt2 enzyme led to the hypothesis 
that Dnmt2 could provide the link between tRNA m5C and DNA m5C 
methyltransferases. Future experiments will be necessary to support this idea. The 
extensive search for further targets in combination with the analysis of additional 
Dnmt2 mutants should contribute to a profound understanding of Dnmt2 function and 
the evolution of the eukaryotic DNA methyltransferases. 
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4  Material and Methods 
 
4.1  Materials 
 
4.1.1 Chemicals, Enzymes, and Reagents 
 
Acetic Acid      Merck, Darmstadt 
Acetone      Sigma-Aldrich, Seelze 
Acrylamide/Bis solution (19:1)   Serva, Heidelberg 
Acrylamide/Bis solution (29:1)   Roth, Karlsruhe 
Agar-Agar      Roth, Karlsruhe 
Agarose      Sigma-Aldrich, Seelze 
Ammonium persulfate    Sigma-Aldrich, Seelze 
Ammonium acetate     Sigma-Aldrich, Seelze 
Ammonium solution (25 %)   Sigma-Aldrich, Seelze  
Ammonium sulphate    Merck, Darmstadt 
Ampicillin      Sigma-Aldrich, Seelze 
[γ-32P]-ATP      Hartmann, Braunschweig 
β-Mercaptoethanol     Sigma-Aldrich, Seelze 
Bakers´ Yeast     Lesaffre, FR 
BAP enzyme      Fermentas, St. Leon-Rot 
Blasticidin      AppliChem, Darmstadt 
Boric acid      Sigma-Aldrich, Seelze 
Bovine serum albumine    New England Biolabs, Frankfurt 
Bradford Reagent      Biorad, München 
Bromphenol blue     Merck, Darmstadt 
BSA       Fermentas, St. Leon-Rot 
CDP star      Roche, Mannheim 
Chloramphenicol     Sigma-Aldrich, Seelze 
Chloroform      Sigma-Aldrich, Seelze 
Complete-mini-protease inhibitor   Roche, Mannheim 
Copper sulfate     Sigma-Aldrich, Seelze 
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[α-32P]-CTP      Hartmann, Braunschweig 
Deoxynucleotide triphosphates   Rapidozym, Berlin 
Diethylpyrocarbonate (DEPC)   Sigma-Aldrich, Seelze 
Disodium hydrogen phosphate   AppliChem, Darmstadt 
Dithiothreitol      Sigma-Aldrich, Seelze 
DNase I       Fermentas, St. Leon-Rot 
DNAzol      Invitrogen, Karlsruhe 
ECL solution (Western Lightening)  Perkin Elmer, Überlingen   
Ethanol (absolute)     Sigma-Aldrich, Seelze 
Ethidium bromide     Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) Gerbu, Gaiberg 
Fetal Calf Serum (FCS)    Invitrogen, Karlsruhe 
Flag peptide (3x)     Sigma-Aldrich, Seelze 
Formaldehyde     JT Baker, Deventer, NL 
Formamide      Merck, Darmstadt 
Glycerol      JT Baker, Deventer, NL 
Glycine      Gerbu Biotechnik, Gaiberg 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic  
acid (HEPES)     Roth, Karlsruhe 
Hydrochloric acid     VWR, Darmstadt 
Hydroquinone     Sigma-Aldrich, Seelze 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Roche, Mannheim 
Isobutyric acid     Sigma-Aldrich, Seelze 
Kanamycin      Sigma-Aldrich, Seelze 
Lithium perchlorate     Sigma-Aldrich, Seelze 
Magnesium chloride    Merck, Darmstadt 
Maleic acid      Sigma-Aldrich, Seelze 
Methanol      Sigma-Aldrich, Seelze 
Milk Powder      Roth, Karlsruhe 
Mineral Oil      Sigma-Aldrich, Seelze 
MOPS      Sigma-Aldrich, Seelze 
N,N,N´,N´-Tetramethylenediamine (TEMED) Roth, Karlsruhe 
Nucleotide triphosphates    Sigma-Aldrich, Seelze 
NP-40 (Igepal)     Sigma-Aldrich, Seelze 
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Penicillin/ Streptomycin    Gibco, Karlsruhe 
Phenol      Roth, Karlsruhe 
Ponceau staining solution    Sigma-Aldrich, Seelze 
Polynucleotide kinase    Fermentas, St. Leon-Rot 
Potassium chloride     Sigma-Aldrich, Seelze 
1-Propanol      AppliChem, Darmstadt 
2-Propanol      Sigma-Aldrich, Seelze 
Proteinase K      Qiagen, Hilden 
Rotiphorese Sequencing Gel buffer (10x) Roth, Karlsruhe 
Rotiphorese Sequencing Gel Concentrate Roth, Karlsruhe 
Rotiphorese Sequencing Gel Diluter  Roth, Karlsruhe 
S-adenosyl-methionine     New England Biolabs, Frankfurt 
[3H]-S-adenosyl-methionine   Hartmann, Braunschweig 
Sucrose      Sigma-Aldrich, Seelze 
Sodium chloride     Sigma-Aldrich, Seelze 
Sodium citrate     Sigma-Aldrich, Seelze 
Sodium hydrogencarbonate   AppliChem, Darmstadt 
Sodium dihydrogen phosphate   AppliChem, Darmstadt 
Sodium hydroxide     Sigma-Aldrich, Seelze 
Sodium pyrosulfite     Sigma-Aldrich, Seelze 
Sodiumhypochlorite solution   Neolab, Heidelberg 
Spermidine      Sigma-Aldrich, Seelze 
Streptavidin MagneSphereR Paramagnetic  
Particles      Promega, Mannheim  
Trichloroacetic acid     Roth, Karlsruhe 
Trizma base      Sigma-Aldrich, Seelze 
Trizol       Invitrogen, Karlsruhe 
Triton X-100      AppliChem, Darmstadt 
tRNA E. coli (total)     Roche, Mannheim 
Trypton      Roth, Karlsruhe 
Tween 20      Sigma-Aldrich, Seelze 
Yeast extract     Gerbu Biotechnik, Gaiberg 
Xylene cyanol     Sigma-Aldrich, Seelze 
Zinc chloride      Sigma-Aldrich, Seelze 
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All other chemicals not listed above were obtained either from the “Zentralbereich 
Neuenheimer Feld” of the University of Heidelberg or from the central storage 
department of the German Cancer Research Center (Heidelberg). 
 
4.1.2 Equipment 
 
Centrifuge       Neolab, Heidelberg 
Cerenkov Counter LS 6500   Beckman Coulter, Krefeld 
Electrophoresis chamber     Biorad, München 
Incubator (37 °C): Innova 4200   New Brunswick Scientific, Nürtingen 
Microscope (Zeiss Axiovert 40)   Zeiss, Göttingen 
Nanodrop 1000     Thermo Scientific, Dreieich 
PTC-200 Peltier Thermal Cycler   Biozym, Hess. Oldendorf 
Photometer       Neolab, Heidelberg   
Shaker      Neolab, Heidelberg 
Speedvac      Thermo Scientific, Schwerte 
Thermomixer      Neolab, Heidelberg   
Typhoon 9400     GE Healthcare, München 
UV-Stratalinker-1800    Stratagene, Heidelberg 
X-ray films (Fuji Medical SuperRX)  Fujifilm, Düsseldorf 
 
4.1.3 Kits 
 
DIG Northern Starter Kit    Roche Diagnostics, Mannheim 
DNeasy Blood and Tissue Kit   Qiagen, Hilden 
Epitect Bisulfite Kit     Qiagen, Hilden 
GeneClean DNA Purification Kit   Oncor Appligene, Heidelberg 
Ni-NTA Fast Start Kit    Qiagen, Hilden  
Plasmid Mini Prep Kit    Qiagen, Hilden 
Plasmid Midi Kit     Qiagen, Hilden 
Qiaquick Gel Extraction Kit   Qiagen, Hilden 
Qiaquick PCR Purification Kit   Qiagen, Hilden 
QuickPrep Micro mRNA Purification Kit  GE Healthcare, München 
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T7 Megascrip Kit (Ambion)    Applied Biosystems, Darmstadt 
Thermoscript RT-PCR System   Invitrogen, Karlsruhe 
TOPO TA Cloning Kit for Sequencing  Invitrogen, Karlsruhe 
 
4.1.4 Primer, DNA templates, DNAzymes, Antibodies, Enzymes, and Fly Strains 
 
All sequences are depicted from 5´ to 3´ and were obtained either by IBA (Göttingen) 
or MWG Biotech (München). 
 
Primer:  
 
RT-PCR Primer for the Dnmt2 gene: 
HD11: GGGGCCCGGGTATGGTATTTCGGGTCTTAGAACTATTTAGTGGC 
HD12: CGAATTCTTTTATCGTCAGCAATTTAATAAGTTCACCG 
HD39: CACCAAATTACTGCCGTAATTGTGC 
HD57: ATCCTCACTGGCTTCCCC 
RT-PCR Primer for Micropia: 
MM_25: TGCCGAAAGCTGTGTTAATG 
MM_26: CTCATTCGGGATTTCTGCAT 
RT-PCR Primer for Invader 4: 
MM_47: TGAGAGAAGACACGCCAATG 
MM_48: GATCGACGTCAGCAGTCAAA 
RT-PCR Primer for Invader 2: 
MM_34: GCAGGAAAGCATATGCAACA 
MM_35: ATCTCAAACGGCACATTTCC 
RT-PCR Primer for EF1α48D: 
EF1α48D_For : AGCAGCTGATCGTTGGTG 
EF1α48D_Rev: TCACGGACACGTTCTTGAC 
Primer Northern Probe Dnmt2:  
For: GGGGCCCGGGTATGGTATTTCGGGTCTTAGAACTATTTAGTGGC 
Rev: TAATACGACTCACTATAGGGAGACCACATTTAATAAGTTCACCG 
Primer Northern Probe Adh: 
Adh for: GCGATCTGAAGAACCTGGTG 
Adh rev: AATTAACCCTCACTAAAGGGAGAGGTTCAGCTCGATAGCCTTG 
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Bisulfite Sequencing Primer for Invader 2: 
MM_37: ATAAAATTTTTGAAATGAGAAATGG 
MM_38: TCTTCAAATATAAAACAAATCCCCC 
Bisulfite Sequencing Primer for Invader 4: 
MM_51: GGAGGAGATTGTGGTTTTGG 
MM_52: CCACATATCCCATTTCATCACA 
MM_60: TGGTTGTGTTGGAGGTATAAAA 
MM_61: AACAACCAACATCTCCATTCC 
MM_55: TGAGTGAGGTTTGATTGAGTGG 
MM_56: 5´-TCAACAAAACAAAAATCTACC-3´ 
MM_88: TGGTATTTGGTGAATTTGTGG 
MM_89: CATTTTAAACAAACATCCAACACC 
MM_76: TGTTTTGTTGGTATTATGTGGTTGTAG 
MM_77: CCAACTTTCCCACAAAAATAAC 
Bisulfite Sequencing Primer within the RS5 Element: 
Region 1 
For TTGGGGTATGTGGTGTTTGA 
Rev CCATCTTCCTCTTCCTAACCAA 
Region 2 
For TATTGATGTTATTGATTTATTTAGAGTT 
Rev CTTACATACCCCATTATTCTCTATTC 
Region 3 
For GTTGAAGAAGGGAAATGTAAGAAG 
Rev TTTTACTCCAATCACAACTTT 
Region 4 
For TTATATAGTGAGTATAGTTATTAGAATAAT 
Rev TAGGTCGATAGCGTCAATGTCCGCCTTCA 
Region 5  
For AAGTGGATGTTTTTTGTTGATGGGA 
Rev CAATCAACACAACCAATCAAACTT 
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Primer for tRNA construct amplification: 
 
MH53 T7 Polymerase Primer: 
CGCGCGAAGCTTAATACGACTCACTATA 
tRNAAsp (M. musculus) Primer (rev): 
TGGCTCCCGTCGGGGAATCGAA 
tRNAAsp (D. melanogaster) Primer (rev): 
TGGCGCCCCGACGGGGAATTG 
MH159 tRNAAsp (P. abyssi) Primer : 
TGGCGCCCGGGCCGGGATTT 
MH60 tRNALeu(CUN) (H. sapiens): 
TGGTACTTTTATTTGGAGTT 
 
 
DNA templates for in vitro transcription: 
 
tRNAAsp (M. musculus) 
MH117:  
TGGCTCCCCGTCGGGGAATCGAACCCCGGTCTCCCGCGTGACAGGCGGGGAT
ACTCACCACTATACTAACGAGGAGACGGTACCGGGTACCGTTTCGTCCTCACGG
ACTCATCAGTCCTCGTTATCTCCCTATAGTGAGTCGTATT 
 
MH346 (71mer): 
 
TCCCCGTCGGGGAATCGAACCCCGGTCTCCCGCGTGACAGGCGGGGATACTC
ACCACTATACTAACGAGGAGACGGTACCGGGTACCGTTTCGTCCTCACGGACTC
ATCAGTCCTCGTTATCTCCCTATAGTGAGTCGTATT 
 
MH238 (anticodon stem loop only; “2”): 
CCCGCGTGACAGGCGGGGACGGTACCGGGTACCGTTTCGTCCTCACGGACTC
ATCAGCCCGCCTGTTCTCCCTATAGTGAGTCGTATT 
 
MH237 (C32 ? G32): 
TGGCTCCCCGTCGGGGAATCGAACCCCGGTCTCCCGCGTGACACGCGGGGAT
ACTCACCACTATACTAACGAGGAGACGGTACCGGGTACCGTTTCGTCCTCACGG
ACTCATCAGTCCTCGTTATCTCCCTATAGTGAGTCGTATT 
 
MH239 (C38 ? U38): 
TGGCTCCCCGTCGGGGAATCGAACCCCGGTCTCCCGCATGACAGGCGGGGAT
ACTCACCACTATACTAACGAGGAGACGGTACCGGGTACCGTTTCGTCCTCACGG
ACTCATCAGTCCTCGTTATCTCCCTATAGTGAGTCGTATT 
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tRNAAsp (D. melanogaster): 
TAATACGACTCACTATAGGCCTCGATAGTATAGTGGTTAGTATCCCCGCCTGTCA
CGCGGGAGACCGGGGTTCAATTCCCCGTCGGGGCGCCA-3´ 
 
tRNAVal (D. melanogaster) 
MH202: tRNAVal T7 DNA template 
TGGTGTTTCCGCCCGGGATCGAACCGGGGGCCTTCTGCGTGTTAGGCAGATGT
GATAACCGCTACACCACGGAAACGACGGTACCGGGTACCGTTTCGTCCTCACG
GACTCATCAGGTTTCCGTGTCTCCCTATAGTGAGTCGTATT-3´ 
 
tRNAAsp (P. abyssi) MH156: 
TGGCGCCCGGGCCGGGATTTGAACCCGGGTCGCGGGAGTGACAGTCCCGCAT
GATAGGCCGGGCTACACCACCCGGGCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): 
GGTCGCCCAACGTGGGGCTCGAACCCACGACCCTGAGATTAAGAGTCTCATGC
TCTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): (a) G30 ? C30; C40 ? G40  
TGGCGCCCAACGTGGGGCTCGAACCCACGACCCTGACATTAAGAGTGTCATGC
TCTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): (b) G28 ? C28; C42 ? G42 
TGGCGCCCAACGTGGGGCTCGAACCCACGACCCTCAGATTAAGAGTCTGATGC
TCTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): (c) G28 ? C28; G30 ? C30; C40 ? G40; C42 ? G42 
TGGCGCCCAACGTGGGGCTCGAACCCACGACCCTCACATTAAGAGTGTGATGC
TCTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): (d) G28 ? U28; G30 ? U30; C40 ? A40; C42 ? A42 
TGGCGCCCAACGTGGGGCTCGAACCCACGACCCTTATATTAAGAGTATAATGCT
CTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALys (D. melanogaster): (e) C40 ? G40 
GGTCGCCCAACGTGGGGCTCGAACCCACGACCCTGACATTAAGAGTCTCATGC
TCTACCGACTGAGCTAGCCGGGCCCTATAGTGAGTCGTATTA 
 
tRNALeu(CUN) (H. sapiens): 
TGGTACTTTTATTTGGAGTTGCACCAAAATTTTTGGGGCCTAAGACCAATGGATA
GCTGTTATCCTTTAAAAGTGACGGTACCGGGTACCGTTTCGTCCTCACGGACTC
ATCAGACTTTCTCCCTATAGTGAGTCGTATT 
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tRNAPhe (S. cerevisiae) : G30 ? C30 ; C40 ? G40 
TGGTGCGAATTTCTGTGATCGAACACAGGACCTCCACATCTTCAGTGTGGCGCT
CTCCCAACTGAGCTAAATCCGCCCTATAGTGAGTCGTATTA 
 
 
The plasmid encoding tRNAPhe (wt) from S. cerevisiae was a gift from O. Uhlenbeck; 
native tRNAPhe and the plasmid encoding human mitochondrial tRNAThr was a gift 
from C. Florentz; the plasmid encoding tRNAAsp from S. cerevisiae was a gift from G. 
Keith (all to M. Helm); the plasmid encoding the gene for human tRNALys was a gift 
from J.-L. Darlix to F. Lyko. 
 
DNA Oligos (biotinylated): 
MH119: Biotin-Sonde tRNA Asp 
TGACAGGCGGGGATACTCACCACTATACTAACGAGGA 
3´-Biotin 
Valin_Sonde_Bio: 
TGTTAGGCAGATGTGATAACCGCTACACCACGGAAAC 
3´-Biotin 
MM_Lys2_Oligo: 
CGCCCAACGTGGGGCTCGAACCCACGACCCTGAGATTA 
5´-Biotin 
 
DNAzymes:  
MH143: DNAzym_Asp (C38) 
CCGGTCTCCCGCGGGCTAGCTACAACGAGACAGGCGGGGA 
 
DNAzym_Asp_F: 
ACCCCGGTCTCCCGCXGGCTAGCTACAACGAGACAGGCGGGGA 
5´- fluorescein 
X: inosine 
 
DNAzym 3:  
CCCGCGTGACAGGGGCTAGCTACAACGAGGGGATACTCACC 
 
DNAzym 4: 
CCCCGGTCTCCCGGGCTAGCTACAACGAGTGACAGGCGGGG 
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DNAzym 34B: 
CCCCGGTCTCCCGGGCTAGCTACAACGAGTGACAGGGGCTAGCTACAACGAGG
G 
 
DNAzym_Val_F: 
GGGGGCCTTCTGCXGGCTAGCTACAACGAGTTAGGCAGATGTG 
X: Inosine 
5´: Fluorescein (FAM) 
 
DNAzym_Lys_1: 
TCGAACCCACGAGGCTAGCTACAACGACCTGAGATTA 
5´: Fluorescein 
 
DNAzym_Lys_2: 
ACGACCCTGAGAGGCTAGCTACAACGATAAGAGTCTCA 
5´: Fluorescein 
 
 
RNA Oligos: 
MH352: UCCUCGUUAGUAUAGUGGUGAGUAUCCCCGCCUGUCA 
MH353: F5CGCGGGAGACCGGGGUUCGA 
MH354: m5CGCGGGAGACCGGGGUUCGA 
MH355: CGCGGGAGACCGGGGUUCGA 
MH356: P-UUCCCCGACGGGGAGCCA 
 
 
Antibodies : 
Rabbit anti-Dnmt2 peptide 2; 1:500 (Kunert et al., 2003); (Schaefer et al., 2008) 
Mouse anti-tubulin; 1:10000  Sigma-Aldrich, Seelze 
goat−α-rabbit-HRP; 1:10000  Jackson Immuno Research, Suffolk, GB 
goat−α-mouse-HRP; 1:10000  Jackson Immuno Research, Suffolk, GB  
anti-Flag     Sigma-Aldrich, Seelze 
anti-Digoxigenin    Roche , Mannheim  
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Enzymes: 
BAP       Fermentas, St. Leon-Rot 
BstNI      New England Biolabs, Frankfurt 
DNase I     Fermentas, St. Leon-Rot  
DNase-free RNase     Roche, Mannheim 
EcoRI      New England Biolabs, Frankfurt 
P1 RNase     Roche, Mannheim 
PNK       Fermentas, St. Leon-Rot 
Proteinase K     Qiagen, Hilden 
Rapidozym Taq Polymerase   Gentherm, Rapidozym, Berlin 
RNase H      Invitrogen, Karlsruhe 
T1 RNase     Gibco, Invitrogen, Karlsruhe 
T4 Ligase     Fermentas, St. Leon-Rot 
T7-RNA-Polymerase    Fermentas, St. Leon-Rot 
Thermoprime Polymerase   Abgene, Hamburg 
Thermoscript Reverse Transcriptase  Invitrogen, Karlsruhe 
 
Fly strains: 
OrR     BloomingtonStock Center (Indiana University) 
EP     Gift from Sameer Phalke (University of Halle) 
Dnmt2149    Gift from Sameer Phalke (University of Halle) 
Dnmt2215    Gift from Sameer Phalke (University of Halle) 
5Ha1925    Gift from Sameer Phalke (University of Halle) 
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4.1.5 Buffers and Solutions 
 
10x boric acid buffer 
15.46 g boric acid 
ad 1 l with H2O 
adjust pH to 8.8 
 
Detection buffer (Southern and Northern Blot): 
0.1 M Tris-HCl 
0.1 M NaCl 
pH 9.5 
 
Dialysis buffer 1: 
300 mM KPO4 pH 7.5 
300 mM KCl 
1 mM EDTA 
0.1 mM DTT 
10 % glycerol 
 
Dialysis buffer 2: 
30 mM KPO4 pH 7.5 
200 mM KCl 
1 mM EDTA 
0.1 mM DTT 
60 % glycerol 
 
5x DNAzyme Buffer: 
250 mM Tris-HCl pH 7.5 
750 mM KCl 
50 mM MgCl2 
 
Egg wash: 
7 g NaCl 
1 g (w/v) Triton X-100 
ad 1 l with H2O 
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KL-buffer: 
50 mM Tris-HCl pH 7.4 
10 mM MgCl2 
 
LB medium: 
10 g tryptone 
5 g yeast extract 
10 g NaCl 
H2O ad 1 l  
 
LB-agar: 
LB medium supplemented with 1.5 % (w/v) agar 
 
Loading buffers: 
 
Loading buffer for DNA: 
0.25 % w/v Bromphenol blue 
0.25 % w/v Xylene cyanol 
30 % v/v glycerol 
 
Loading buffer (denaturing) :    
90 % formamide      
9.8 % 10x TBE      
0.1 % Xylene cyanol      
0.1 % Bromphenol blue     
 
Loading buffer (native): 
90 % TBE 
9.8 % glycerol 
0.1 % Xylene cyanol 
0.1 % Bromphenol blue 
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Loading buffer (for Northern Blot): 
For a volume of 500 µl: 
250 µl 100 % formamide 
83 µl 37 % formaldehyde 
50 µl 10x MOPS 
50 µl 100 % glycerol 
10 µl 2.5 % Bromphenol blue 
57 µl H2ODEPC 
 
10x MOPS buffer: 
200 mM MOPS 
50 mM NaAc 
20 mM EDTA 
pH 7.0 with NaOH 
 
Pb-Stop Solution: 
1x TBE 
8 M urea 
10 mM EDTA 
0.1 % Xylene cyanol 
0.1 % Bromphenol blue 
 
QEB-buffer:       
50 mM MOPS pH 7.5     
15 % EtOH 
300 mM NaCl      
0.1 % Triton X-100 
 
QEL-buffer: 
50 mM MOPS pH 7.5 
15 % EtOH 
750 mM NaCl 
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QLW-buffer:        
50 mM MOPS pH 7.5     
15 % EtOH       
300 mM NaCl      
 
5x SDS-Loading buffer: 
250 mM Tris-HCl pH 6.8 
10 % SDS 
0.5 % Bromphenol blue 
50 % glycerol 
500 mM β-Mercaptoethanol 
 
Shearing buffer: 
TE pH 8 
10 % glycerol 
 
20x SSC:  
3 M NaCl 
0.3 M sodium citrate 
pH 7.0 
 
Strasbourg Buffer: 
40 mM Tris-HCl pH 8.1 
1 mM Spermidine 
5 mM DTT  
 
10x TBE: 
108 g Tris-Base 
55 g boric acid 
200 ml 0.5 M EDTA pH 8.0 
ad 1 l with H2O 
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T1-Buffer: 
40 mM Tris-HCl pH 7.5 
40 mM NaCl 
10 mM MgCl2 
 
TBST: 
50 mM Tris-HCl pH 8.0 
150 mM NaCl 
0.1 % Triton X-100 
 
TE: 
10 mM Tris-HCl pH 7.4 
1 mM EDTA pH 8.0 
 
Wash buffer 1 (Southern and Northern Blot): 
2x SSC 
0.1 % SDS 
 
Wash buffer 2 (Southern and Northern Blot): 
0.5x SSC 
0.1 % SDS 
 
Wash buffer 3 (Southern and Northern Blot): 
0.1 M Maleic acid  
0.15 M NaCl  
0.3 % Tween-20 
pH 7.5 
 
4.1.6 Marker 
 
DNA Marker:  Hyperladder I     Bioline, Luckenwalde 
Protein Marker:  PageRuler Prestained Protein Ladder Fermentas, St. Leon-Rot 
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4.2  Methods 
 
4.2.1 Standard maintenance of Drosophila melanogaster 
Flies were raised in glass vials with foam plugs at 25 °C and ~ 70 % humidity. Fly 
food was prepared by the Division of Developmental Genetics of the DKFZ (standard 
fly food: 10 l H2O; 80 g agar; 180 g dry yeast; 100 g soy flour; 220 g beet syrup; 
800 g cornmeal; 24 g Nipagin; 62.5 ml propionic acid), and directly poured into the 
glass vials. Every one to two weeks, freshly hatched flies were moved to a new vial.  
 
4.2.2 Acetic acid agar plates 
For 1 l, 17 g of agar were mixed with 500 ml H2O and shortly boiled in the microwave 
oven. Another 500 ml H2O and 8 ml acetic acid were added. After thorough mixing, 
the liquid acetic acid agar was poured into standard petri dishes. After cooling, the 
agar plates were stored in sealed plastic bags to avoid drying out.  
 
4.2.3 Embryo collection 
Flies were put into plexiglass collection cages. The opening was sealed with an 
acetic-acid-agar plate containing bakers´ yeast mixed with water as a food source in 
the middle of the plate. Flies were allowed to acclimate one day to the cage. One 
hour prior to the start of the collection, the plate was exchanged for a fresh one, so 
the female flies could lay their withheld eggs. With the starting of the collection time, 
a new plate was fixed on the cage for the desired collection time, ranging from 3 to 
24 hours. Afterwards, the plate was removed and exchanged for a fresh one for 
further collection. The embryo containing collection plate was cleaned of dead flies, 
and the yeast was cut out. The chorion membrane was removed by bleaching for 
3 min in 50 % sodium hypochlorite solution. The embryos were washed extensively 
with egg wash (7 g NaCl, 1 g (w/v) Triton X-100 in 1 l H2O), transferred into a tube 
and frozen in liquid nitrogen after complete removal of residual egg wash. Frozen 
embryos were stored at -80 °C until further use.  
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4.2.4 Preparation of genomic DNA using DNAzol and the DNeasy tissue kit  
Unless indicated otherwise, genomic DNA of 0 - 3h old embryos was prepared by 
applying two subsequent purification steps using DNAzol (Invitrogen) and the 
DNeasy tissue Kit (Qiagen). The protocols supplied with the kits were closely 
followed. Briefly, 50 – 100 µl of flash-frozen 0 - 3 h old embryos were homogenized in 
1 ml DNAzol (Invitrogen) using a loose fitting glass homogenizer. Debris was 
removed by a 10 min centrifugation step at 10000 x g. The supernatant was 
transferred to a new reaction vial and the DNA was precipitated by the addition of 
100 % Ethanol. After centrifugation, the DNA pellet was washed with 70 % ethanol 
and dissolved in 8 mM NaOH according to the manufacturer´s instructions. The pH 
was adjusted to 7.2 by the addition of 1 M HEPES buffer. Residual RNA was 
removed by an one hour digest using 10 µl DNase-free RNAse (10 u/µl; Roche) at 
37 °C, followed by a 5 h to overnight incubation with proteinase K (10 mg/ml; Qiagen) 
at 50 °C to digest protein. In a second purification step, the DNA was bound to the 
column provided in the DNeasy tissue Kit and further purified using the supplied 
wash buffers. Finally, the genomic DNA was eluted in 10 mM TrisHCl pH 8.0. 
 
4.2.5 Shearing of DNA 
Genomic DNA was sheared to an average size of 1000 bp using the Nebulizer 
technique (Invitrogen) by following the instructions of the corresponding protocol. In 
short, 700 µl DNA were mixed with 1.3 – 2 ml shearing buffer (TE pH 8 containing 
10 % glycerol), transferred to the Nebulizer and subjected to a pressure of 2 bar for 
2 min. The sheared fragments were precipitated by the addition of 3 M sodium 
acetate and Isopropanol, washed with 70 % Ethanol and dissolved in 10 mM Tris-
HCl.  
 
4.2.6 Restriction digest 
Digestion of genomic DNA was performed according to the manufacturer´s 
instructions. Most enzymes were purchased from New England Biolabs and were 
used with the supplied reaction buffers under appropriate reaction conditions.  
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4.2.7 Standard PCR  
PCR was performed using Thermoprime Plus DNA Polymerase (5 u/µl) and 
10x Reddy MixTM PCR Buffer (Thermo Scientific/ ABgene). A standard PCR reaction 
contained 2 µl DNA template, 2 µl 10x Reddy Mix, 2 µl dNTPs (100 µM end 
concentration), 2 µl forward primer (10 µM end), 2 µl reverse primer (10 µM end), 
0.3 µl Thermoprime polymerase, 9.7 µl H2O. PCR reactions were incubated in a 
PTC-200 Peltier Thermal Cycler (MJ Research). The temperature steps of a typical 
PCR programme were: step 1: 94 °C for 2 min, step 2: 94 °C for 30 s, step 3: 50 –
60 °C for 30 s (depending on the optimal annealing temperature for the chosen 
primers), step 4: 72 °C for 1 min. Steps 2 – 4 were repeated for a total of 25 – 30 
cycles. After a final incubation of the PCR reaction at 72 °C for 5 min, the PCR 
reaction was either directly loaded on an 1 % agarose gel or stored at -20 °C. 
 
4.2.8 Standard gel electrophoresis (agarose gels) 
DNA or RNA preparations, digestion fragments, and PCR reactions were resolved on 
1 – 3 % agarose gels consisting of agarose melted in TAE-buffer (1 g agarose per 
100 ml buffer). After heating in the microwave and a brief cooling period, 2 µl of 
ethidium bromide stock solution (10 mg/ml) were added per 100 ml of melted 
agarose. The liquid gel was poured into previously prepared gel chambers and a 
comb was added. After polymerization, the samples were mixed with 6x loading 
buffer (0.25 % w/v bromphenol blue; 0.25 % w/v xylene cyanol; 30 % v/v glycerol). 
Unless stated otherwise, gels were run in 1x TAE at 100 V for 20 – 30 min. 
 
4.2.9 Bisulfite treatment of DNA 
Bisulfite treatment of DNA was carried out after the following protocol: up to 1 µg of 
purified, protein-free DNA was dissolved in 50 µl H2O; 5.5 µl of freshly prepared 3 M 
NaOH were added for denaturing. The mixture was incubated for 20 min at 37 °C. 
Meanwhile, 2.16 g sodium bisulfite were added to 3 ml of H2O. The pH was adjusted 
to 5.0 by adding 200 µl of 10 M NaOH (also freshly prepared). 0.11 g hydroquinone 
were dissolved in 5 ml H2O. 250 µl of the fresh hydroquinone solution were added to 
the bisulfite solution (final concentration 10 mM), and the volume of the bisulfite-
hydroquinone solution was adjusted to 5 ml final with H2O. 600 µl of the 
hydroquinone-bisulfite solution was added to the denatured DNA, mixed thoroughly 
and layered with mineral oil. The reaction was incubated for 12 – 14 h at 55 °C. 
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Afterwards, the deaminated DNA was purified according to the instructions of the 
GeneClean DNA purification kit (Oncor Appligene) using glass milk and the supplied 
washing buffers. After ethanol-precipitation, the DNA pellet was resuspended in 
1 mM Tris-HCl pH 8 and stored at -20 °C.  
 
4.2.10 Topo TA cloning for sequencing 
To determine the sequence of PCR fragments of interest, the gel-purified PCR 
fragments were cloned into the pCR4-TOPO-vector in accordance with the 
instructions provided with the TOPO TA Cloning Kit for Sequencing (Invitrogen). 
Briefly, 0.5 to 4 µl of gel-purified PCR product were mixed with 1 µl salt solution, 1 µl 
TOPO vector and H2O to a final volume of 6 µl. After 5 min of incubation at room 
temperature, 2 µl of the reaction were added to one vial of One Shot Chemically 
Competent E. coli, gently mixed and stored for 20 min on ice. Heat shock was 
performed for 30 s at 42 °C. Tubes were immediately put on ice and 250 µl SOC 
medium was added. After one hour at 37 °C and 200 rpm under constant shaking, 
appropriate volumes were spread on LB-agar plates containing 100 µg/ml ampicillin 
as antibiotic.  
 
4.2.11 Expression of transformed E. coli 
For liquid cultures of transformed E. coli – small scale for a Mini-Prep or large scale 
for a Midi-Prep – single colonies were picked with a sterile toothpick and incubated in 
an appropriate volume of LB medium (5 ml for a Mini-prep, 100 ml for a Midi-Prep) 
supplemented with the selection antibiotic ampicillin (100 µg/ml final concentration). 
The cultures were incubated at 37 °C under constant shaking at 220 rpm. 
 
4.2.12 Mini-and Midi-Prep 
Plasmid preparations on a “mini” or “midi” scale yielding from a few to up to 100 µg 
DNA were performed using the Qiagen Mini/Midi plasmid purification kit in 
accordance with the manufacturer´s instructions. 
 
4.2.13 Sequencing 
The bisulfite treated, PCR-amplified, and cloned sequences were diluted in water to a 
concentration of 100 ng/µl. Sequencing was performed by the company GATC 
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(Konstanz, Germany) using T7 or T3 standard primers. The sequences were 
analyzed using the 4peaks software (GATC).  
 
4.2.14 Isolation of total RNA out of 0 – 3 h old Drosophila embryos 
Total RNA was isolated using the reagent Trizol (Invitrogen) in accordance with the 
manufacturer´s instructions. The embryos were homogenized in appropriate volumes 
of Trizol using a plastic homogenizer, debris was removed by centrifugation, and total 
RNA was separated from DNA and proteins by the addition of chloroform. The 
aqueous, RNA containing phase was transferred to a new reaction vial and the RNA 
was precipitated with isopropanol, washed with 70 % Ethanol and dissolved in 200 µl 
H2ODEPC. The RNA yield was quantified using a photometer at 260 nm wavelength. 
The integrity of the RNA was confirmed on an 1 % agarose gel.  
 
4.2.15 mRNA Preparation 
mRNA was prepared using the QuickPrep micro mRNA purification kit 
(GE Healthcare). Either frozen embryos were disrupted according to the 
manufacturer´s instructions or total RNA preparations were used as starting material. 
In short, 500 µg total RNA was mixed with extraction buffer to a final volume of 
400 µl, and 800 µl elution buffer were added. 1 ml oligo(dT) cellulose was prepared 
as stated in the protocol, mixed with the RNA and incubated for 3 min on a rotating 
wheel. Washing steps were performed as recommended, adding to a total of 5 times 
high salt wash and 2 times low salt wash. After the addition of oligo(dT) cellulose to 
the column, the column was washed two more times with low salt buffer. The mRNA 
was eluted by adding 200 µl prewarmed (65 °C) elution buffer to the column and 
subsequent centrifugation for 5 s at maximum speed.  
After the elution, the mRNA was precipitated by adding 20 µl potassium acetate 
(provided with the kit), 5 µl glycogen and 500 µl 100 % ethanol and 1 h incubation at 
-20 °C. Subsequent centrifugation and washing was performed as in the preparation 
of total tRNAs. The precipitated mRNA was resuspended in 50 µl H2ODEPC .  
 
4.2.16 Reverse transcription 
cDNA Synthesis was performed according to the instructions provided with the 
ThermoScript™ RT-PCR System (Invitrogen) using oligo(dT) primers. Briefly, RNA, 
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primer, H2ODEPC and dNTPs were mixed and incubated at 65 °C for 5 min and then 
placed on ice. 5x cDNA synthesis buffer, DTT, RNaseOUT and Thermoscript reverse 
transcriptase were added as stated in the protocol. The reaction was incubated for 
one hour at 55 °C and afterwards terminated by heating for 5 min at 85 °C and by the 
addition of 1 µl of RNase H (2 u/µl; from E. coli; Invitrogen) with subsequent 
incubation at 37 °C for 20 min. The synthesized cDNA was stored at -20 °C or 
directly subjected to PCR. 
 
4.2.17 Semi-quantitative RT-PCR 
As a measure to compare expression levels of certain mRNAs, a semi-quantitative 
PCR was performed on cDNA which was obtained by reverse transcription of 
Drosophila mRNA (see above). The cDNA was used as a template for standard PCR 
(see above), but special care was taken to remain within the linear amplification 
range by using low cycle numbers (20 – 22) and including a housekeeping gene as a 
control for equal loading. For very weakly expressed mRNAs and therefore low 
amounts of cDNA, the cycle number was raised to 30. After the PCR, the 
housekeeping-gene-PCR was loaded on an 1 % agarose gel in different 
concentrations to adjust equal loading between PCR of wt and mutant and to be able 
to determine the corresponding volumes of the PCR of the cDNA of interest. Gels 
were photographed.  
 
4.2.18 Northern blot  
Northern Blots were performed as downward blots using 20x SSC for capillary 
transfer. By closely following the instruction manual of the DIG Northern Starter Kit 
(Roche), DIG-labeled probes were generated and the labeling efficiency determined.  
Up to 5 µg total RNA was mixed with 2 - 3 volumes of freshly prepared loading buffer 
(250 µl 100 % formamide, 83 µl 37 % formaldehyde, 50 µl 10x MOPS, 50 µl 
100 % glycerol, 10 µl 2.5 % bromphenol blue and 57 µl H2ODEPC), heated for 10 min 
at 65 °C, then chilled on ice for 1 min and run on a 2 % formaldehyde gel (3.6 g 
agarose, 282 ml 1x MOPS, 16.2 ml 37 % formaldehyde) in 1x MOPS running buffer 
for 2 - 5 h. Prior to blotting, the gel was rinsed in 20x SSC for 2 x 15 min. The blot 
was assembled from bottom to top as follows: a 3 – 4 cm stack of dry whatman 
paper, one whatman paper soaked in 20x SSC, the positively charged nylon 
membrane (Roche) soaked in 20x SSC, the gel, 3 pieces of whatman paper soaked 
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in 20x SSC, one large whatman paper soaked in 20x SSC (functioning as “bridge” by 
touching the 20x SSC surface with its edges), and on top a light weight (e.g. a plastic 
lid or an empty plastic box). Blotting was performed over night at room temperature. 
The RNA was fixed on the membrane by UV-crosslinking in a UV-stratalinker 
(Stratagene) with 120000 microjoules/ cm2 for 20 – 25 seconds. After the crosslink 
the membrane was stored dry at 4 °C.  
Prehybridization, hybridization and subsequent washes, as well as blocking and 
antibody incubation were performed using the reagents supplied with the DIG 
Northern Starter Kit (strictly following the protocol). For signal detection, the 
membrane was equilibrated in detection buffer (0.1 M Tris-HCl, 0.1 M NaCl pH 9.5) 
for 5 min. 2 ml of detection buffer was spread in several drops on a plastic surface 
and mixed with CDP-Star (a kit component). The membrane was placed upside down 
on the buffer-CDPS-mixture. Air bubbles were carefully avoided, excess liquid 
removed and the plastic bag was sealed. After 20 min incubation at room 
temperature, the membrane was exposed to an X-ray film for 5 – 10 min. Due to the 
signal increase during the first 24 h, multiple exposures could be taken.  
 
4.2.19 Stripping and reprobing of Northern blots 
To remove probe and antibody signal, the membrane was first thoroughly soaked in 
H2ODEPC and then incubated in freshly prepared stripping buffer (50 % formamide, 
50 mM TrisHCl pH 7.5, 5 % SDS) for 2 x 60 min at 80 °C. Then the membrane was 
rinsed in 2x SSC for 2 x 5 min. The membrane was stored at 4 °C in 2x SSC in a 
sealed bag or directly used for prehybridization.  
 
4.2.20 Embryonic protein extracts 
Roughly 100 - 200 µl embryos were transferred from collection plates into a glass 
homogenizer using a soft brush and egg-wash (0.1 % Triton and 7 g NaCl/l). The 
embryos were rinsed two more times with egg-wash. Finally, the last wash was 
completely removed and replaced with 200 µl protein extraction buffer 
(50 mM HEPES, 0.5 mM EDTA, 100 mM NaCl, 0.05 % NP-40; pH 7.5); just before 
use, proteinase inhibitor cocktail was added (Complete mini EDTA free, Roche). 
Twenty strokes with a tight-fitting pestle were sufficient to homogenize the embryos. 
After 20 min incubation on ice, the homogenate was transferred into a 1.5 ml reaction 
tube and was centrifuged for 30 min at 4 °C and 13200 rpm in a tabletop-centrifuge. 
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The supernatant was carefully transferred into another reaction tube. For Western 
blotting, appropriate amounts of 5x SDS loading buffer were added, and the extract 
was incubated for 5 min at 95 °C. Quantification of total protein was determined by 
Bradford assay. 
 
4.2.21 Western blot 
For two 10 % polyacrylamide gels, the following ingredients were mixed: separation 
gel: 10 ml 30 % acrylamide, 13.6 ml H2O, 6 ml 1.6 M Tris-HCl pH 6.8; 200 µl 10 % 
SDS, 150 µl 10 % APS and 15 µl TEMED. Stacking gel: 4.5 ml 30 % acrylamide, 
0.6 M Tris-HCl pH 6.8; 19 ml H2O, 300 µl 10 % SDS, 150 µl 10 % APS, 15 µl 
TEMED. Up to 100 µg protein extract was run per mini-gel lane in a SDS-PAGE 
electrophoresis chamber (“Mighty-small II for 8 x 7 cm gels”, Amersham Biosciences) 
with 90 V (constant) through the stacking gel and 130 V (constant) through the 
separation gel. The running buffer consisted of 14.4 g glycine (192 mM), 3.03 g Tris 
base (25 mM), and 1 % SDS per litre. The pH was adjusted to 8.3.  
The wet transfer was performed in a vertical wet chamber (“Mini trans-blot cell”, 
Biorad) using transfer buffer (600 ml H2O, 200 ml methanol, 100 ml 10x borate buffer, 
4 ml EDTA (0.5 M), 1 ml DTT (1M)) for 5 min at 100 mA (constant), 5 min at 200 mA 
(constant), 5 min at 300 mA (constant) and 45 min at 400 mA (constant). After the 
blotting, the membrane was stained with Ponceau S for 5 min, then destained with 
water, and the blotting efficiency was determined by scanning the Ponceau S signal. 
The membrane was blocked in 5 % non-fat dried milk in 1x PBS for 1 h at room 
temperature or at 4 °C over night, then the first antibody (anti-peptide 2 from rabbit; 
dilution 1:500) was added in 5 % milk/ PBS for 1 h at room temperature. Subsequent 
washing of the membrane was performed for 3 x 10 min in blocking solution. The 
secondary antibody (goat-anti-rabbit, from Jackson Immuno Research) was added in 
a 1:10000 dilution for 30 min at room temperature. This was again followed by three 
washes in blocking solution, followed by one wash in 1x PBS/ 0.1 % Tween 20.  
ECL solution was prepared according to the manufacturers instructions and applied 
to the membrane for 1 min at room temperature. The membrane was sealed in a 
plastic bag and exposed to X-ray films (Fujifilm).  
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4.2.22 Stripping and reprobing of Western blots 
The to-be-stripped membrane was incubated twice for 1 h in 100 ml stripping buffer 
(4.5 g glycine, 3 ml 10 % SDS, 3 ml Tween 20; ad 300 ml with H2O; pH 2.2) at room 
temperature, then rinsed for another 10 min in stripping buffer at room temperature. 
Subsequently, the membrane was washed four times for 5 min in TBST, and then 
blocked for one hour in 5 % milk/PBS prior to incubation with the new first antibody.  
 
4.2.23 Pseudo-PCR 
To fill in the second strand of the single-stranded tRNA-ribozyme-oligo, 3 µl of 
template oligo (3 µM final concentration) were mixed with 6 µl 50 mM MgCl2, 10 µl 
10x PCR buffer (Rapidozym Gentherm), 3 µl T7-Primer (3 µM final concentration), 
10 µl of each dNTP (final concentration 1 mM) 36 µl H2O and 2 µl Taq polymerase 
(5 u/µl; Rapidozym, Gentherm) in a total volume of 100 µl. The reaction mixture was 
subjected to temperature cycling, which included the following steps: 1. 94 °C for 
2 min; 2. 94 °C for 30 s; 3. 54 °C for 30 s; 4. 72 °C for 30 s; 5. go to step 2 for 34 
additional cycles; 6. 72 °C for 3 min. Samples were stored at -20 °C. 
 
4.2.24 Digest of plasmids for in vitro transcription 
Some tRNAs were not encoded by a single stranded DNA template but had been 
obtained from collaborators cloned into a plasmid (see above). Prior to in vitro 
transcription, the plasmid had to be linearized right behind the tRNA sequence to 
generate a stop for the T7 polymerase. Linearization was achieved by cutting the 
plasmid (0.4 µg/µl) with 0.5 u/µl of the restriction enzyme BstNI (10 u/µl; New 
England Biolabs) in buffer NEB2 supplemented with BSA for 3 hours at 60 °C. After 
linearization, the DNA was purified via phenol-diethylether extration and precipitated 
in 0.5 M ammonium acetate and ethanol. The pellet was washed once in 80 % 
ethanol and resuspended in water.  
 
4.2.25 In vitro transcription 
Prior to transcription, a 2x “T7-Premix” was prepared, containing 400 µl 
5x Strasbourg buffer (200 mM TrisHCl, pH 8.1; 5 mM Spermidine, 25 mM DTT and 
0.05 % Triton X-100), 60 µl 1M MgCl2, 20 µl 1M DTT, 4 µl BSA [1 mg/ml], and H2O 
ad 1 ml. Also, a 5x NTP mastermix was prepared, with 25 mM each NTP. For 
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radioactive in vitro transcription, the concentration of the cold nucleotide triphosphate 
which was also added in a radioactive form, e.g. [α-32P]-CTP, was lowered to 5 mM 
- resulting in 1 mM final concentration of cold nucleotide triphosphate - while the 
other NTPs were kept constant at 5 mM final concentration in the transcription 
mixture. The transcription reaction was usually set up in a volume of 400 µl, 
containing 100 µl PCR reaction, 200 µl 2x T7-premix, 80 µl 5x NTP-mix, 10 µl T7-
polymerase (250 u/µl, Fermentas) and 10 µl H2O. For radioactive transcription, the 
reaction was supplemented with 10 – 20 µl [α-32P]-CTP (10 µCi/µl). The transcription 
reaction was incubated for 3h at 37 °C in a waterbath. Alternatively, the T7-
Megascript Kit (Ambion) was used following the manufacturer´s instructions.  
 
4.2.26 Polyacrylamide-Gel-Electrophoresis (PAGE) 
Polyacrylamide gels in various sizes and thicknesses were poured using standard 
glass plates and spacer sets. Unless indicated otherwise, 12 % denaturing 
polyacrylamide gels were used to separate tRNAs. For one 12 % polyacryamide gel, 
the glass plates were cleaned thoroughly and coated with 2 % dichlordimethylsilane 
(Fluka) in chloroform. Roughly 60 ml of 12 % stock solution (prepared from 
Rotiphorese sequencing gel buffer concentrate, acrylamide concentrate, and diluter 
(Roth)) were mixed with 500 µl 10 % APS and 100 µl TEMED and poured. After 
polymerization, the gel pockets were rinsed with 1x TBE buffer. After fitting the gel 
tightly into the gel running apparatus, the samples were loaded, and the gel was run 
in 1x TBE for two hours at 20 – 25 W (constant). To avoid overheating, the glass 
plates were cooled with a ventilator.  
 
4.2.27 Elution and precipitation of gel-purified tRNAs 
tRNA was eluted from the excised gel piece by over night incubation in 400 µl 0.5 M 
ammonium acetate. On the following day, the solution was cleared from residual gel 
fragments by centrifuging for 3 min at 2700 rpm through a Nanosep 0.45 µm 
centrifugal device (Pall Life Sciences). Precipitation of tRNA was performed by 
adding 800 µl 100 % EtOH cooled to -80 °C, incubation for 30 min at -20 °C and 
centrifugation at 13000 rpm for at least 40 min. Then the EtOH was carefully 
removed, and the pellet washed once with 80 % EtOH. After a brief drying period 
(under vacuum), the tRNA pellet was resuspended in H2O and stored at -20 °C.  
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4.2.28 Precipitation of small tRNA fragments using lithium perchlorate 
RNA fragments smaller than 15 nucleotides were precipitated using 2 % lithium 
perchlorate in acetone (2 g in 100 ml) to ensure quantitative recovery of the RNA out 
of the solution. After clearance from gel pieces by centrifugation through the column 
(see above), the RNA containing solution was divided into 100 µl aliquots in fresh 
eppendorf tubes. Per aliquot, 1 ml of lithium perchlorate/acetone solution was added, 
followed by centrifugation for at least 40 min at 13000 rpm at room temperature. Salt 
pellets were clearly visible.  
 
4.2.29 NAP5 Column Purification 
For desalting of the small precipitated radioactive RNA fragments, the pellets were 
dissolved in 100 µl H2O and purified over a NAP5 column (GE Healthcare). The 
column was equilibrated with two times 5 ml H2O (gravity flow). After addition of the 
sample, the column was washed with 400 µl H2O once, followed by two times 500 µl 
H2O. Aliquots of three drops were collected and the RNA-containing fractions 
determined by Cerenkov counting of the aliquots. The correct fractions were pooled 
and the water was evaporated using a speedvac. 
 
4.2.30 Autoradiography 
Radioactive gels and cellulose plates were exposed to luicide imaging screens 
(Amersham, GE Healthcare, Munich) in light-proof film cassettes. Scanning of the 
imaging screens was performed using the phosphoimager Typhoon 9400 
(Amersham). The images were analysed using ImageQuant software (Version 5.2).  
 
4.2.31 Liquid scintillation counting and Cerenkov counting 
Tritiated samples were spotted on whatman filters and measured by scintillation 
counting in 3 ml UltimaGold scintillation liquid (Packard) in a LS 6500 Counter 
(Beckman Coulter, Krefeld). [α-32P]-CTP labeled samples were measured without 
scintillation liquid by Cerenkov-counting.  
 
4.2.32 Magnetic Bead Experiment 
600 µl Streptavidin MagneSphereR ParaMagnetic Particles (Promega) were put into 
the magnetic rack and the supernatant removed. The magnetic beads were washed 
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twice with 600 µl solution A (100 mM NaOH, 50 mM NaCl) for 2 min at room 
temperature, then twice with 600 µl solution B (100 mM NaCl).  
To coat the magnetic particles with the biotinylated oligo via the biotin-streptavidin 
interaction, 180 µl biotinylated Oligo (30 µM end) was pipetted to 420 µl B+W-
solution (10 mM Tris-HCl pH 7.5; 1 mM Na2EDTA; 2 M NaCl) and incubated for 
20 min at 37 °C. The beads were again put into the magnetic rack, and the 
supernatant saved for reuse. The beads were washed twice for 2 min in 12x SSC 
(made from a dilution of 20x SSC in H2ODEPC) and stored in 600 µl 12x SSC at 4 °C. 
400 - 1000 µg total RNA or 50 - 100 µg of total tRNA in 600 µl H2ODEPC were heated 
for 5 min at 75 °C, as well as 600 µl of prepared magnetic beads in 12x SSC . Then 
the beads and the RNA were pooled in one tube and heated for additional 5 min at 
75 °C. After a cooling period of 40 min at room temperature, the beads were washed 
twice for 2 min with 6x SSC and then directly resuspended in 30 – 50 µl of loading 
buffer.  
 
4.2.33 Dephosphorylation 
tRNA (10 µl) isolated from Drosophila embryos mixed with 5 µl 10x BAP-buffer 
(Fermentas) and 35 µl H2O. After 5 min of incubation at 80 °C, 0.5 µl BAP enzyme 
(150 u/µl, Fermentas) was added, followed by 15 min incubation at 37 °C, 15 min at 
50 °C and 15 min at 65 °C. 
 
4.2.34 Phenol-Diethylether-Extraction 
After dephosphorylation, the enzyme was removed by a phenol-diethylether 
extraction. 50 µl reaction mix were added to 50 µl Roti-Aqua-Phenol (Roth), vortexed 
and centrifuged for 3 min at 3000 rpm. The aqueous phase was removed and the 
extraction repeated with another 50 µl phenol. After centrifugation, the aqueous 
phase was added to 150 µl diethylether (saturated with water). After vortexing, the 
mixture was centrifuged for 3 min at 3000 rpm. The diethylether-extraction-step was 
repeated once as well. The aqueous phase was transferred into a new reaction tube 
and 100 µl 100 % EtOH (-80 °C) were added. Precipitation of the tRNA was 
performed over night at -20 °C. 
Material and Methods 
 
  118  
4.2.35 End-Labeling 
5´-Endlabeling with [γ-32P]-ATP was performed with polynucleotide kinase 
(Fermentas). 14 µl tRNA in H2O were incubated with 2 µl buffer A (Fermentas), 2 µl 
[γ-32P]-ATP (10 µCi/µl) and 2 µl PNK (10 u/µl, Fermentas) for one hour at 37 °C in a 
waterbath. 
 
4.2.36 OH--Ladder 
1 µl tRNA (3000 – 20000 cpm) was incubated with 1 µl total tRNA from E. coli 
(10 µg/µl) and 8 µl NaHCO3 (pH 9) for 10 min at 90 °C, then immediately put on ice 
for 2 min and afterwards mixed with 10 µl Pb-Stop-solution. 
 
4.2.37 T1-Digest 
1 µl tRNA (3000 – 20000 cpm) was incubated with 1 µl tRNA E.coli (10 µg/µl) and 
8 µl T1-Puffer (40 mM Tris-HCl pH 7.5; 40 mM NaCl; 10 mM MgCl2) for 10 min at 
55 °C. 2 µl T1-RNase (several dilutions; 0.1 – 0.001 units, Gibco) were added, 
followed by 10 min incubation at 55 °C. After cooling on ice for 2 min, 10 µl Pb-Stop-
solution were added.  
 
4.2.38 DNAzyme experiment and subsequent quantitative end-labeling 
Appropriate amounts of tRNA (depending on the experiment from 60 ng to several 
micrograms) were mixed with a 5 - 10 molar excess of DNAzyme, 5 µl 5x buffer 
(250 mM TrisCl pH 7.5; 750 mM KCl, and 50 mM MgCl2), and H2O to an end volume 
of 25 µl. The tRNA was cut by the DNAzyme during 15 – 20 cycles of incubation at 
80 °C for 2 min, controlled cooling to 37 °C by 0.3 °C/sec, and 5 min at 37 °C. After 
that, 32P-labeled tRNA was loaded directly onto a 12 % polyacrylamide gel. 
Unlabeled tRNA was end-labeled quantitatively by directly adding 2.5 µl buffer A 
(Fermentas), 1 µl  [γ-32P]-ATP (10 µCi), 2.5 µl non-radioactive ATP (100 µM), 18 µl 
H2O and 1 µl PNK (10 u/µl, Fermentas) and incubating the reaction for 1 h at 37 °C in 
a waterbath. DNAzyme was afterwards removed by the addition of 1 µl Dnase I 
(50 u/µl, Fermentas) for 30 min at 37 °C. The end-labeling reaction was then gel-
purified. 
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4.2.39 P1-Digest 
4 µl tRNA in H2O were mixed with 1 µl total tRNA of E. coli (10 µg/µl), 1 µl 5 mM 
ZnCl, 1 µl 0.2 M NaOAc pH 5.5 and 3 µl P1 (0.3 u/µl Roche), in a total volume of 
10 µl. The reaction mixture was incubated for 2 h at 50 °C. 
 
4.2.40 TLC (Thin-Layer-Chromatography) 
Two-dimensional TLC was carried out on 20 x 10 cm cellulose F plates (Merck). 
1 - 1.5 µl of a P1 digest were spotted. After drying, the first (20 cm) dimension 
(solvent A: isobutyric acid/ 25 % ammonium solution/ H2O (70/ 1.1/ 28.9: v/v/v)) was 
run over night. After complete drying of the cellulose plate, the second dimension 
was run in solvent B (0.1 M sodium phosphate pH 6.8/ ammonium sulphate/ 
1-propanol (100/60/2; v/p/v)) for 5 – 6 h. The cellulose plate was dried and exposed 
to a luicide imaging screen (Amersham).  
 
4.2.41 Drosophila S2R+ cell culture 
Stably Flag-Dnmt2 transfected S2R+ cells (a gift of Dr. Matthias Schaefer) were 
cultured in Schneider´s medium supplemented with penicillin (1000 u/ml), 
streptomycin (100 µg/ml) and 10 % FCS. To ensure the stable expression of the 
transfected sequences, blasticidin was added as a selection reagent at a final 
concentration of 2.5 µg/ml. Cells were splitted once a week in 75 cm2 – 175 cm2 
flasks in a 1:5 to 1:10 ratio. Briefly, cells were detached from the flask bottom by 
gentle rinsing with a 10 ml pipette. Since the cells are only semi-adherent, the 
addition of trypsin was not necessary. To pellet, cells were centrifuged for 3 min at 
130 g. The debris containing supernatant was removed, fresh medium was added in 
an appropriate volume, and cells were plated in a new flask. The cells were 
incubated at 25 °C in an incubator or at room temperature.  
 
4.2.42 Preparation of Drosophila cell extracts and immunoprecipitation of Flag-
Dnmt2 
Cells were grown in Schneider´s Medium which had been supplemented with 
penicillin (1000U/ml), streptomycin (100 µg/ml), 10 % FCS and blasticidine as 
described above. Protein expression was achieved by adding CuSO4 (1 mM stock) to 
a final concentration of 1 µM for 72 h. After the induction period, the cells were 
collected into a 50 ml Falcon tube using a cell scraper and centrifuged at 150 g for 
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10 min at 4 °C. The cells were once suspended in 10 ml ice-cold PBS, a 500 µl 
aliquot was taken for cell count determination, and the cells were spun a second time 
at 150 g for 10 min at 4 °C.  
PBS was removed and the cells were resuspended in 1 ml hypotonic buffer A 
(10 mM HEPES pH 7.9; 10 mM KCl; 340 mM Sucrose; 1.5 mM MgCl2; 1 mM DTT; 
10 % glycerol; proteinase inhibitor cocktail (from Roche; 1 tablet per 15 ml); 
1 mM PMSF), transferred to an eppendorf tube and incubated on ice for 10 min for 
swelling. The cells were broken open by drawing them 10 times through a syringe, 
using a hypodermic needle (25 G); next Triton X-100 was added to a final 
concentration of 0.1 %. For continued lysis, the cells were rotated at 4 °C for 15 min, 
then centrifuged at 480 g for 9 min at 4 °C to remove cell debris. The supernatant 
was transferred into a new tube and again spun down at 1300 g for 5 min at 4 °C 
(this step separated intact nuclei from cytosol). Again the supernatant was 
transferred and centrifuged at 16100 g for 30 min at 4 °C. 50 µl of the supernatant 
were taken as an input control for Western analysis as well as for Bradford protein 
measurement.  
The anti-FLAG M2 affinity gel resin (Sigma) was thoroughly resuspended to form a 
uniform 50 % slurry. Per ml protein extract, 60 – 70 µl slurry was used. The aliquoted 
resin was centrifuged at 8200 g for 30 s and let to settle for 1 - 2 min. The 
supernatant was carefully removed, and the packed gel was washed twice for 5 min 
at RT with 0.5 ml TBS with constant rotation. Following centrifugation and 
supernatant removal, the resin was equilibrated by washing it once with 0.5 ml 
buffer A. For immunoprecipitation, the protein extract was added to the resin-
containing tubes and rotated at 4 °C over night. Next, the resin was centrifuged at 
8200 g to remove the supernatant, and the beads were washed five times for 5 min 
with 0.5 ml buffer A at 4 °C. The washing was repeated once with 0.5 ml tRNA-MT 
assay buffer (100 mM Tris pH 8.0; 100 mM NH4OAc; 10 mM DTT (freshly added), 
0.1 mM EDTA; 10 mM MgCl2) at 4 °C. The supernatant was removed completely. To 
elute the FLAG-Dnmt2-protein from the resin, 3 µl of a 5 µg/µl 3x FLAG peptide stock 
solution were added to 100 µl tRNA-MT assay buffer. 100 µl of this elution solution 
were added to each tube of resin, and the samples were incubated with gentle 
shaking at 25 °C for 15 min. The resin was spun down for 30 s at 8200 g. The 
protein-containing supernatant was transferred to a new reaction tube, supplemented 
with 50 % glycerol, and stored at -20 °C. 
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4.2.43 Preparation of recombinant, His-tagged hDnmt2  
The plasmid pET28a(+) containing His-tagged, human Dnmt2 gene was a gift from 
Tomek Jurkowski (Jacobs University Bremen; Hermann et al., 2003; Jurkowski et al., 
2008). 200 µl of E. coli (DE3) Rosetta 2 pLysS cells (Novagen) were transformed 
with 50 ng of the plasmid as follows: Cells were carefully thawed on ice, mixed with 
the plasmid DNA and incubated on ice for 5 min. After a 30 s heat shock at 42 °C, 
cells were again incubated on ice for 2 min, followed by the addition of 300 µl SOC-
medium. Expression of the resistance genes was allowed for one hour by constant 
shaking at 37 °C. Aliquots ranging from 50 to 150 µl were spread on kanamycin/ 
chloramphenicol-containing LB-agar plates. The concentration for kanamycin was 50 
µg/ml; for chloramphenicol 170 µg/ml. On the next day, a single colony was picked 
and an over night culture was prepared in 10 ml LB medium supplemented with 
kanamycin and chloramphenicol (same antibiotics concentration as above) under 
constant shaking at 220 rpm at 37 °C over night. A large-scale culture (250 – 500 ml) 
was inoculated with the over night culture and grown to an optical density of 0.6. 
Then, the culture was induced with 1 mM IPTG (final concentration) and grown for an 
additional three hours. The bacteria were harvested by centrifugation for 20 min at 
4000 g. Purification of the recombinant protein was performed according to the 
protocol of the Qiaexpress Ni-NTA fast start kit (Qiagen). Briefly, the cells were lysed 
under native conditions, cell debris was removed by centrifugation and the cleared 
supernatant poured over a Ni-NTA column. After washing with the supplied wash 
buffer, the hDnmt2 protein was eluted with the elution buffer supplied with the kit in 
4 x 0.5 ml aliquots. The aliquots containing the highest protein concentration were 
pooled and dialyzed in a 2 l volume of dialysis buffer 1 for two hours, then in 2 l of 
dialysis buffer 2 over night.  
 
4.2.44 In vitro methylation assay 
The in vitro methylation assay measures the transfer of a tritiated methyl group from 
its donor S-adenosyl-methionine (SAM) onto the target tRNA, which is catalyzed by 
m5C methyltransferases. The tRNA is precipitated on small filters and the radioactive 
signal counted in a scintillation counter. The standard reaction volume was 40 µl. 
Unless stated otherwise, 120 pmol tRNA were diluted in water and heated to 80 °C 
for 2 min. tRNA-MT-assay buffer and DTT were added immediately to final 
concentrations of 100 mM Tris-HCl pH 8.0; 100 mM NH4OAc; 0.1 mM EDTA, 10 mM 
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MgCl2 and 10 mM DTT. 3H-SAM-Stock solution (10x; containing cold and 3H-SAM) 
was added to a final concentration of 20 µM SAM and 1 µCi per sample. After 2 min 
incubation at 37 °C, the enzyme of interest was added to final concentrations of 0.5 – 
1 µM and mixed well by pipetting. After 140 min, the reaction was spotted onto small 
whatman filters and precipitated in 5 % ice-cold TCA, followed by two washes for 
10 min in 5 % TCA on ice. Then the filters were swirled in EtOH. After drying, the 
incorporated tritium signal was measured by liquid scintillation counting. One 
microliter of the 10x SAM-stock solution was also spotted in duplicate. 
 
4.2.45 Visualisation of gel shifts on native (non-denaturing) Gels 
Native gels were poured by diluting 19:1 acrylamide: bisacrylamide solution 
(corresponding to 40 %) in 0.5x TBE to 8 %. Polymerization was achieved by the 
addition of 400 µl 10 % APS and 80 µl TEMED. Gels were prerun for 1 h at 8 – 10 W 
in 0.5x TBE at 4 °C. Samples were mixed with native gel loading buffer prior to 
loading. After the samples had run into the gel at 10 W, the gel was run over night at 
75 V (constant) in the cold room. 
 
4.2.46 Splint Ligation of mouse tRNAAsp containing either C, m5C or F5C at C38
RNA oligos can be ligated to a full length tRNA molecule with the help of a DNA 
splint. The ligation of mouse tRNAAsp was essentially performed as described in 
(Kurschat et al., 2005). Prior to ligation, the oligo comprising the middle part of the 
tRNA was phosphorylated. 3000 pmol oligo MH353 (or MH354 or MH355) were 
incubated in 50 mM TrisHCl pH 7.4; 10 mM MgCl2 final concentration (pipetted as 
5 µl 5x KL-buffer), 5 mM ATP and 5 mM DTT, as well as 3.75 µl PNK (Fermentas, 
10 u/µl) in a total volume of 40 µl for one hour at 37 °C. Next, 3000 pmol of the 5´-
oligo (MH352) and of the 3´-oligo (MH356) were added, together with 10 µl 5x KL 
buffer, 30 µl DNA splint (oligo MH117; final concentration 10 µM), 2.5 µl 100 mM ATP 
and 2.5 µl 100 mM DTT to a total volume of 91 µl. The reaction mixture was 
incubated first for 5 min at 75 °C, then for 15 min at room temperature. 10 µl of T4 
DNA Ligase (30 weiss units/µl; Fermentas) were added, and the reaction incubated 
over night at 16 °C. On the next day, the DNA splint was digested with 300 weiss 
units of Dnase I (Fermentas; 30 weiss units/µl). The ligated tRNA was then purified 
via denaturing PAGE.
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